News from Virtual Press Office

The Award Winning TAKEYA Tea Maker Now Available Nationwide Brews, Serves, Stores Fresh Tea

Wed, 16 May 2012 13:13:36 -0400

The TAKEYA® Flash Chill™ Iced Tea Maker Set A Practical Gift for Father's Day Under $40

Wed, 16 May 2012 13:11:48 -0400

TAKEYA® PRESENTS PRODUCTS TO ENHANCE THE AT HOME TEA EXPERIENCE

Wed, 16 May 2012 13:09:28 -0400

Concur to Present at the 40th Annual J.P. Morgan Global Technology, Media and Telecom Conference

Mon, 14 May 2012 19:00:00 -0400

May 14, 2012 19:00 ET

Concur to Present at the 40th Annual J.P. Morgan Global Technology, Media and Telecom Conference

REDMOND, Wash., May 14, 2012 /PRNewswire/ -- Concur (NASDAQ: CNQR), a leading provider of integrated travel and expense management solutions, today announced that Concur chairman and CEO Steve Singh will deliver a presentation on behalf of the company at the 40th Annual J.P. Morgan Global Technology, Media and Telecom Conference, on Wednesday, May 16 at 1:30 p.m. ET at The Westin Boston Waterfront Hotel. The live webcast and replay of the presentation will be available for a limited time at http://www.concur.com/en-us/investors.

About Concur
Concur is a leading provider of integrated travel and expense management solutions. Concur's easy-to-use Web-based and mobile solutions help companies and their employees control costs and save time. Concur Connect is the platform that enables the entire travel and expense ecosystem of customers, suppliers, and developers to access and extend Concur's T&E cloud. Concur's systems adapt to individual employee preferences and scale to meet the needs of companies from small to large. Learn more at www.concur.com.

SOURCE Concur

RAUSCH CREATES A DRINKING CHOCOLATE FIRST

Fri, 18 May 2012 15:07:05 -0400

CARL BRANDT MARKS 100TH ANNIVERSARY YEARS OF GROWTH AND ACCOMPLISHMENT

Fri, 18 May 2012 15:01:11 -0400

CARL BRANDT OFFERS NEW MICRO MINIS

Fri, 18 May 2012 14:58:30 -0400

NIEDEREGGER MARZIPAN DEBUTS WHITE BOXED SERIES

Fri, 18 May 2012 14:49:59 -0400

Mountain Valley Spring 2012 Summer Fancy Food Show Press Kit

Thu, 17 May 2012 17:15:10 -0400

Keeping it Fresh: Natural Ingredients, Classic Southern Recipes and Homemade Baking Make Up The Sweetery's Recipe for Success

Thu, 17 May 2012 11:52:43 -0400

For Immediate Release
May 17, 2012

Contact:
Ryan Jarahian
864-276-7969
ryjarahian@gmail.com

Keeping it Fresh: Natural Ingredients, Classic Southern Recipes and Homemade Baking Make Up The Sweetery’s Recipe for Success
ANDERSON, SC – (Virtual Press Office) - For 30 years, The Sweetery, a South Carolina dessert retailer (http://www.thesweetery.com), has been delighting the taste buds of customers near and far with homemade baked goods made fresh each day and served locally or shipped nationwide. Mother and son Jane and Ryan Jarahian offer the perfect blend of traditional recipes from grandma’s kitchen, along with exciting new creations to satisfy today’s tastes. All are made by hand with no preservatives, using the freshest natural ingredients available.

“We specialize in classic Southern recipes, many of which are more than a century old,” said Jane Jarahian. “Some were passed down through my family and some were obtained from friends. Just today, we had a customer bring in a selection of her favorite recipes for us to consider.”

Jarahian opened The Sweetery three decades ago in her hometown of Anderson, S.C. Having baked all her life as a hobby, she knew that mass-produced baked goods could never equal the flavor of confections mixed by hand and made with fresh ingredients. She began in the early 80s by supplying homemade desserts to local restaurants and stores. The sweet treats were so popular, Jarahian soon opened her own shop, The Sweetery, and began selling directly to the public. The Sweetery also offers daily lunch options, made fresh to order, along with take-home entrees and casseroles.

“Among our most popular desserts are Strawberry Cake, Brownies & Cream, our famous ‘Uggly Cake’ and our newly-created Sangria Pound Cake, a delicious swirl of strawberry, orange and grape cake finished with a red wine glaze,” she said.

Eight years ago, son Ryan became the family’s newest “Cake Whisperer”, following an apprenticeship with Master Baker Wallace Grantland. Ryan brought his own dessert ideas to The Sweetery, and also began developing new lunch entrees and take-home casseroles for The Sweetery’s deli.

“You could say I have sugar in my blood,” said Ryan. “I have a good idea of what appeals to young adults and I love adding fanciful twists to traditional recipes. “My favorite creation has been the Roxi’s Citrus Sensation Cake, named after my daughter. It’s a layer of key lime cake, a layer of orange cake and a layer of pink lemonade cake stacked together and surrounded with our Citrus Cream Cheese Frosting. We’ve also developed The Sweetery’s Cake Croutons which are sweet versions of traditional croutons and are perfect as snacks and ice cream and hot chocolate toppers.”

The Sweetery will bring its popular new Wine Sticks to the 2012 Summer Fancy Food Show in Washington, DC. “We will premier our newest Wine Sticks flavor, Goldbar, a blend of popular spices, at the show. The original three flavors of this crunchy, cracker alternative are Chocolate, Apple and Cinnamon Espresso. “The Chocolate Sticks are an ideal match for red wines, Apple Sticks are great with whites and Cinnamon Espresso Sticks go with any wine, as well as coffee and tea. Our customers also love to match them with their favorite cheese or sweet dips and spreads like The Sweetery’s homemade pimento cheese,” Ryan said.

Obviously, everyone isn’t fortunate enough to live in or pass through the friendly town of Anderson, S.C., so The Sweetery ships many of its creations to all 50 states. Each item is carefully hand-packaged to preserve its fresh taste before being boxed and sent via UPS. Always the proper Southern lady, Jane likes to tell her customers “If you want to pretend you made the dessert yourself, then that will just be our little secret.”

And, to ensure continuity at this family business, Ryan is already bringing the sweetest thing in his life, young daughter Roxi, to work where she can make sure Daddy stays busy and taste all of her grandmother’s desserts. “I think she’s going to be a great help in the kitchen, once she’s old enough to see over the counter,” says her proud father.

The Sweetery is a member of the National Retail Bakery Association, the National Association of Specialty Foods, the South Carolina Specialty Food Association and several local business organizations. For more information call 800-752-1188 or visit http://www.thesweetery.com. Visitors can also see what’s going on in the kitchen by clicking on The Sweetery’s Facebook page or following the Sweetery on Twitter.

# # #

Belly Up to the Booth to Try The Sweetery's Unique Confection, Wine Sticks, At the Fancy Food Show June 17-19

Thu, 17 May 2012 11:46:11 -0400

For Immediate Release
May 17, 2012

Contact:
Ryan Jarahian
864-276-7969
ryjarahian@gmail.com

Belly Up to the Booth to Try The Sweetery’s Unique Confection, Wine Sticks, At the Fancy Food Show June 17-19

Chocolate, Apple, Cinnamon Espresso and Newest Flavor, Goldbar Wine Sticks, Pair Perfectly with Red and White Wines, as well as Dips and Spreads
ANDERSON, SC – (Virtual Press Office) - Georgia may have Paula Deen & Sons, but South Carolina can boast its own mother-son culinary duo: Jane and Ryan Jarahian. Jane began her homemade baked goods business, The Sweetery (http://www.thesweetery.com), over 30 years ago in her hometown of Anderson, S.C. Son Ryan joined the family business eight years ago, expanding its product line and growing the company’s local restaurant offerings and nationwide shipping business. The kitchen kinfolk will bring one of their most popular original products, Chocolate, Apple and Cinnamon Espresso Wine Sticks, to the Summer Fancy Food Show, June 17-19, in Washington, DC, and will offer samples with wine pairings and dips in booth # 3327A. At the show, the Sweetery will premier its newest Wine Stick flavor, Goldbar. The flavor is a blend of popular spices that, when combined, create a completely different taste that can be paired with sweet white wines as well as a few red wines.

“Wine Sticks are among The Sweetery’s most popular and versatile creations,” said Ryan Jarahian. “These cracker alternatives are crunchy, flavorful treats created to be paired with beverages and spreads. The Chocolate Wine Sticks are an ideal match for red wines, while the Apple Wine Sticks were created to enjoy with whites. Cinnamon Espresso Wine Sticks pair beautifully with any glass of wine, but they are especially tasty with a cup of coffee or tea. Our new Goldbar Wine Sticks work with sweet white wines, reds and especially well with cheeses, dips and spreads.”

Added Jane Jarahian, “It’s fun to see the combinations our customers come up with. My own favorite is Apple Wine Sticks paired with The Sweetery’s homemade Pimento Cheese and a glass of Riesling.”

While The Sweetery’s products are popular with today’s consumers, the creation process is decidedly old-fashioned. “We make everything by hand, using time-tested recipes and the freshest natural ingredients available,” said Jane Jarahian. “Ryan and I oversee all operations and new recipe creations, and we also use recipes that have been in our family and families of friends for many decades. We give our customers a taste of homemade goodness they may remember from the mother’s, grandmother’s or even great-grandmother’s kitchens.”

In addition to the baked goods business, The Sweetery operates a charming restaurant in Anderson, S.C. open Monday-Saturday for lunch, and also offering take-home dishes and casseroles in addition to the cakes, pies, brownies and Wine Sticks for which the bakery is famous.

For those that are not fortunate enough to live near Anderson, S.C. or are unable to pass through the friendly town, The Sweetery ships its products to all 50 states. Each item is carefully hand – packaged to preserve its fresh taste before being sent via UPS. And just to ensure the family business continues well into the future, Ryan is already bringing one-year-old daughter Roxi to work where she can make sure her father stays busy and taste all of his and her grandmother’s desserts. “I think she’s going to be a great help in the kitchen once she’s old enough to see over the counter,” says her proud father. “She already has no problem telling me what to do!”

The Sweetery is a member of the National Retail Bakery Association, the National Association of Specialty Foods, the South Carolina Specialty Food Association and several local business organizations. For more information call 800-752-1188 or visit http://www.thesweetery.com. Visitors can also see what’s going on in the kitchen by clicking on The Sweetery’s Facebook page or following the Sweetery on Twitter.

The National Association for the Specialty Food Trade presents the Summer Fancy Food Show, North America’s Largest Specialty Food & Beverage Event. The Summer Show will be held June 17-18 at the Walter E. Washington Convention Center in Washington, DC. Nearly 180,000 products will be showcased including confections, cheese, coffee, snacks, spices, ethnic, natural, organic and more. Over 2,400 exhibitors from 80 countries and 24,000 attendees are expected to participate. http://www.specialtyfood.com/fancy-food-show/summer-fancy-food-show

# # #

Béquet Confections to Introduce Cinnamon Swirl Caramel at 2012 Summer Fancy Food Show (Booth #5544)

Wed, 16 May 2012 16:52:52 -0400

Venus Wafers launches Non-GMO certified Water Cracker

Wed, 16 May 2012 12:27:03 -0400

May 16, 2012

For information, please contact:
Michael Thompson, Venus Wafers, Inc.
800-545-4538 • mthompson@venuswafers.com

Venus Wafers launches Non-GMO certified Water Cracker
Hingham, MA

(Virtual Press Office) - Venus Wafers announced today that they will be launching Non-GMO certified water crackers under their The Original Mariner Biscuit Company brand. Venus has received authority from the Non-GMO Project to display their seal of approval on the newly developed packaging for this new and expanded range. The Non-GMO Project offers North America’s only independent verification for products made according to best practices for GMO avoidance.

GMO’s (Genetically Modified Organisms) have been linked to potential harmful affects to health and the environment. “We care deeply about this issue and we believe people have the right to know what they are eating,” said Venus Wafers President Michael Thompson. Thompson went on to say, “the re-launch of our Mariner Biscuit brand is just the first step in gaining Non-GMO certification for all of Venus Wafers’ family brands. We are committed to being a Non-GMO commercial bakery.”

The Mariner Biscuit Company Water Crackers have also been verified Vegan by the Vegan Action/Vegan Awareness Foundation and certified Kosher by the Orthodox Union and will carry both of these symbols as well..

About Venus Wafers

Since 1931, family-owned and operated Venus Wafers has pioneered healthful crackers and flatbreads to meet the changing tastes of convenience-driven consumers. From their founder’s first product more than 80 years ago, a 100% whole wheat wafer bread, through their all natural Nejaime’s Lavasch, USDA organic 8 grain flatbreads and Haute Cuisine gourmet crackers, Venus has always strived to bake great ingredients into a variety of shapes and sizes and package them in an appealing fashion.

Venus Wafers launches Non-GMO certified Stoned Wheat crackers

Wed, 16 May 2012 12:22:44 -0400

May 16, 2012

For information, please contact:
Michael Thompson, Venus Wafers, Inc.
800-545-4538 • mthompson@venuswafers.com

Venus Wafers launches Non-GMO certified Stoned Wheat crackers
Hingham, MA

(Virtual Press Office) - Venus Wafers announced today that they will be launching Non-GMO certified stoned wheat crackers under their The Original Mariner Biscuit Company brand. Venus has received authority from the Non-GMO Project to display their seal of approval on the newly developed packaging for this new and expanded range. The Non-GMO Project offers North America’s only independent verification for products made according to best practices for GMO avoidance.

GMO’s (Genetically Modified Organisms) have been linked to potential harmful affects to health and the environment. “We care deeply about this issue and we believe people have the right to know what they are eating,” said Venus Wafers President Michael Thompson. Thompson went on to say, “the re-launch of our Mariner water crackers earlier this year was well received and we are convinced that adding stoned wheat crackers to this Non-GMO range will further enhance its appeal. We are committed to being a Non-GMO commercial bakery.”

The Mariner Biscuit Company Stoned Wheat Crackers have also been verified Vegan by the Vegan Action/Vegan Awareness Foundation and certified Kosher by the Orthodox Union. The new packaging carries both of these symbols as well.

About Venus Wafers

Since 1931, family-owned and operated Venus Wafers has pioneered healthful crackers and flatbreads to meet the changing tastes of convenience-driven consumers. From their founder’s first product more than 80 years ago, a 100% whole wheat wafer bread, through their all natural Nejaime’s Lavasch, Venus 8 grain crackers and Haute Cuisine gourmet crackers, Venus has always strived to bake great ingredients into a variety of shapes and sizes and package them in an appealing fashion.

Coach Farm to Unveil Trimmed Down Goat Milk Yogurt at Summer Fancy Food

Tue, 15 May 2012 14:22:17 -0400

Busy Bee Apiaries partners with Sitti Restaurant to Bring rooftop Honeybees to Downtown Raleigh

Mon, 14 May 2012 17:32:21 -0400

Cadbury Cookies Expanded Gift Assortment

Mon, 14 May 2012 15:41:10 -0400

Cadbury Cookies are now Kosher

Mon, 14 May 2012 15:28:33 -0400

Acme Import Co. announces the addition of Coronet Danish Cookies

Mon, 14 May 2012 15:17:08 -0400

Deceuninck North America Unveils Genius, World's First Interlinked Ultra-Performance Window, During AIA 2012 National Convention and Expo

Thu, 17 May 2012 10:00:00 -0400

MONROE, Ohio, May 17, 2012 /PRNewswire/ -- Deceuninck North America, a leading designer and manufacturer of high-quality systems for windows, doors, and outdoor living, is changing the conversation regarding innovation and sustainability with the launch of the Genius™ system, the world's first interlinked dual sash window that enables thermal performance values exceeding R-14 without the use of exotic films or gasses. With these exceptional thermal capabilities, Genius™ becomes one of the most energy-efficient window systems available on the market today.

(Photo: http://photos.prnewswire.com/prnh/20110214/NE47651LOGO)

Deceuninck unveiled the new window system at a news conference during the American Institute of Architects (AIA) 2012 National Convention and Expo (May 17-19, Washington, D.C.). The company was also showcasing some of its other recent innovations at an exhibitor booth during the show (#4031 in the Walter E. Washington Convention Center).

"Innovation is at the forefront of our business, and the Genius system is destined to be one of the most innovative products in the fenestration industry today," said Filip Geeraert, president and CEO of Deceuninck North America. "It is the epitome of form meeting function."

The patent-pending window system is designed with two separate, interlinked insulated glass sashes. This creates an additional bonus air space between the two sash members and results in an extremely effective barrier to thermal energy flow. In addition, a unique thermal-activated ventilation system serves as an integral part of the window's design, turning Genius into an energy generator by automatically venting solar-heated air into the building interior in the winter and venting it to the outside in the summer.

Beyond its advanced thermal efficiency, the innovative design of Genius provides for ease of operation, extreme structural wind load resistance (range of DP-130 or more), exceptional sound transmission reduction in the range of low 50s in STC (Sound Transmission Class) ratings, and superior resistance to water and air infiltration.

"We selected the AIA Convention and Expo to unveil the Genius system because architects attending the show were looking for the latest innovations that can take their future building projects to the next level," added Geeraert. "In our view, Genius has now reset the bar for window systems in terms of thermal performance and functionality."

The AIA 2012 National Convention and Expo brought together thousands of architects from across the nation, and is the architectural industry's most comprehensive event each year. Attendees got the opportunity to network, attend professional development and education events, and obtain a first glimpse at some of the latest products and technologies in the industry.

About Deceuninck

Deceuninck® North America, LLC is part of the Deceuninck® Group, an integrated global organization specializing in compounding, tool fabrication, design, development, extrusion, finishing of PVC-U window systems and composite applications for the building industry. The company is active in more than 75 countries, has 35 subsidiaries (production and/or sales), and is supported by over 2,800 personnel worldwide. In 2010, Deceuninck Group achieved consolidated sales of $706 million worldwide. Deceuninck® North America encompasses fully-integrated design, compounding, tooling, extrusion and quality assurance disciplines for the production of vinyl window and door systems and composite applications for the building industry at its corporate headquarters in Monroe, Ohio. For more information, please visit: www.deceuninck-americas.com.

Contact:
Jeff Donaldson
412-642-7700
jeff.donaldson@elias-savion.com

SOURCE Deceuninck North America

ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting

Fri, 18 May 2012 08:00:00 -0400

May 18, 2012 08:00 ET

ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting

Note: This release corresponds to ASCO abstracts LBA 4518, 4521, 4556 and 4558

RARITAN, N.J., May 18, 2012 /PRNewswire/ -- Data related to ZYTIGA® (abiraterone acetate) clinical studies have been selected for presentation at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO). Additionally, data regarding the investigational compounds ibrutinib and siltuximab also have been accepted for presentation. Additional abstracts were also accepted as publication-only or in the trial in progress category. These studies were sponsored by Janssen Research & Development, LLC.

"The depth and breadth of data sponsored by Janssen Research & Development that will be presented at this year's ASCO Annual Meeting will add important scientific insight in a number of key oncology disease states," said William N. Hait, M.D., Ph.D., Global Head, Janssen R&D and Head, Oncology Therapeutic Area. "These data presentations demonstrate our ongoing commitment to furthering the understanding of our compounds in a number of hematology and oncology settings."

The following ZYTIGA clinical study abstracts have been selected for presentation:

Interim analysis (IA) results of COU-AA-302, a randomized, phase 3 study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) (Abstract LBA 4518)
Clinical Science Symposium: New Paradigms for Hormone Therapy in Prostate Cancer, Saturday, June 2, 8:00 – 8:15 a.m., E. Arie Crown Theater

Lead Author: C.J. Ryan, M.D., Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA

Effect of neoadjuvant abiraterone acetate (AA) plus leuprolide acetate (LHRHa) on PSA, pathological complete response (pCR) and near pCR in localized high-risk prostate cancer (LHRPC): Results of a randomized phase 2 study (Abstract 4521)
Clinical Science Symposium: New Paradigms for Hormone Therapy in Prostate Cancer, Saturday, June 2, 9:10 – 9:20 a.m., E. Arie Crown Theater

Lead Author: M.-E. Taplin, M.D., Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA

Exploratory analysis of survival benefit and prior docetaxel (D) treatment in COU-AA-301, a phase 3 study of abiraterone acetate (AA) plus prednisone (P) in metastatic castration-resistant prostate cancer (mCRPC) (Abstract 4558)
Poster Discussion Session: Genitourinary (Prostate) Cancer, Monday, June 4, 8:00 a.m. – 12:00 p.m., E450a, Poster Board #12

Lead Author: O.B. Goodman, Jr, M.D., Ph.D., Nevada Cancer Institute, Las Vegas, NV

Cytoreduction and androgen signaling modulation by abiraterone acetate (AA) plus leuprolide acetate (LHRHa) vs LHRHa in localized high-risk prostate cancer (PCa): Preliminary results of a randomized preoperative study (Abstract 4556)
Poster Discussion Session: Genitourinary (Prostate) Cancer, Monday, June 4, 8:00 a.m. – 12:00 p.m., E450a, Poster Board #10

Lead Author: E. Efstathiou, M.D., Ph.D., David H Koch Center for Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; University of Athens, Athens, Greece

About ZYTIGA
"Since its first approval in the U.S. in 2011, ZYTIGA has been approved in more than 40 additional countries, many thousands of men have received treatment with it, and it is quickly becoming one of the cornerstones of our oncology offerings," said Hait.

ZYTIGA in combination with prednisone was approved by the U.S. Food and Drug Administration (FDA) in April 2011 for the treatment of men with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel. The Phase 3 study for this initial ZYTIGA indication was unblinded in August 2010, based on results from a planned interim analysis showing a statistically significant improvement in overall survival and an acceptable safety profile. A subsequent analysis with more mature data confirmed the survival benefit and safety profile.

For more information about ZYTIGA, visit www.ZYTIGA.com.

Indication
ZYTIGA® (abiraterone acetate) in combination with prednisone is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC) who have received prior chemotherapy containing docetaxel.

Important Safety Information

Contraindications - ZYTIGA® (abiraterone acetate) may cause fetal harm (Pregnancy Category X) and is contraindicated in women who are or may become pregnant.

Hypertension, Hypokalemia and Fluid Retention Due to Mineralocorticoid Excess - Use with caution in patients with a history of cardiovascular disease or with medical conditions that might be compromised by increases in hypertension, hypokalemia, and fluid retention. ZYTIGA® may cause hypertension, hypokalemia, and fluid retention as a consequence of increased mineralocorticoid levels resulting from CYP17 inhibition. Safety has not been established in patients with LVEF less than 50% or New York Heart Association (NYHA) Class III or IV heart failure because these patients were excluded from the randomized clinical trial. Control hypertension and correct hypokalemia before and during treatment.

Monitor blood pressure, serum potassium, and symptoms of fluid retention at least monthly.

Adrenocortical Insufficiency (AI) - AI has been reported in clinical trials in patients receiving ZYTIGA® in combination with prednisone, after an interruption of daily steroids and/or with concurrent infection or stress. Use caution and monitor for symptoms and signs of AI if prednisone is stopped or withdrawn, if prednisone dose is reduced, or if the patient experiences unusual stress. Symptoms and signs of AI may be masked by adverse reactions associated with mineralocorticoid excess seen in patients treated with ZYTIGA®. Perform appropriate tests, if indicated, to confirm AI. Increased dosages of corticosteroids may be used before, during, and after stressful situations.

Hepatotoxicity - Increases in liver enzymes have led to drug interruption, dose modification, and/or discontinuation. Monitor liver function and modify, withhold, or discontinue ZYTIGA® dosing as recommended (see Prescribing Information for more information). Measure serum transaminases [alanine aminotransferase (ALT) and aspartate aminotransferase (AST)] and bilirubin levels prior to starting treatment with ZYTIGA®, every two weeks for the first three months of treatment, and monthly thereafter. Promptly measure serum total bilirubin, AST, and ALT if clinical symptoms or signs suggestive of hepatotoxicity develop. Elevations of AST, ALT, or bilirubin from the patient's baseline should prompt more frequent monitoring. If at any time AST or ALT rise above five times the upper limit of normal (ULN) or the bilirubin rises above three times the ULN, interrupt ZYTIGA® treatment and closely monitor liver function.

Food Effect - ZYTIGA® must be taken on an empty stomach. Exposure of abiraterone increases up to 10-fold when abiraterone acetate is taken with meals. No food should be eaten for at least two hours before the dose of ZYTIGA® is taken and for at least one hour after the dose of ZYTIGA® is taken. Abiraterone Cmax and AUC0-infinity (exposure) were increased up to 17- and 10-fold higher, respectively, when a single dose of abiraterone acetate was administered with a meal compared to a fasted state.

Adverse Reactions - The most common adverse reactions (greater than or equal to 5%) are joint swelling or discomfort, hypokalemia, edema, muscle discomfort, hot flush, diarrhea, urinary tract infection, cough, hypertension, arrhythmia, urinary frequency, nocturia, dyspepsia, fractures and upper respiratory tract infection.

Drug Interactions - ZYTIGA® is an inhibitor of the hepatic drug-metabolizing enzyme CYP2D6. Avoid coadministration with CYP2D6 substrates that have a narrow therapeutic index. If an alternative cannot be used, exercise caution and consider a dose reduction of the CYP2D6 substrate. Additionally, abiraterone is a substrate of CYP3A4 in vitro. Strong inhibitors and inducers of CYP3A4 should be avoided or used with caution.

Use in Specific Populations - The safety of ZYTIGA® in patients with baseline severe hepatic impairment has not been studied. These patients should not receive ZYTIGA®.

About Ibrutinib (formerly PCI-32765)
Ibrutinib is a first-in-class oral, selective Bruton's tyrosine kinase (Btk) inhibitor being investigated for its potential in treating patients with chronic lymphocytic leukemia, Mantle Cell lymphoma, diffuse large B cell lymphoma, follicular lymphoma and multiple myeloma, all of which are considered B-cell malignancies. Ibrutinib is being jointly developed by Janssen and Pharmacyclics, Inc.

About Siltuximab (formerly CNTO 328)
Siltuximab is a novel anti-interleukin-6 monoclonal antibody that is being investigated for its potential to treat patients with multi-centric Castleman's disease, multiple myeloma, smoldering myeloma and myelodysplastic syndromes.

About Janssen Research & Development, LLC
Janssen Research & Development, LLC is headquartered in Raritan, N.J. and has affiliated facilities in Europe, the United States and Asia. Janssen Research & Development is leveraging a combination of internal and external innovation to discover and develop novel medicines and solutions in five distinct therapeutic areas: Neuroscience, Oncology, Immunology, Infectious Diseases and Vaccines, and Cardiovascular and Metabolism. For more information about Janssen Research & Development, LLC visit www.janssenrnd.com.

Janssen Research & Development is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Driven by our commitment to patients, we work together to bring innovative ideas, products, services and solutions to address serious unmet medical needs around the world.

SOURCE Janssen Research & Development, LLC

Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting

Thu, 17 May 2012 16:09:00 -0400

May 17, 2012 16:09 ET

Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting

WOODCLIFF LAKE, N.J., May 17, 2012 /PRNewswire/ -- Eisai announced today that 15 abstracts highlighting new study results will be presented during the 48^th Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicago from June 1 to June 5, 2012.

These studies highlight Eisai's current product portfolio and oncology pipeline, reinforcing the company's commitment to patients and their families affected by cancer.

"Our human health care mission is to help address unmet medical needs and increase benefits to patients and their families," said Takashi Owa, Ph.D., Chief Scientific Officer, Eisai Product Creation Systems. "Our portfolio of oncology compounds and therapies underscores our commitment to this important mission."

The following Eisai abstracts are accepted for presentation at this year's ASCO meeting:

Product

Abstract Name

Eribulin Mesylate

Abstract No:

TPS 1145

A Phase II Single-Arm, Feasibility Study of Dose-Dense Doxorubicin and Cyclophosphamide (AC) Followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer (EBC)

Poster Session

Eribulin Mesylate

Abstract No: 2552

A Phase 1b Dose-Escalation Study of Eribulin Mesylate in Combination with Capecitabine in Patients with Advanced/ Metastatic Cancer

Poster Session

Decitabine for Injection

Abstract No: 6559

Post Hoc Analysis of Relationship Between Baseline White Blood Cell Count and Survival Outcome in a Randomized Phase III Trial of Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia Poster Session

Decitabine for Injection

Abstract No: 6632

Post hoc analysis of relationship between baseline white blood cell count and renal and hepatic function and response in a randomized phase III trial of Decitabine in patients age 65 or older with acute myeloid leukemia

Poster Session

Decitabine for Injection

Abstract No: 6627

Post Hoc Analysis of Association Between Treatment Response and Various Indicators of Efficacy and Safety in Randomized Phase III Trial of Decitabine in Older Patients with Acute Myeloid Leukemia

Poster Session

Lenvatinib

(E7080)

AbstractNo:

TPS 4682

Treatment of Refractory Metastatic Renal Cell Carcinoma (RCC) with Lenvatinib (E7080) and Everolimus

Poster Session

Lenvatinib

(E7080)

Abstract No: 8594

A Phase IB Study of Lenvatinib (E7080) in Combination with Temozolomide for Treatment of Advanced Melanoma

Poster Session

Lenvatinib

(E7080)

Abstract No: 5518

Lenvatinib Treatment of Advanced RAI-refractory Differentiated Thyroid Cancer (DTC); Cytokine and Angiongenic Factor (CAF) Profiling in Combination with Tumor Genetic Analysis to Identify Markers Associated with Response

Poster Discussion

Lenvatinib

(E7080)

Abstract No: 5591

A Phase II Trial of the Multitargeted Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer (MTC)

Poster Session

E7050

Abstract No: 3079

A Phase I Dose-Finding Study of Golvatinib (E7050), a c-Met and Eph Receptor Targeted Multi-Kinase Inhibitor, Administered Orally BID to Patients with Advanced Solid Tumors

Poster Session

E7050

Abstract No: 3030

A Phase I Dose-Finding Study of Golvatinib (E7050), a c-Met and Eph Receptor Targeted Multi-Kinase Inhibitor, Administered Orally QD to Patients with Advanced Solid Tumors

Poster Discussion

Farletuzumab

(MORAb-003)

Abstract No: 5062

Phase I Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) in Patients with Platinum-Sensitive Epithelial Ovarian Cancer (EOC)

Poster Session

Farletuzumab

(MORAb-003)

Abstract No: 3084

Phase I and Pharmacokinetic Study of Farletuzumab in Solid Tumors

Poster Session

Amatuximab

(MORAb-009)

Abstract No: 7030

Amatuximab, A Chimeric Monoclonal Antibody to Mesothelin, in Combination with Pemetrexed and Cisplatin in Patients with Unresectable Pleural Mesothelioma: Results of a Multicenter Phase II Clinical Trial

Poster Discussion

MORAb-004

Abstract No: 3016

A First-in-Human Phase I Study of MORAb-004 (M4), a Humanized Monoclonal Antibody Recognizing Endosialin (TEM-1), in Patients with Solid Tumors

Poster Discussion

The information discussed in this release is about investigational agents that are not Food and Drug Administration (FDA)-approved and investigational uses for FDA-approved products. It is not intended to convey conclusions of efficacy and safety. There is no guarantee that any of these agents will successfully complete clinical development or gain FDA approval.

HALAVEN® (eribulin mesylate) Injection

Halaven is indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease. Prior therapy should have included an anthracycline and a taxane either in the adjuvant or metastatic setting.

Important Safety Information about HALAVEN®

Decreased White Blood Cells (Neutropenia)

Your doctor should do a blood test to monitor your blood cells before you receive each dose of HALAVEN, and should monitor you more often if you develop lower white blood cells. If you develop severe neutropenia lasting longer than 7 days or neutropenia with a fever, your next dose of HALAVEN should be delayed and reduced. Severe neutropenia occurred in 57% (287/503) of patients who received HALAVEN and lasted more than 1 week in 12% (62/503) of patients. Neutropenia with a fever occurred in 5% (23/503) of patients; 2 patients died from complications of neutropenia with a fever. Neutropenia with a fever can result in serious infections that could lead to hospitalization or death. Call your healthcare provider immediately if you have any of the following symptoms; fever (temperature above 100.5 degrees F), chills, coughing, burning or pain when you urinate.

Nerve Disorders (Peripheral Neuropathy)

HALAVEN can cause numbness, tingling, or burning in your hands and feet (peripheral neuropathy). You should be monitored closely for signs of neuropathy. If you develop severe neuropathy, treatment with HALAVEN should be delayed until the neuropathy improves and the next dose of HALAVEN should be reduced. Severe peripheral neuropathy occurred in 8% (42/503) of patients who received HALAVEN. Neuropathy lasting more than one year occurred in 5% of patients. Twenty-two percent (109/503) of patients developed a new or worsening neuropathy that had not recovered after an average of 269 days. Peripheral neuropathy was the most common side effect that caused patients to stop receiving HALAVEN.

Pregnancy and Nursing

HALAVEN may harm your unborn baby. Avoid becoming pregnant while you are receiving HALAVEN. Tell your healthcare provider right away if you become pregnant or think you are pregnant while you are receiving HALAVEN. You and your healthcare provider should decide if you will receive HALAVEN or breastfeed. You should not do both.

Heartbeat Changes

HALAVEN can cause changes in your heartbeat (called QTc prolongation). This can cause irregular heartbeats that may lead to death. Your healthcare provider will decide if you need heart monitoring (electrocardiogram or ECG), or blood tests during your treatment with HALAVEN to watch for this problem.

Liver and Kidney Problems

In patients with mild or moderate liver problems, and/or moderate kidney problems, a lower starting dose of HALAVEN is recommended.

Most Common Side Effects

The most common side effects reported in greater than or equal to 25% of patients receiving HALAVEN were low white blood cells (82%), low red blood cells (58%), weakness/tiredness (54%), hair loss (45%), numbness, tingling or burning in your hands and feet (35%), nausea (35%), and constipation (25%). The most common serious side effects reported in patients receiving HALAVEN were neutropenia with or without a fever (4% and 2%, respectively).

For full prescribing information for HALAVEN, please visit: http://www.halaven.com/sites/default/files/HALAVEN_full_Prescribing_Information.pdf

DACOGEN^® (decitabine) for Injection

Dacogen is a nucleoside metabolic inhibitor indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate- 2, and high-risk International Prognostic Scoring System groups. (1)

Important Safety Information

Treatment with DACOGEN is associated with neutropenia and thrombocytopenia. Complete blood and platelet counts should be performed as needed to monitor response and toxicity but at a minimum prior to each dosing cycle. After administration of the recommended dosage for the first cycle, treatment for subsequent cycles should be adjusted if indicated by dose adjustment guidelines. Clinicians should consider the need for early institution of growth factors and/or antimicrobial agents for the prevention or treatment of infections in patients with MDS.

DACOGEN may cause fetal harm when administered to a pregnant woman. Women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with DACOGEN and for 1 month following completion of treatment. Women of childbearing potential should be counseled to use effective contraception during this time. Men should be advised not to father a child while receiving treatment with DACOGEN and for 2 months following completion of treatment. DACOGEN may cause fetal harm. Men with female partners of childbearing potential should use effective contraception during this time.

In a phase 3 clinical trial in MDS patients, the highest incidence of Grade 3 or Grade 4 adverse events in the DACOGEN arm was neutropenia (87%), thrombocytopenia (85%), febrile neutropenia (23%), and leukopenia (22%). Bone marrow suppression was the most frequent cause of dose reduction, delay, and discontinuation. Six patients had fatal events associated with their underlying disease and myelosuppression (anemia, neutropenia, and thrombocytopenia) that were considered at least possibly related to drug treatment. Of the 83 DACOGEN-treated patients, 8 permanently discontinued therapy for adverse events compared to 1 of 81 patients in the supportive care arm.

In a single-arm study in MDS patients, the highest incidence of Grade 3 or Grade 4 adverse events was neutropenia (37%), thrombocytopenia (24%), and anemia (22%). Seventy-eight percent of patients had dose delays, the median duration of this delay was 7 days. Hematologic toxicities and infections were the most frequent causes of dose delays and discontinuation. Eight patients had fatal events due to infection and/or bleeding that were considered at least possibly related to drug treatment. Nineteen of 99 patients permanently discontinued therapy for adverse events.

Other commonly occurring reactions include fatigue, pyrexia, nausea, cough, petechiae, constipation, diarrhea, and hyperglycemia.

If hematologic recovery from a previous DACOGEN treatment cycle requires more than 6 weeks when administering the 3-day dosing, then the next DACOGEN cycle should be delayed and dosing temporarily reduced. When administering the 5-day dosing, the DACOGEN cycle should be delayed until there is hematologic recovery. If the following nonhematologic toxicities are present, DACOGEN treatment should not be restarted until the toxicity is resolved: (1) serum creatinine greater than or equal to 2 mg/dL; (2) SGPt, total bilirubin greater than or equal to 2 × ULN; and (3) active or uncontrolled infection.

Because there are no data on use of DACOGEN in patients with renal or hepatic dysfunction, DACOGEN should be used with caution in these patients.

For full prescribing information, please see http://us.eisai.com/pdf_files/Dacogen_PI.pdf.

Eisai Oncology

Eisai Oncology is dedicated to discovering, developing and producing innovative oncology therapies that can help make a difference and impact the lives of patients and their families. This passion for people is part of Eisai's human health care (hhc) mission, which strives for better understanding of the needs of patients and their families to increase the benefits health care provides. Our commitment to meaningful progress in oncology research, built on scientific expertise, is supported by a global capability to conduct discovery and preclinical research, and develop small molecules, biologic and supportive care agents for cancer across multiple indications.

Eisai Inc.

Eisai Inc. was established in 1995 and began marketing its first product in the United States in 1997. Since that time, Eisai Inc. has rapidly grown to become a fully integrated pharmaceutical business. Eisai's key areas of commercial focus are neurology and oncology. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

Eisai has a global product creation organization that includes U.S.-based R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as manufacturing facilities in Maryland and North Carolina. The company's areas of R&D focus include neuroscience; oncology; vascular, inflammatory and immunological reaction; and antibody-based programs. For more information about Eisai, please visit www.eisai.com/US.

Morphotek

Morphotek^®, Inc., a subsidiary of Eisai Inc., is a biopharmaceutical company specializing in the development of protein and antibody products through the use of a novel and proprietary gene evolution technology. The technology has been successfully applied to a broad variety of cell lines and organisms to yield genetically diverse offspring that are suitable for pharmaceutical product development in the areas of antibody therapeutics, protein therapeutics, product manufacturing, drug target discovery, and improved output traits for commercial applications. The company is currently focusing its platform on the development and manufacturing of therapeutic antibodies for the treatment of cancer, inflammation and infectious disease. For more information, please visit www.morphotek.com

Eisai Co., Ltd.

Eisai Co., Ltd. is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system.

(Logo: http://photos.prnewswire.com/prnh/20120413/MM87168LOGO )

SOURCE Eisai Inc.

Esperance Pharmaceuticals Initiates Phase 2 Clinical Trial of its Novel Membrane-disrupting Agent, EP-100, in Patients with Advanced Ovarian Cancer

Thu, 17 May 2012 13:57:00 -0400

May 17, 2012 13:57 ET

Esperance Pharmaceuticals Initiates Phase 2 Clinical Trial of its Novel Membrane-disrupting Agent, EP-100, in Patients with Advanced Ovarian Cancer

-- Results from Phase 1 clinical trial of EP-100 to be presented at ASCO --

BATON ROUGE, La., May 17, 2012 /PRNewswire/ -- Esperance Pharmaceuticals today announced that it has begun enrollment of a Phase 2, randomized, multi-center trial of EP-100 in combination with paclitaxel for the potential treatment of advanced ovarian cancer. EP-100 is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers including ovarian cancer. The Phase 2 study design is based on the recent successful completion of a Phase 1 study of EP-100 in advanced solid tumors, the results of which will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in June this year.

"Based on our successful Phase 1 study and results of preclinical studies, we believe there is a compelling rationale for the study of EP-100 in ovarian cancer -- which is known to over express LHRH receptors," said Hector Alila, PhD, Chief Executive Officer of Esperance. "We are hopeful EP-100 may hold promise for this patient population with very few treatment options."

The EP-100 phase 2 study is enrolling five to eight patients in a run-in to confirm the maximum safe dose of EP-100 to be combined with paclitaxel. The randomized study will then enroll 40 patients randomized in a 1:1 ratio to receive either the standard weekly dose of 80 mg/m(2) paclitaxel or the same regimen of paclitaxel plus twice weekly EP-100 for 3 of 4 weeks during each of six cycles. The primary outcome of the study will be objective response rate and secondary outcome measures include quality and duration of response, time to progression and follow-up for survival as well as the safety of this new doublet regimen. Details of the trial are provided on clinicaltrials.gov, NCT 01485848.

ASCO :

Abstract #3060/Poster Board 15B, "A phase I study of EP-100, a luteinizing hormone releasing hormone (LHRH) ligand conjugated to a synthetic cytolytic peptide in patients with advanced refractory LHRH- receptor (R)-expressing tumors" will presented by Ramesh K. Ramanathan, MD from the Virginia G. Piper Cancer Center/TGen, (Scottsdale, AZ) on Monday, June 4, 2012 at 8:00 a.m. CT in S Hall A2 at McCormick Place in Chicago, IL.

About EP-100

EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP™) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers including breast, prostate, endometrial, pancreatic, ovarian, blood, skin and testicular cancers. Results from pre-clinical studies of EP-100 have shown that the drug regresses established tumors in breast, prostate, ovarian and endometrial cancer xenografts in mice. Preclinical results in ovarian cancer were presented at the 2009 American Association for Cancer Research (AACR) Annual Meeting. In in vivo studies, the efficacy of EP-100 in comparison to saline or untargeted membrane-disrupting peptide or cisplatinum was studied in an ovarian cancer xenograft model (OVCAR-3). EP-100 regressed established OVCAR-3 xenografts following weekly injections at doses as low as 0.2 mg/kg bodyweight (p<0.03 vs. baseline). In comparison, tumor growth was observed across the saline control, untargeted membrane-disrupting peptide or cisplatinum arms. In addition, in the EP-100 arm tumor volumes, weights and CA125 (a clinical biomarker for ovarian cancer) were reduced. LHRH receptor levels were also reduced and PET imaging revealed that EP-100 treated tumors became necrotic, lacking viable tumor cells after treatment. EP-100 was well tolerated in all treated groups.

About Esperance Pharmaceuticals

Esperance Pharmaceuticals, Inc. is a clinical stage company developing a new class of targeted anticancer drugs using its Cationic Lytic Peptide (CLYP™) platform technology. These drug candidates, called targeted membrane-disrupting peptides (tMDPs) and antibody drug conjugates (ADCs) selectively seek and destroy cancer cells, including cells known to be resistant to chemotherapeutic drugs, without harming normal cells. Targeting occurs through binding to specific receptors and antigens on the cell's surface. The Company was founded on patented technology discovered by scientists at the Pennington Biomedical Research Center, the Louisiana State (LSU) Ag Center and LSU main campus. Founding investors include the Louisiana Fund I, Themelios Ventures and Research Corporation Technologies. Additional investors include Sanofi, Advantage Capital Partners, Louisiana Technology Fund and private investors. More information can be found at www.esperancepharma.com.

SOURCE Esperance Pharmaceuticals

Genomic Health Announces Presentation of Eighteen Studies Highlighting Progress in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology 2012 Annual Meeting

Wed, 16 May 2012 18:01:00 -0400

May 16, 2012 18:01 ET

Genomic Health Announces Presentation of Eighteen Studies Highlighting Progress in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology 2012 Annual Meeting

REDWOOD CITY, Calif., May 16, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from 18 separate studies covering breast, colon and prostate cancers will be presented at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting, reflecting the company's ongoing commitment to the research, development and delivery of innovative diagnostic tests to help individualize cancer treatment decisions. The annual meeting is taking place June 1-5, 2012 in Chicago, Illinois.

Key study results to be presented at the meeting include:

Additional data on the clinical value of the Oncotype DX DCIS Score™
Further validation of the Oncotype DX colon cancer test
Company's first prostate needle biopsy study
First Oncotype DX breast cancer treatment decision impact study results from Canada and France
Multiple studies reconfirming the clinical utility and cost effectiveness of the Oncotype DX breast cancer test

The majority of ASCO Annual Meeting abstracts are now publicly available on ASCO's website: www.asco.org.

Presentation details are as follows (all times are in Central Time):

DCIS Breast Cancer

Tuesday, June 5, 2012

Oral Presentation: "Correlation between the DCIS Score and traditional clinicopathologic features in the prospectively designed E5194 clinical validation study" (Abstract #1005)

Presenter: Sunil S. Badve, Indian University School of Medicine
Session Time and Location: 11:15 AM – 11:30 AM; E Hall D1

Colon Cancer

Friday, June 1, 2012

Poster Discussion: "Validation of the 12-gene colon cancer recurrence score (RS) in NSABP C-07 as a predictor of recurrence in stage II and III colon cancer patients treated with 5FU/LV (FU) and 5FU/LV+oxaliplatin (FU+Ox)" (Abstract #3512)

Presenter: Michael O'Connell, MD, National Surgical Adjuvant Breast and Bowel Project and Allegheny General Hospital Cancer Center
Poster Discussion Session Time and Location: 1 PM – 5 PM; E450b; E Arie Crown Theater
Poster Board: #4

Monday, June 4, 2012

Poster Session: "Effect of the 12-gene colon cancer assay results on treatment recommendations in patients with stage II colon cancer"(Abstract #3626)

Presenter: Thomas H. Cartwright, MD, Ocala Oncology
Session Time and Location: 8 AM – 12 PM; S Hall A2
Poster Board: #37G

Prostate Cancer

Monday, June 4, 2012

Poster Discussion: "Development of a needle biopsy-based genomic test to improve discrimination of clinically aggressive from indolent prostate cancer" (Abstract #4560)

Presenter: Eric A. Klein, MD, Cleveland Clinic
Poster Discussion Session Time and Location: 8 AM – 12 PM; E450a
Poster Board: #14

Invasive Breast Cancer

Saturday, June 2, 2012

Poster Session: "Prospective comparison of recurrence score and independent central pathology assessment of prognostic tools in early breast cancer (BC): focus on HER2, ER, PR, Ki-67 results from the Phase III WSG-Plan B trial" (Abstract #552)

Presenter: Oleg Gluz, MD, West German Study Group
Session Time and Location: 8 AM – 12 PM; S Hall A2
Poster Board: #3C

Poster Session: "Prospective study of the impact of using the 21-gene recurrence score assay on clinical decision making in women with estrogen receptor-positive, HER2-negative, early-stage breast cancer in France" (Abstract #568)

Presenter: Joseph Gligorov, MD, PhD, Tenon Hospital, Paris
Session Time and Location : 8 AM – 12 PM; S Hall A2
Poster Board: #5C

Poster Session: "Evaluation of Oncotype DX testing and subsequent patterns of care in patients (pts) with early-stage breast cancer (ESBC)" (Abstract #569)

Presenter: Meghan Fitzgerald, MPH, MBA, Cardinal Health Specialty Solutions
Session Time and Location: 8 AM – 12 PM; S Hall A2
Poster Board: #5D

Poster Session: "Obesity at diagnosis and breast cancer (BC) recurrence risk based on the 21-gene assay recurrence score (RS)" (Abstract #555)

Presenter: Kimberly Ridolfi, MD, University of Wisconsin
Session Time and Location: 8 AM – 12 PM; S Hall A2
Poster Board: #3F

Poster Session: "Impact of exogenous female hormone use (EHU) on breast cancer (BC) recurrence as assessed by the 21-gene assay (Oncotype DX)" (Abstract #563)

Presenter: Wendy M. Ledesma, MD, University of Wisconsin
Session Time and Location: 8 AM – 12 PM; S Hall A2
Poster Board: #4F

Poster Session: "Evaluation of variables that may impact chemotherapy (CT) administration after determination of Oncotype DX (ODX) Recurrence Score (RS)" (Abstract #571)

Presenter: Kristina E. Bowen, MD, Georgia Cancer Specialists
Session Time and Location: 8 AM – 12 PM; S Hall A2
Poster Board: #5F

Poster Session: "A Prospective clinical utility study of the impact of the 21-gene Recurrence Score assay (Oncotype DX) in Estrogen Receptor Positive (ER+) Node Negative (pN0) Breast Cancer in Academic Canadian Centers" (Abstract #549)

Presenter: James A. Davidson, MD, British Columbia Cancer Agency
Session Time and Location: 8 AM – 12 PM; S Hall A2
Poster Board: #2G

Sunday, June 3, 2012

Poster Discussion: "Cost-effectiveness of the 21-gene recurrence core assay in the setting of multifactorial decision making for chemotherapy in early-stage breast cancer" (Abstract #1525)

Presenter: Shelby D. Reed, PhD, Duke University
Poster Session Time and Location: 8 AM – 12 PM; S102
Poster Board: #14

Monday, June 4, 2012

Poster Session: "Relationship between Oncotype DX testing and the use of chemotherapy in high-risk patients (pts)" (Abstract #6098)

Presenter: Winston Wong, PharmD, CareFirst BlueCross BlueShield
Session Time and Location: 1:15 PM – 5:15 PM; S Hall A2
Poster Board: #8G

Poster Session: "Rural vs urban differences among patients (pts) with hormone-receptor positive (HR+) breast cancer (BC) and a 21-gene assay recurrence score (RS)" (Abstract #6063)

Presenter: Molly Andreason, BS, University of Wisconsin-Madison
Session Time and Location: 1:15 PM – 5:15 PM; S Hall A2
Poster Board: #4D

Poster Discussion: "10-year update of E2197: Phase III doxorubucin/docetaxel (AT) vs doxorubicin/cyclophosphamide (AC) adjuvant treatment of LN + and high risk LN - breast cancer and the comparison of the prognostic utility of the 21-gene recurrence score (RS) with clinicopathologic features" (Abstract #1021)

Presenter: Joseph A. Sparano, MD, Albert Einstein Cancer Center-Montefiore Medical Center
Poster Session Time and Location: 1:15 PM – 5:15 PM; E450b
Poster Board: #13

About Genomic Health
Genomic Health, Inc. (NASDAQ: GHDX) is a global health company that provides actionable genomic information to personalize genomic health decisions. The company's lead product, the Oncotype DX® breast cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer and has been shown to predict the likelihood of recurrence in ductal carcinoma in situ (DCIS). In addition to this widely adopted test, Genomic Health provides the Oncotype DX colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease. As of March 31, 2012, more than 10,000 physicians in over 65 countries had ordered more than 275,000 Oncotype DX tests. Genomic Health has a robust pipeline focused on developing tests to optimize the treatment of prostate and renal cell cancers, as well as additional treatment decisions in breast and colon cancers. The company is based in Redwood City, California with European headquarters in Geneva, Switzerland. For more information, please visit, www.GenomicHealth.com. To learn more about Oncotype DX tests, visit: www.OncotypeDX.com and www.mybreastcancertreatment.org.

Forward Looking Statement: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to our ability to generate similar results in further studies; the ability of any tests the company may develop to optimize cancer treatment; the applicability of clinical study results to actual outcomes; our ability to develop and launch a test for prostate cancer in 2013; the ability of the company to develop additional tests in the future; the scope, success or results of clinical trials and the timing of such activities; and the ability of the company's tests to impact clinical practice. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: the risks and uncertainties associated with the regulation of our tests; the risks associated with competition; the applicability of clinical study results to actual outcomes; the risks associated with the commercialization of current and future products; the risks and potential delays associated with such studies; and the other risks set forth in the company's filings with the Securities and Exchange Commission, including the risks set forth in the company's Quarterly Report on Form 10-Q for the quarter ended March 30, 2012. These forward-looking statements speak only as of the date hereof. Genomic Health disclaims any obligation to update these forward-looking statements.

NOTE: The Genomic Health logo, Oncotype, Oncotype DX and Recurrence Score are trademarks or registered trademarks of Genomic Health, Inc. All other trademarks and service marks are the property of their respective owners.

SOURCE Genomic Health, Inc.

Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012

Wed, 16 May 2012 18:00:00 -0400

May 16, 2012 18:00 ET

Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012

LUX-Lung 3 clinical trial data selected for late-breaking oral presentation

RIDGEFIELD, Conn., May 16, 2012 /PRNewswire/ -- Boehringer Ingelheim will present results from LUX-Lung 3, the company's pivotal Phase III clinical trial investigating afatinib in patients with stage IIIB or IV non-small cell lung cancer (NSCLC) harboring an epidermal growth factor receptor (EGFR) mutation (EGFR M+), at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 1-5, 2012. LUX-Lung 3, which compares the investigational oral, once-daily therapy, afatinib, to pemetrexed/cisplatin, is the largest Phase III trial to date in first-line EGFR mutation-positive, advanced, metastatic NSCLC patients, and the first to use pemetrexed/cisplatin as a comparator in this population.

The presentation of the LUX-Lung 3 trial will shed light on a distinct and specific NSCLC patient population, those with EGFR mutations. EGFR mutations occur in 10 to 15 percent of NSCLC patients, and are well-established predictive biomarkers that provide specific targets for therapeutic intervention in NSCLC.

Title

Lead Author

Presentation details

LUX-Lung 3: A randomized,
open-label, phase III study of
afatinib versus pemetrexed and
cisplatin as first-line treatment for
patients with advanced
adenocarcinoma of the lung
harboring EGFR-activating mutations.

James Chih-Hsin Yang, MD, PhD

Oral Abstract #LBA7500

Date: Monday, June 4
Time: 3:00 PM-3:15 PM CDT

"We are excited to share the results of our pivotal LUX-Lung 3 trial, the largest and most robust ever conducted in EGFR mutation-positive patients," said Berthold Greifenberg, M.D., Vice President, Clinical Development and Medical Affairs, Oncology, Boehringer Ingelheim Pharmaceuticals, Inc. "We are continuously advancing the development of our oncology pipeline and look forward to opportunities to contribute to the body of scientific knowledge in this area."

Additional Presentations of Boehringer Ingelheim Investigational Compounds

In addition to the LUX-Lung 3 presentation, more than 15 studies of Boehringer Ingelheim's investigational therapies have been selected for inclusion at ASCO, demonstrating the company's innovative clinical development program across a variety of cancer types.

Select Poster Presentations
Title	Lead Author	Poster details
*Afatinib*
LUX-breast 3: Randomized phase II study of afatinib alone or with vinorelbine versus investigator's choice of treatment in patients (pts) with HER2-positive breast cancer (BC) with progressive brain metastases (BM) after trastuzumab or lapatinib-based therapy.	Heikki Joensuu, MD, Professor	Abstract #TPS647 Poster #15B Date: Saturday, June 2 Time: 8:00 AM - 12:00 PM CDT

LUX-breast 1: Randomized, phase III trial of afatinib and vinorelbine versus trastuzumab and vinorelbine in patients with HER2-overexpressing metastatic breast cancer (MBC) failing one prior trastuzumab treatment.	Nadia Harbeck, MD, PhD	Abstract #TPS649 Poster #15D Date: Saturday, June 2 Time: 8:00 AM - 12:00 PM CDT

LUX-breast 2: Phase II, open-label study of oral afatinib in HER2-overexpressing metastatic breast cancer (MBC) patients (pts) who progressed on prior trastuzumab (T) and/or lapatanib (L).	Tamas Hickish, MD	Abstract # TPS651 Poster #15F Date: Saturday, June 2 Time: 8:00 AM - 12:00 PM CDT

LUX-head and neck 1: A phase III, randomized trial of afatinib versus methotrexate (MTX) in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) who progressed after platinum-based therapy.	Jean-Pascal H. Machiels, MD, PhD	Abstract # PS5598 Poster #32H Date: Saturday, June 2 Time: 1:15 – 5:15 PM CDT

LUX-head and neck 2: A randomized, double- blind, placebo-controlled, phase III study of afatinib as adjuvant therapy after chemoradiation in primarily unresected, clinically high-risk, head and neck cancer patients.	Barbara Burtness, MD	Abstract # TPS5599 Poster # 33A Date: Saturday, June 2 Time: 1:15 – 5:15 PM CDT
*Nintedanib*
TRICC-c: BIBF 1120 versus placebo in patients receiving oxaliplatin plus fluorouracil and leucovorin (mFOLFOX6) for advanced, chemorefractory metastatic colorectal cancer (mCRC)—A multicenter, randomized phase II trial in progress.	Andreas Berger, MD	Abstract # TPS3636 Poster # 39A Date: Monday, June 4 Time: 8:00 AM - 12:00 PM CDT
*Volasertib*
Phase I trial of the polo-like kinase (Plk) inhibitor volasertib (BI 6727) combined with cisplatin or carboplatin in patients with advanced solid tumors.	Herlinde Dumez	Abstract # 3018 Poster #10 Date: Saturday, June 2 Time: 1:15 – 5:15 PM CDT

About Lung Cancer

Lung cancer is the second most common cancer and kills more people than any other cancer. In 2012, approximately 226,160 new cases of lung cancer will be diagnosed in the United States, with 160,340 Americans dying from the disease. NSCLC is the most common form, accounting for about 85 percent of all lung cancers.[1] Lung cancer remains an area of high unmet need, especially in its advanced stages where it is particularly aggressive and patients have limited treatment options.

About Afatinib

Afatinib is an investigational compound. Afatinib is not approved by the FDA; its safety and efficacy have not been established.

Afatinib is an investigational oral, once-daily irreversible ErbB Family Blocker that specifically inhibits epidermal growth factor receptor (EGFR or ErbB1), human epidermal receptor 2 (HER2 or ErbB2), ErbB3 and ErbB4. It is currently in phase III clinical development in NSCLC, head and neck and breast cancer.

About the Afatinib Clinical Trial Program in Advanced NSCLC

The LUX-Lung studies evaluate the use of afatinib in various settings of advanced NSCLC, including in patients harboring EGFR mutations and those with recurrent disease. These trials include:

LUX-Lung 1, a Phase IIb/III trial investigating afatinib plus best supportive care (BSC) versus placebo plus BSC in NSCLC patients who were previously treated with first-line chemotherapy and the reversible EGFR TKIs erlotinib or gefitinib.
LUX-Lung 2, a Phase II trial evaluating afatinib in NSCLC patients with EGFR mutations (EGFR M+), either treatment-naive or after one line of treatment with chemotherapy.
LUX-Lung 3, a Phase III trial investigating afatinib as a first-line treatment in patients with advanced NSCLC with EGFR mutations.
LUX-Lung 4, a Phase I/II trial of afatinib in NSCLC patients who have progressed after conventional EGFR-TKI treatment.
LUX-Lung 5, a global Phase III trial in patients previously treated with erlotinib or gefitinib. This is the first randomized Phase III trial investigating whether patients who initially benefit from treatment with afatinib alone may further benefit from afatinib beyond progression when given in combination with chemotherapy.
LUX-Lung 6, a Phase III trial investigating the efficacy and safety of afatinib compared to standard chemotherapy for first-line treatment of NSCLC patients with EGFR mutations.
LUX-Lung 7, a Phase IIb trial evaluating afatinib head-to-head versus gefitinib as a first-line treatment in EGFR M+ NSCLC patients. Patient recruitment for this trial has recently initiated.
LUX-Lung 8, a Phase III trial evaluating afatinib head-to-head versus erlotinib in second-line treatment of squamous cell carcinoma of the lung. Patient recruitment for this trial has recently initiated.

For more information on these trials, please visit www.clinicaltrials.gov.

About Boehringer Ingelheim in Oncology

Building on scientific expertise and excellence in the fields of pulmonary and cardiovascular medicine, metabolic disease, neurology, virology and immunology, Boehringer Ingelheim has embarked on a major research program to develop innovative cancer treatments. Working in close collaboration with the international scientific community and a number of the world's leading cancer centers, Boehringer Ingelheim's commitment to oncology is underpinned by using advances in science to develop a range of targeted therapies for various solid tumors and hematological cancers.

The current focus of late-stage research includes compounds in three areas: signal transduction inhibition, angiogenesis inhibition and cell-cycle kinase inhibition. Afatinib is an investigational orally-administered irreversible inhibitor of the ErbB family of receptor tyrosine kinases, which is currently in phase III clinical development in advanced NSCLC, head and neck cancer, and breast cancer. Nintedanib (BIBF 1120) is an investigational orally-administered triple angiokinase inhibitor that targets three of the receptor tyrosine kinases shown to aid in the regulation of angiogenesis and is currently in phase III clinical development in NSCLC and ovarian cancer. Volasertib is an investigational inhibitor of polo-like kinase that is currently being investigated in early phase trials. Boehringer Ingelheim's oncology pipeline continues to evolve and demonstrates the company's continued commitment to the disease area.

For information about participating in a Boehringer Ingelheim clinical trial, please visit www.bicancertrials.com or call 1.866.725.7110. Healthcare providers interested in learning more about Boehringer Ingelheim clinical trials in oncology can visit www.inoncologyus.com for additional information.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim has a demonstrated commitment to corporate social responsibility. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavors.

In 2011, Boehringer Ingelheim achieved net sales of about $17.1 billion (13.2 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 23.5% of its net sales.

For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.

References

[1] American Cancer Society. Cancer Facts and Figures: 2012. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf. Last accessed April 27, 2012.

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.

Jennerex Announces Data Presentations Relating to Oncolytic Virus JX-594 at American Society of Clinical Oncology Annual Meeting

Wed, 16 May 2012 18:00:00 -0400

May 16, 2012 18:00 ET

Jennerex Announces Data Presentations Relating to Oncolytic Virus JX-594 at American Society of Clinical Oncology Annual Meeting

SAN FRANCISCO, Calif., May 16, 2012 /PRNewswire/ -- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer will be covered in three separate abstracts released today by the American Society of Clinical Oncology (ASCO). The data relate to completed and ongoing clinical trials of JX-594 in lead indication, hepatocellular carcinoma (liver cancer), as well as in colorectal cancer where JX-594 was administered via multiple intravenous infusions. The ASCO Annual Meeting takes place June 1st through 5th, 2012 in Chicago, Illinois.

Following is information relating to the three abstracts:

Abstract #TPS4152: " Phase IIb randomized trial of JX-594, a targeted multi-mechanistic oncolytic vaccinia virus, plus best supportive care (BSC) versus BSC alone in patients with advanced hepatocellular carcinoma who have failed sorafenib treatment (TRAVERSE)." Poster to be presented in S Hall A2 on June 4, 2012, 8:00 a.m. – 12:00 p.m. CDT, in the General Poster Session: Gastrointestinal (Noncolorectal) Cancer.
Abstract #e14566: " A phase II trial of JX-594, a targeted multi-mechanistic oncolytic vaccinia virus, followed by sorafenib in patients with advanced hepatocellular carcinoma (HCC)." Abstract available on ASCO website only (http://chicago2012.asco.org/Home.aspx)
Abstract #e13044: "A phase Ib dose escalation study of JX-594 (TK-vaccinia virus expressing GM-CSF) administered by biweekly intravenous infusion in patients with metastatic, refractory colorectal carcinoma." Abstract available on ASCO website only (http://chicago2012.asco.org/Home.aspx).

JX-594: A Multi-Mechanistic Approach To Targeting Cancer
JX-594 is a proprietary, engineered oncolytic virus that is designed to selectively target and destroy cancer cells. JX-594 is designed to attack cancer through three diverse mechanisms of action: 1) the lysis of cancer cells through viral replication, 2) the shutdown of the blood supply to tumors through vascular targeting and destruction, and 3) the stimulation of the body's immune response against cancer cells, i.e., active immunotherapy. Phase 1 and Phase 2 clinical trials in multiple cancer types to date have shown that JX-594, delivered either directly into tumors or intravenously, induces tumor shrinkage and/or necrosis and is well-tolerated by patients (over 130 treated to date). Objective tumor responses have been demonstrated in a variety of cancers including liver, colon, kidney, lung cancer and melanoma. JX-594 has had a favorable safety profile to date with predictable and generally mild side effects that typically include flu-like symptoms that resolve in 24 to 48 hours.

JX-594 is the most advanced product candidate from Jennerex's proprietary SOLVE™ (Selective Oncolytic Vaccinia Engineering) platform. SOLVE takes advantage of the natural attributes of poxviruses as well as their ability to be genetically engineered to produce safe, therapeutic viruses that can infect solid tumors both systemically and locally. The vaccinia poxvirus strain backbone of JX-594 has been used safely in millions of people as part of a worldwide vaccination program. This strain naturally targets cancer cells due to common genetic defects in cancer cells. JX-594 was engineered to enhance this natural safety and cancer-selectivity by inactivating its thymidine kinase (TK) gene, thus making it dependent on the cellular TK expressed at persistently high levels in cancer cells. To enhance product efficacy, JX-594 is also engineered to express the immunogenic GM-CSF protein. GM-CSF complements the cancer cell lysis of the product candidate, leading to a cascade of events resulting in tumor necrosis, tumor vasculature shutdown and sustained anti-tumoral immune attack.

About Jennerex's Partners for JX-594
Transgene (NYSE Euronext Paris: FR0005175080), a bio-pharmaceutical company specialized in the development of immunotherapeutic products, holds an exclusive license to develop and commercialize JX-594 in Europe and neighboring countries. Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, holds an exclusive license to develop and commercialize JX-594 in South Korea, and Lee's Pharmaceutical Ltd. holds an exclusive license to develop and commercialize JX-594 in China.

Transgene, a member of the Institut Merieux Group, is a publicly traded French biopharmaceutical company dedicated to the development of therapeutic vaccines and immunotherapeutic products in oncology and infectious diseases, and has five compounds in clinical development: TG4010 and JX-594 (TG6006) having completed initial phase II trials, TG4001 in phase IIb trial, TG4040 in phase II trial and TG4023 in phase I trial. Transgene has concluded strategic agreements for the development of two of its immunotherapy products, an option agreement with Novartis for the development of TG4010 to treat various cancers, and an in-licensing agreement with U.S.-based Jennerex Biotherapeutics, Inc., to develop and market JX-594 (TG6006), an oncolytic product. Transgene has bio-manufacturing capacities for viral-based products. Additional information about Transgene is available on the internet at www.transgene.fr

Green Cross Corp. is a publicly traded and leading Korean biopharmaceutical company specialized in development and commercialization of vaccines, plasma-derivatives, recombinant proteins and therapeutic antibodies in oncology and infectious diseases. Green Cross Corp. has been collaborating with Jennerex in Korea since 2006 to jointly conduct the Phase 1 and 2 clinical trials in patients with liver cancer. Additional information about Green Cross Corp. is available on the internet at www.greencross.com.

Lee's Pharmaceutical Holdings Limited is a public biopharmaceutical company with over 16 years operation in China's pharmaceutical industry. It is fully integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales and marketing in China with global perspectives and currently markets nine products. Lee's Pharma focuses on several different areas such as cardiovascular and infectious diseases, dermatology, oncology, gynecology and others. It has more than 30 products under different development stages stemming from both internal R&D as well as from the recent acquisition of licensing and distribution rights from various U.S. and European companies. The mission of Lee's is to become a successful biopharmaceutical group in Asia providing innovative products to fight diseases and improve health and quality of life. Additional information about Lee's Pharma is available on the internet at www.leespharm.com.

About Jennerex
Jennerex, Inc. is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594 is currently in an international, randomized Phase 2b clinical trial (TRAVERSE) in patients with advanced primary liver cancer who have failed sorafenib therapy. In addition, JX-594 is being tested in the same patient population in combination with sorafenib. JX-594 is also in a Phase 1 clinical trial in patients with treatment-refractory colorectal cancer. Published studies designed to establish optimal dose levels and the safety profile of JX-594 have shown its ability to selectively target and cause destruction of a variety of common cancer types. JX-594 and other product candidates under development are designed to attack cancer tumors through three diverse mechanisms of action: the lysis of cancer cells through viral replication, the ablation of the blood supply to tumors through vascular targeting and destruction and the stimulation of the body's immune response against the cancer. Jennerex is headquartered in San Francisco and has related research and development operations in Ottawa, Canada and Pusan, South Korea. For more information about Jennerex, please visit www.jennerex.com.

SOURCE Jennerex, Inc.

48th Annual Meeting of the American Society of Clinical Oncology (ASCO): Bayer to Present Data on Late-Stage Oncology Compounds at ASCO 2012

Wed, 16 May 2012 08:00:00 -0400

May 16, 2012 08:00 ET

48th Annual Meeting of the American Society of Clinical Oncology (ASCO): Bayer to Present Data on Late-Stage Oncology Compounds at ASCO 2012

-- First data from Phase III trial for regorafenib in gastrointestinal stromal tumor (GIST) presented as Late-Breaking Abstract in Oral Abstract Session

WAYNE, N.J., May 16, 2012 /PRNewswire/ -- Bayer HealthCare announced today that data on Nexavar® (sorafenib) tablets and several of its investigational oncology compounds will be presented in a scientific forum at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago, IL. These data, including oral presentations of two Late-Breaking Abstracts on the late-stage compounds regorafenib and radium-223 chloride, reflect Bayer's commitment to oncology research and development.

"We are pleased to present Phase III data in cancers that warrant further development. At Bayer, we are dedicated to researching new treatments for people living with cancer," said Pamela A. Cyrus, M.D., Vice President and Head of U.S. Medical Affairs, Bayer HealthCare Pharmaceuticals.

Notable studies evaluating Bayer's oncology products and compounds at ASCO include:

Regorafenib

Randomized Phase 3 Trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU) – GRID trial
- Late-breaking Abstract #LBA10008, Oral Abstract Session: Sarcoma
- Monday, June 4, 5:30 p.m. – 5:45 p.m., Theater S406
Phase 3 CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC)
- Abstract #3502, Oral Abstract Session: Gastrointestinal (Colorectal) Cancer
- Sunday, June 3, 10:15 a.m. – 10:30 a.m., E Hall D1

Radium-223 Chloride

Final overall survival analysis results from the Phase III, double-blind, randomized, multinational study of radium-223 chloride (Alpharadin) in the treatment of patients with castration-resistant prostate cancer (CRPC) with bone metastases (ALSYMPCA)
- Late-breaking Abstract #LBA4512, Oral Abstract Session: Genitourinary (Prostate) Cancer
- Tuesday, June 5, 10:45 a.m. – 11:00 a.m., E Arie Crown Theater
Radium-223 chloride (Ra-223) impact on skeletal-related events (SREs) & ECOG performance status (PS) in patients with castration-resistant prostate cancer (CRPC) with bone metastases: interim results of a Phase III trial (ALSYMPCA)
- Abstract #4551, Poster Discussion: Genitourinary (Prostate) Cancer
- Poster Discussion: Monday, June 4, 11:30 a.m. – 12:30 p.m., E Arie Crown Theater
- Poster Session: Monday, June 4, 8:00 a.m. – 12:00 p.m., E450A, Poster Board 5

BAY 86-9766

A Phase II trial of MEK inhibitor BAY 86-9766 in combination with sorafenib as first-line systemic treatment for patients with unresectable hepatocellular carcinoma (HCC)
- Abstract #4103, General Poster Session: Gastrointestinal (Noncolorectal) Cancer
- Monday, June 4, 8:00 a.m. – 12:00 p.m., S Hall A2, Poster Board 48F

Regorafenib and radium-223 chloride are investigational agents and are not approved by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) or other Health Authorities.

About Nexavar
Nexavar is approved in the U.S. for the treatment of patients with unresectable liver cancer and for the treatment of patients with advanced kidney cancer. Nexavar inhibits both the tumor cell and tumor vasculature. In preclinical studies, Nexavar has been shown to inhibit members of two classes of kinases thought to be involved in both cell proliferation (growth) and angiogenesis (blood supply) – two important processes that enable cancer growth. These kinases included Raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET.

Nexavar is currently approved in more than 100 countries.

Nexavar is also being evaluated by the companies, international study groups, government agencies and individual investigators.

Important Safety Considerations for Patients Taking Nexavar

Nexavar in combination with carboplatin and paclitaxel is contraindicated in patients with squamous cell lung cancer. Nexavar may cause fetal harm when administered to a pregnant woman. Women of childbearing potential are advised to avoid becoming pregnant and female patients should also be advised against breastfeeding while receiving Nexavar.

Cardiac ischemia and/or myocardial infarction may occur. Temporary or permanent discontinuation of Nexavar should be considered in patients who develop cardiac ischemia and/or myocardial infarction. Gastrointestinal perforation was an uncommon adverse reaction and has been reported in less than 1% of patients taking Nexavar.

Uncommon but serious adverse reactions, including keratoacanthomas/squamous cell cancer of the skin and Stevens-Johnson Syndrome, have been reported in clinical trials.

An increased risk of bleeding may occur following Nexavar administration. If bleeding necessitates medical intervention, consider discontinuation of Nexavar. Hypertension may occur early in the course of treatment. Monitor blood pressure weekly during the first 6 weeks and periodically thereafter and treat, as required.

Hand-foot skin reaction and rash are common and management may include topical therapies for symptomatic relief. In cases of any severe or persistent adverse reactions, temporary treatment interruption, dose modification, or permanent discontinuation of Nexavar should be considered. Temporary interruption of Nexavar therapy is recommended in patients undergoing major surgical procedures. Nexavar can prolong the QT/QTc interval and increase the risk for ventricular arrhythmias. Avoid use in patients with congenital long QT syndrome and monitor patients with congestive heart failure, bradyarrhythmias, drugs known to prolong the QT interval, and electrolyte abnormalities.

Elevations in serum lipase and reductions in serum phosphate of unknown etiology have been associated with Nexavar. Monitor patients taking concomitant warfarin regularly for changes in prothrombin time, INR, or clinical bleeding episodes. Avoid concomitant use of strong CYP3A4 inducers, when possible, because inducers can decrease the systemic exposure of sorafenib. Nexavar exposure decreases when co-administered with oral neomycin. Effects of other antibiotics on Nexavar pharmacokinetics have not been studied.

Most common adverse reactions reported for Nexavar-treated patients vs placebo-treated patients in unresectable HCC, respectively, were: diarrhea (55% vs 25%), fatigue (46% vs 45%), abdominal pain (31% vs 26%), weight loss (30% vs 10%), anorexia (29% vs 18%), nausea (24% vs 20%), and hand-foot skin reaction (21% vs 3%). Grade 3/4 adverse reactions were 45% vs 32%.

Most common adverse reactions reported for Nexavar-treated patients vs placebo-treated patients in advanced RCC, respectively, were: diarrhea (43% vs 13%), rash/desquamation (40% vs 16%), fatigue (37% vs 28%), hand-foot skin reaction (30% vs 7%), alopecia (27% vs 3%),and nausea (23% vs 19%). Grade 3/4 adverse reactions were 38% vs 28%. During postapproval use of Nexavar, the following adverse drug reactions have been identified: angioedema and drug-induced hepatitis, including reports of hepatic failure and death.

For information about Nexavar including U.S. Nexavar prescribing information, visit www.nexavar.com or call 1.866.NEXAVAR (1.866.639.2827).

About Bayer HealthCare Pharmaceuticals Inc.
Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Medical Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare provides products for General Medicine, Hematology, Neurology, Oncology and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

Bayer®, the Bayer Cross® and Nexavar® are registered trademarks of Bayer.

Forward-Looking Statement
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

SOURCE Bayer HealthCare

Onyx Pharmaceuticals Announces Data Presentations at 48th American Society of Clinical Oncology Annual Meeting

Wed, 16 May 2012 08:00:00 -0400

May 16, 2012 08:00 ET

Onyx Pharmaceuticals Announces Data Presentations at 48th American Society of Clinical Oncology Annual Meeting

SOUTH SAN FRANCISCO, Calif., May 16, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the upcoming presentations of data highlighting Nexavar® (sorafenib) tablets, Kyprolis™ (proposed trademark for carfilzomib) and regorafenib, a Bayer-owned compound for which Onyx will receive a royalty on global net sales. These presentations will take place at the 48th American Society of Clinical Oncology (ASCO) Annual Meeting, June 1-5, 2012, in Chicago, IL.

"The data being presented at ASCO demonstrates Onyx's commitment to bringing innovative treatment options to cancer patients, and we are excited to share this breadth of data across a range of cancers," said Ted W. Love, M.D., Executive Vice President, Research and Development and Technical Operations at Onyx Pharmaceuticals.

Regorafenib

Randomized Phase III trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU) – GRID trial

Dr. George D. Demetri, Dana Farber Cancer Institute, United States
Monday, June 4, 2012
Oral presentation: 5:30 PM – 5:45 PM, S406
Oral abstract session – Sarcoma
Abstract #LBA10008

Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC)

Dr. Eric Van Cutsem, University of Leuven and Gasthuisberg University Hospital, Leuven, Belgium
Sunday, June 3, 2012
Oral presentation: 10:15 AM – 10:30 AM, E Hall D1
Oral abstract session – Gastrointestinal (Colorectal) Cancer
Abstract #3502

Regorafenib is an investigational agent and is not approved by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) or other health authorities.

Kyprolis™ (proposed trademark for carfilzomib)

Response rates to single-agent carfilzomib in patients refractory or intolerant to both bortezomib and immunomodulators in trial PX-171-003-A1

Dr. David S. Siegel, Hackensack University Medical Center, United States
Saturday, June 2, 2012
Poster viewing: 8:00 AM - 12:00 PM, E450b
Poster discussion: 12:00 PM-1:00 PM, E354a
Poster discussion session – Lymphoma and Plasma Cell Disorders, Poster #15
Abstract #8035

Phase I/II study of carfilzomib plus melphalan-prednisone (CMP) in elderly patients with de novo multiple myeloma

Dr. Brigitte Kolb, University Hospital, Nantes, France
Sunday, June 3, 2012
Oral presentation: 8:00 AM - 8:15 AM, E354a
Oral Abstract Session - Myeloma
Abstract #8009

A Phase I/II trial of cyclophosphamide, carfilzomib, thalidomide and dexamethasone (CYCLONE) in patients with newly diagnosed multiple myeloma

Dr. Joseph Mikhael, Mayo Clinic, United States
Sunday, June 3, 2012
Oral presentation: 8:15 AM - 8:30 AM, E354a
Oral Abstract Session - Myeloma
Abstract #8010

Stringent complete response (sCR) in patients (pts) with newly diagnosed multiple myeloma (NDMM) treated with carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (DEX)

Dr. Andrzej J. Jakubowiak, University of Chicago, United States
Sunday, June 3, 2012
Oral presentation: 8:30 AM - 8:45 AM, E354a
Oral Abstract Session – Myeloma
Abstract #8011

Hematologic safety data from four phase II studies of single-agent carfilzomib in relapsed and/or refractory multiple myeloma

Dr. Ajay K. Nooka, Emory University School of Medicine, United States
Monday, June 4, 2012
Poster time: 1:15 PM - 5:15 PM, S Hall A2
General poster session – Lymphoma and Plasma Cell Disorders, Poster #37C
Abstract #8086

A phase I/II study of carfilzomib (CFZ) as a replacement for bortezomib (BTZ) for multiple myeloma (MM) patients (Pts) progressing while receiving a BTZ-containing combination regimen

Dr. James R. Berenson, Institute for Myeloma and Bone Cancer Research (IMBCR), United States
Monday, June 4, 2012
Poster time: 1:15 PM - 5:15 PM, S Hall A2
General poster session – Lymphoma and Plasma Cell Disorders, Poster #38G
Abstract #8098

A single-arm, open-label, multicenter phase I/II study of the combination of panobinostat (pan) and carfilzomib (cfz) in patients (pts) with relapsed/refractory multiple myeloma (RR MM)

Dr. Jesus G. Berdeja, Sarah Cannon Research Institute, United States
Monday, June 4, 2012
Poster time: 1:15 PM - 5:15 PM, S Hall A2
General poster session – Lymphoma and Plasma Cell Disorders, Poster #40H
Abstract #TPS8115

Nexavar® (sorafenib) tablets

A Phase II trial of MEK inhibitor BAY 86-9766 in combination with sorafenib as first-line systemic treatment for patients with unresectable hepatocellular carcinoma (HCC)

Dr. Ho Yeong Lim, Sungkyunkwan University School of Medicine, Korea
Monday, June 4, 2012
Poster viewing: 8:00 AM – 12:00 PM, S Hall A2
General poster session – Gastrointestinal (Noncolorectal) Cancer, Poster #48F
Abstract #4103

About the Kyprolis™ (proposed trademark for carfilzomib) Development Program

Kyprolis is an investigational agent and is not approved by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) or other health authorities.

A new drug application (NDA) for Kyprolis for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior therapies is currently being reviewed by the U.S. FDA, and the anticipated date for completion of review is July 27, 2012. The NDA submission is based on the Kyprolis 003-A1 study, an open-label, single-arm Phase 2b trial, as well as safety data from additional studies.

Kyprolis is being studied in several clinical trials either as a single-agent or in combination with other therapies, including:

A Phase 3 clinical trial, known as the ASPIRE trial, has completed enrollment and is evaluating the combination of lenalidomide and low-dose dexamethasone with or without Kyprolis in patients with relapsed multiple myeloma who have received one to three prior therapies. The company has an agreement with the FDA on a Special Protocol Assessment (SPA) and has received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the trial.
A Phase 3 clinical trial, called the FOCUS trial, is evaluating single-agent Kyprolis in patients with relapsed and refractory myeloma who have received three or more prior therapies. The trial is designed to facilitate regulatory approvals around the world.
A Phase 3 clinical trial, called ENDEAVOR, is planned to begin enrolling patients in mid-2012. The head-to-head trial will evaluate the combination of Kyprolis and low-dose dexamethasone vs. the combination of bortezomib and low-dose dexamethasone.
A Phase 1/2 study being conducted by Onyx's partner Ono Pharmaceutical Co., Ltd is evaluating Kyprolis in Japanese patients with relapsed/refractory multiple myeloma.

About Nexavar (sorafenib) tablets

Nexavar is approved in the U.S. for the treatment of patients with unresectable liver cancer and for the treatment of patients with advanced kidney cancer. Nexavar inhibits both the tumor cell and tumor vasculature. In preclinical studies, Nexavar has been shown to inhibit members of two classes of kinases thought to be involved in both cell proliferation (growth) and angiogenesis (blood supply) – two important processes that enable cancer growth. These kinases included Raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET.

Nexavar is currently approved in more than 100 countries.

Nexavar is also being evaluated by the companies, international study groups, government agencies and individual investigators.

Important Safety Considerations for Patients Taking Nexavar

Uncommon but serious adverse reactions, including keratoacanthomas/squamous cell cancer of the skin and Stevens-Johnson Syndrome, have been reported in clinical trials.

For information about Nexavar including U.S. Nexavar prescribing information, visit www.nexavar.com or call 1.866.NEXAVAR (1.866.639.2827).

About Onyx Pharmaceuticals, Inc.

Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx.com.

Nexavar® (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals, Inc. ("Bayer")

Kyprolis is the proposed trade name for carfilzomib.

Regorafenib is a compound under development by Bayer; Onyx will receive a royalty on potential future global net sales in human oncology and will co-promote with Bayer in the U.S.

This news release contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include, without limitation, statements regarding the potential expansion of Onyx's product portfolio, the possibility of royalty payments to Onyx from the sale of regorafenib, and the timing, progress and results of clinical development and the regulatory approval process. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including, but not limited to, risks and uncertainties related to: Nexavar being our only approved product; we may never receive marketing approval for Kyprolis (carfilzomib) or regorafenib; competition; failures or delays in our clinical trials or the regulatory process; dependence on our collaborative relationship with Bayer; if approved, we or Bayer, as the case may be, may be unsuccessful in launching, maintaining adequate supply of or obtaining reimbursement for Kyprolis or regorafenib; market acceptance and the rate of adoption of our products; pharmaceutical pricing and reimbursement pressures; serious adverse side effects, if they are associated with Nexavar, regorafenib or Kyprolis; government regulation; possible failure to realize the anticipated benefits of business acquisitions or strategic investments; protection of our intellectual property; the indebtedness incurred through the sale of our 4.0% convertible senior notes due 2016; and product liability risks. Reference should be made to Onyx's Annual Report on Form 10-K for the year ended December 31, 2011 filed with the Securities and Exchange Commission, as updated by Onyx's subsequent Quarterly Reports on Form 10-Q, under the heading "Risk Factors" for a more detailed description of these and other risks. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release. Onyx undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

SOURCE Onyx Pharmaceuticals, Inc.

Lilly Oncology To Disclose New Pipeline Data At ASCO 2012

Mon, 14 May 2012 09:00:00 -0400

May 14, 2012 09:00 ET

Lilly Oncology To Disclose New Pipeline Data At ASCO 2012

Updates on Three of Six Ongoing Phase III Ramucirumab Trials to Be Presented

INDIANAPOLIS, May 14, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present data from several molecules that make up its clinical oncology pipeline during the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, Ill. from June 1 – 5, 2012.

Lilly Oncology has more than 30 molecules in early- and late-stage development to treat various types of cancer. The company remains committed to evaluating each of its molecules for biomarkers or genetic mutations that can help better identify the specific patients who will better respond to these medicines.

Early-Stage Pipeline Results

Lilly early-stage pipeline molecules will be featured at oral presentations at ASCO with two first-in-human Phase I studies, one on its oral NOTCH inhibitor LY900009 and the other for its oral p38 MAPK inhibitor LY2228820 dimesylate, both being evaluated in patients with advanced cancer. Another oral presentation will highlight LY2780301, an oral P70S6K/AKT inhibitor, a first-in-human Phase I study of patients with refractory solid tumors.

Late-Stage Ramucirumab Updates

Lilly will also present several trials-in-progress posters representing a portion of the broad Phase III clinical development program for ramucirumab, a fully human IgG1 monoclonal antibody receptor antagonist designed to bind to the extracellular domain of vascular endothelial growth factor receptor-2 (VEGFR-2). Trial updates for ramucirumab will focus on its ongoing Phase III trials in metastatic colorectal cancer, metastatic gastric adenocarcinoma and hepatocellular cancer, as well as results of a Phase II study in persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.

Ramucirumab represents one of the largest clinical programs currently underway at Lilly. Six global Phase III trials – one each in breast, colorectal, hepatocellular and lung cancer, and two in gastric cancer – are ongoing and patient enrollment milestones have recently been achieved in both the Phase III breast and gastric (monotherapy) cancer trials.

"Lilly Oncology's clinical pipeline is one of the most diverse in the industry, including a mix of large and small molecules that target a broad range of cancers," said Richard Gaynor, M.D., vice president, product development and medical affairs for Lilly Oncology. "We believe that our broad oncology research and development program will lead to new therapies for a wide array of patients."

Times and Locations of the Data Sessions:

Ramucirumab (IMC-1121B)

Abstract #5012: Poster Session: Friday, June 1, 2012, 1:00 PM - 5:00 PM
- A phase II, open-label, multicenter study of IMC-1121B (ramucirumab; RAM) monotherapy in the treatment of persistent or recurrent epithelial ovarian (EOC), fallopian tube (FTC), or primary peritoneal (PPC) carcinoma (CP12-0711/NCT00721162).
- Author/Speaker: Richard T. Penson
- Location: E450a; Poster Board 1

Abstract #TPS3634: Trials in Progress Poster Session: Monday, June 4, 2012, 8:00 AM - 12:00 PM
- A randomized, double-blind, phase (Ph) III study of the irinotecan-based chemotherapy FOLFIRI plus ramucirumab (RAM) or placebo (PL) in patients (pts) with metastatic colorectal carcinoma (mCRC) progressive during or following first-line therapy with bevacizumab (BEV), oxaliplatin (OXALI), and a fluoropyrimidine (FP) (RAISE) (NCT01183780).
- Author/Speaker: Axel Grothey
- Location: S Hall A2; Poster Board 38G

Abstract #TPS4139: Trials in Progress Poster Session: Monday, June 4, 2012, 8:00 AM - 12:00 PM
- A randomized, multicenter, double-blind, placebo (PBO)-controlled phase III study of paclitaxel (PTX) with or without ramucirumab (IMC-1121B; RAM) in patients (pts) with metastatic gastric adenocarcinoma, refractory to or progressive after first-line therapy with platinum (PLT) and fluoropyrimidine (FP).
- Author/Speaker: Hansjochen Wilke
- Location: S Hall A2; Poster Board 53B

Abstract #TPS4146: Trials in Progress Poster Session: Monday, June 4, 2012, 8:00 AM - 12:00 PM
- A multicenter, randomized, double-blind, phase III study of ramucirumab (IMC-1121B; RAM) and best supportive care (BSC) versus placebo (PBO) and BSC as second-line treatment in patients (pts) with hepatocellular carcinoma (HCC) following first-line therapy with sorafenib (SOR).
- Author/Speaker: Andrew X. Zhu
- Location: S Hall A2; Poster Board 54A

NOTCH inhibitor (LY900009)

Abstract #3008: Oral Abstract Session: Sunday, June 3, 2012, 12:15 PM - 12:30 PM
- A first-in-human phase I study of the oral Notch inhibitor LY900009 in patients with advanced cancer
- Author/Speaker: Shubham Pant
- Location: E Arie Crown Theater

p38 MAPK inhibitor (LY2228820 dimesylate)

Abstract # 3001: Oral Abstract Session: Sunday, June 3, 2012, 10:00 AM – 10:15 AM
- A first-in-human phase I study of the oral p38 MAPK inhibitor LY2228820 dimesylate in patients with advanced cancer.
- Author/Speaker: Matthew P. Goetz
- Location: E Arie Crown Theater

P70S6K/AKT inhibitor (LY2780301)

Abstract # 3005: Oral Abstract Session: Sunday, June 3, 2012, 11:15 AM – 11:30 AM
- First-in-human phase I study of LY2780301, an oral P70S6K/AKT inhibitor, in patients with refractory solid tumors.
- Author/Speaker: Emiliano Calvo
- Location: E Arie Crown Theater

P-LLY

This press release contains forward-looking statements about the potential of ramucirumab, LY900009, LY2228820 dimesylate and LY2780301 and reflects Lilly's current beliefs. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. There is no guarantee that the products will be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO)

SOURCE Eli Lilly and Company

Lilly Oncology to Highlight Final Results for Phase III Study in Most Common Form of Lung Cancer

Mon, 14 May 2012 09:00:00 -0400

May 14, 2012 09:00 ET

Lilly Oncology to Highlight Final Results for Phase III Study in Most Common Form of Lung Cancer

PARAMOUNT Study One of More than 25 Lilly Oncology Studies at Key Cancer Meeting

INDIANAPOLIS, May 14, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present data from more than 25 studies at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. from June 1 – 5, 2012, including overall survival results from PARAMOUNT, a Phase III study of an ALIMTA® (pemetrexed for injection)-based continuation maintenance regimen for the treatment of advanced nonsquamous non-small cell lung cancer. Lilly presented progression-free survival data from PARAMOUNT at the 2011 ASCO meeting.

Other Lilly Oncology research being presented at ASCO will include additional clinical data on ALIMTA.

ALIMTA Studies:

Abstract # LBA7507: Oral Abstract Session: Monday, June 4, 2012; 5:15 PM – 5:30 PM
- PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed plus best supportive care versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer
- Author/Speaker: Luis Paz-Ares
- Location: E Hall D2

Abstract # 7002: Oral Abstract Session: Monday, June 4, 2012; 8:30 AM – 8:45 AM
- Phase II Study of pemetrexed plus carboplatin or cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIA/B non-small cell lung cancer
- Author/Speaker: Hak Choy
- Location: E Hall D2

P-LLY

This press release contains forward-looking statements about the potential of ALIMTA and reflects Lilly's current beliefs. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. There is no guarantee that the product will continue to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )

SOURCE Eli Lilly and Company

Embedded Wireless Announces Connected Health Solution with Real-Time Data Accessible Over the Cloud at ATA 2012

Wed, 16 May 2012 08:34:15 -0400

Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer

Thu, 17 May 2012 08:00:00 -0400

SAN FRANCISCO, May 17, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) will showcase radiosurgery technologies for treating early-stage inoperable lung cancer and other conditions non-invasively at the 2012 International Conference of the American Thoracic Society (ATS) later this week in San Francisco.

"We're excited about putting our technology in front of pulmonologists who may not be familiar with radiosurgery as a treatment option for early-stage, inoperable lung cancer," said Calvin Huntzinger, M.S., senior director of surgical sciences at Varian. "Research has been accruing to show that radiosurgery can be a viable option for these patients.[1] In addition, a major NCI-funded study is under way to see if that viability extends to high-risk operable Stage I lung cancer patients." [2]

Varian will exhibit RapidArc® Radiosurgery on its TrueBeam™ STx system at the meeting. The technology enables clinicians to precisely target and rapidly treat tumors using finely shaped high-energy X-ray beams. Clinicians who are gaining early experience in the clinical use of RapidArc® Radiosurgery are reporting that this approach can be performed quickly and accurately in the treatment of many thoracic tumors.[3],[4],[5],[6]

The TrueBeam STx system was engineered to enable precise, efficient treatment, two to eight times faster than other radiosurgery machines. A high-definition multileaf collimator, or beam-shaping device, shapes the dose so that it closely matches the shape of the targeted tumor to minimize exposure of delicate healthy lung tissues and of other nearby organs, such as the heart or spinal cord.

"Radiosurgery procedures in the body have been made possible by a fairly recent convergence of technological innovations that enable precise beam shaping, real-time image guidance, and motion management," says Robert Timmerman, M.D., professor of radiation oncology at the University of Texas Southwestern Medical Center in Dallas. Dr. Timmerman will be speaking at the conference on the role of stereotactic body radiation therapy in the treatment of lung cancer.

"Radiosurgery for lung cancer, which historically has been very difficult to treat, is of growing interest to the members of the American Thoracic Society, as evidenced by the rapid growth of its Section on Thoracic Oncology," Huntzinger said. "Since last year, the section went from 230 to 505 members, more than doubling in size. We're delighted to see the heightened interest in thoracic oncology because we want clinicians to know how high precision radiosurgery can be used to treat patients who would have had few or no treatment options before."

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications. Varian Medical Systems employs approximately 6,000 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter. Varian's medical devices are indicated to provide stereotactic radiosurgery and precision radiotherapy for lesions, tumors, and conditions anywhere in the body when radiation treatment is indicated. While clinical studies such as those highlighted here may support the effectiveness of Varian's technology when used for radiotherapy or radiosurgery, individual results may vary. There are no guarantees of outcome.

[1] Timmerman R et al. Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer. JAMA. 2010;303(11):1070-1076. doi: 10.1001/jama.2010.261

[2]Phase III Randomized Study of Sublobar Resection With or Without Brachytherapy Versus Stereotactic Body Radiotherapy in High-Risk Patients With Stage I Non-Small Cell Lung Cancer. Information is available at the NCI website at the following URL: http://www.cancer.gov/clinicaltrials/search/view?cdrid=698986&protocolsearchid=9090456&version=patient.

[3] Palma DA, Senan S, Haasbeek CJ, Verbakel WF, Vincent A, Lagerwaard F. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques. Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):506-13.

[4] Ong CL, Verbakel WF, Cuijpers JP, Slotman BJ, Lagerwaard FJ, Senan S. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques. Radiother Oncol. 2010 Dec;97(3):437-42

[5] Ong CL, Palma D, Verbakel WF, Slotman BJ, Senan S. Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity. Radiother Oncol. 2010 Dec;97(3):431-6.

[6] Verbakel WF, Senan S, Cuijpers JP, Slotman BJ, Lagerwaard FJ. Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. Radiother Oncol. 2009 Oct;93(1):122-4.

FOR INFORMATION CONTACT:
Meryl Ginsberg, 650.424.6444
meryl.ginsberg@varian.com

SOURCE Varian Medical Systems

CTG to Present on May 23, 2012 at the B. Riley & Co. 13th Annual Investor Conference

Wed, 16 May 2012 11:52:00 -0400

May 16, 2012 11:52 ET

CTG to Present on May 23, 2012 at the B. Riley & Co. 13th Annual Investor Conference

BUFFALO, N.Y., May 16, 2012 /PRNewswire/ -- CTG (NASDAQ: CTGX), an information technology (IT) solutions and services company, today announced that its Chairman and Chief Executive Officer James R. Boldt will present at the B. Riley & Co. 13^th Annual Investor Conference at the Loews Santa Monica Beach Hotel in Santa Monica, California on Wednesday May 23, 2012 at 10:00 AM Pacific Time.

At the time of the presentation, a live audio webcast of CTG's presentation and a copy of the presentation materials will be available on the Company's web site at www.ctg.com and archived there for 60 days following completion of the presentation.

About CTG
CTG develops innovative IT solutions to address the business needs and challenges of companies in several higher-growth industries including healthcare, energy, and technology services. As a leading provider of IT and business consulting solutions to the healthcare market, CTG offers hospitals, physician groups, and regional health information exchanges a full range of electronic medical record services. Additionally, CTG has developed for the healthcare provider and payer markets unique, proprietary software solutions that support better and lower cost healthcare. CTG also provides managed services IT staffing for major technology companies and large corporations. Backed by 46 years' experience, proprietary methodologies, and an ISO 9001-certified management system, CTG has a proven track record of delivering high-value, industry-specific solutions. CTG had 3,700 employees at the end of the 2012 first quarter and operates in North America and Western Europe. CTG posts news and other important information on the Web at www.ctg.com.

About B. Riley & Co.
B. Riley & Co. is a leading independent investment bank which provides a full array of corporate finance, research, sales, trading and otcqx dad services to corporate, institutional and high net worth individual clients. Investment banking services include merger and acquisitions advisory to public and private middle market companies, initial and secondary public offerings and institutional private placements. Its Corporate Governance Advisory Services Group is engaged by both companies and investors to help maximize value for shareholders. The firm is recognized for its distinguished Equity Research. Founded in 1997, B. Riley is headquartered in Los Angeles and maintains offices in Newport Beach, San Francisco, Boston and New York. It is a member of FINRA and SIPC. For more information, please visit www.brileyco.com

Safe Harbor Statement

This document contains certain forward-looking statements concerning the Company's current expectations as to future growth. These statements are based upon a review of industry reports, current business conditions in the areas where the Company does business, the availability of qualified professional staff, the demand for the Company's services, and other factors that involve risk and uncertainty. As such, actual results may differ materially in response to a change in such factors. Such forward-looking statements should be read in conjunction with the Company's disclosures set forth in the Company's 2011 Form 10-K, which is incorporated by reference. The Company assumes no obligation to update the forward-looking information contained in this release.

ctgx-g

SOURCE CTG

The Female Health Company to Present At B. Riley & Co. 13th Annual Investor Conference

Wed, 16 May 2012 08:30:00 -0400

May 16, 2012 08:30 ET

The Female Health Company to Present At B. Riley & Co. 13th Annual Investor Conference

CHICAGO, May 16, 2012 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO) – today announced that the company will present at the B. Riley & Co. 13th Annual Investor Conference on Monday, May 21, 2012 at 3:30 p.m. in the Arcadia D room, at the Loews Santa Monica Beach Hotel.

Management will provide an overview of the company that will be available to interested parties through a live, listen-only audio web broadcast via the Internet on the Company's website: www.femalehealth.com. Listeners are encouraged to visit the web site at least 15 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software. The presentation will available for replay after 24 hours, and will be archived and accessible on the web site for at least 90 days.

About The Female Health Company

The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom® (FC2), which is available in the U.S. and in about 130 other countries globally. The Company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued in the U.S., the European Union, Canada, Australia, South Africa, Japan, The People's Republic of China, Spain, Mexico, Greece, Turkey and the African Regional Intellectual Property Organization (ARIPO), which includes Botswana, The Gambia, Ghana, Kenya, Lesotho, Malawi, Mozambique, Namibia, Sierra Leone, Somalia, Sudan, Swaziland, Uganda, United Republic of Tanzania, Zambia and Zimbabwe. FC2 patent applications are pending in various countries. The FC2 Female Condom® is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted infections, including HIV/AIDS, and unintended pregnancy. The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies.

"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:
The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings. Actual events affecting the Company and the impact of such events on the Company's operations may vary from those currently anticipated.

For more information about The Female Health Company visit the Company's website at http://www.femalehealth.com and http://www.femalecondom.org. If you would like to be added to the Company's e-mail alert list, please send an e-mail to FHCInvestor@femalehealthcompany.com

SOURCE The Female Health Company

Heska to Present at B. Riley Investor Conference

Wed, 16 May 2012 07:00:00 -0400

May 16, 2012 07:00 ET

Heska to Present at B. Riley Investor Conference

LOVELAND, Colo., May 16, 2012 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA - News), a provider of advanced veterinary diagnostic and other specialty veterinary products, today announced it is to present at the 13th Annual B. Riley & Co. Investor Conference on Wednesday, May 23, 2012 at the Loews Santa Monica Beach Hotel, 1700 Ocean Avenue – Arcadia D in Santa Monica, California. The presentation is scheduled to begin at 1 p.m. Pacific Time (2 p.m. Mountain Time). The presentation is to be available via live webcast and for two weeks following through a link on Heska Corporation's website (www.heska.com).

About Heska

Heska Corporation (NASDAQ: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, pharmaceuticals and vaccines. The company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at www.heska.com.

SOURCE Heska Corporation

ClearOne to Present at the 13th Annual B. Riley & Co. Investor Conference

Tue, 15 May 2012 19:49:00 -0400

SALT LAKE CITY, May 15, 2012 /PRNewswire/ -- ClearOne (NASDAQ: CLRO) today announced it will present to the financial community at the 13th Annual B. Riley & Co. Investor Conference.

Date:	May 22, 2012
Time:	1:00 p.m. PDT
Location:	Lowes Santa Monica Beach Hotel
Presenter:	Zee Hakimoglu, President and CEO

The three-day annual event brings together a targeted audience of leading institutional investors, financial services professionals and other qualified investors. The conference will feature presentations from nearly 200 companies in a broad range of sectors, including technology, consumer, retail and financials.

About ClearOne
ClearOne is a global company that designs, develops and sells conferencing, collaboration, streaming and digital signage solutions for audio, video and data multimedia communication. The performance and simplicity of its advanced comprehensive solutions enhance the quality of life. ClearOne products are designed for business and residential use, offering unprecedented levels of functionality, reliability and scalability. More information about the company can be found at www.clearone.com.

Contact:
Jeff LeFevre
Investor Relations
801-303-3438
jeff.lefevre@clearone.com

SOURCE ClearOne

Symmetricom to Present at the 13th Annual B. Riley & Co. Investor Conference on May 23

Mon, 14 May 2012 12:00:00 -0400

SAN JOSE, Calif., May 14, 2012 /PRNewswire/ --Symmetricom®, Inc. (NASDAQ:SYMM), a worldwide leader in precision time and frequency technologies, today announced that Dave Cote, President and Chief Executive Officer, will present at the 13th Annual B. Riley & Co. Investor Conference in Santa Monica, CA on Wednesday, May 23, 2012. The presentation is scheduled to begin at 8:30 a.m. Pacific Time.

(Logo: http://photos.prnewswire.com/prnh/20110829/AQ59077LOGO)

The presentation will be webcast and will be available on the Investor Relations section of the company's website at http://www.symmetricom.com.

About Symmetricom, Inc.
Symmetricom (NASDAQ:SYMM), a world leader in precise time solutions, sets the world's standard for time. The company generates, distributes and applies precise time for the communications, aerospace/defense, IT infrastructure and metrology industries. Symmetricom's customers, from communications service providers and network equipment manufacturers to governments and their suppliers worldwide, are able to build more reliable networks and systems by using the company's advanced timing technologies, atomic clocks, services and solutions. All products support today's precise timing standards, including GPS-based timing, IEEE 1588 (PTP), Network Time Protocol (NTP), Synchronous Ethernet and DOCSIS® timing. Symmetricom is based in San Jose, Calif., with offices worldwide. For more information, visit: http://www.symmetricom.com or join the dialogue at http://www.twitter.com/symmetricom.

SYMM-G

Contact:
Dan Madden
VP Finance & Investor Relations
+1-408-428-7929
dmadden@symmetricom.com

SOURCE Symmetricom, Inc.

Cogent Communications CEO to Present at Two Upcoming Conferences

Mon, 14 May 2012 11:46:00 -0400

May 14, 2012 11:46 ET

Cogent Communications CEO to Present at Two Upcoming Conferences

WASHINGTON, May 14, 2012 /PRNewswire/ -- Cogent Communications Group, Inc. (NASDAQ: CCOI), one of the largest Internet service providers in the world, today announced that Dave Schaeffer, Cogent's chief executive officer, will present at the following conferences:

The Barclays Capital 2012 Global Technology, Media and Telecommunications Conference is being held at the Sheraton New York Hotel & Towers in New York, NY. Dave Schaeffer will be presenting on Tuesday, May 22nd at 9:30 a.m. ET.

The B. Riley & Co. 13th Annual Investor Conference is being held at the Loews Santa Monica Beach Hotel in Santa Monica, CA. Dave Schaeffer will be presenting at 3:00 p.m. PT on Wednesday, May 23rd.

(Logo: http://photos.prnewswire.com/prnh/20020204/DCM032LOGO )

Investors and other interested parties may access a live audio webcast of the conference presentations by going to the "Events" section of Cogent's website at www.cogentco.com/events. A replay of the webcasts will be available on Cogent's website for 90 days following the presentations.

About Cogent Communications
Cogent Communications (NASDAQ: CCOI) is a multinational, Tier 1 facilities-based ISP, consistently ranked as one of the top five networks in the world. Cogent specializes in providing businesses with high speed Internet access, point-to-point transport and colocation services. Cogent's facilities-based, all-optical IP network backbone provides IP services in over 175 markets globally.

Since its inception, Cogent has unleashed the benefits of IP technology, building one of the largest and highest capacity IP networks in the world. This network enables Cogent to offer large bandwidth connections at highly competitive prices. Cogent also offers superior customer support by virtue of its end-to-end control of service delivery and network monitoring.

Cogent Communications is headquartered at 1015 31st Street, NW, Washington, D.C. 20007. For more information, visit www.cogentco.com. Cogent Communications can be reached in the United States at (202) 295-4200 or via email at info@cogentco.com.

Information in this release may involve expectations, beliefs, plans, intentions or strategies regarding the future. These forward-looking statements involve risks and uncertainties. All forward-looking statements included in this release are based upon information available to Cogent Communications Group, Inc. as of the date of the release, and we assume no obligation to update any such forward-looking statement. The statements in this release are not guarantees of future performance and actual results could differ materially from our current expectations. Numerous factors could cause or contribute to such differences. Some of the factors and risks associated with our business are discussed in Cogent's registration statements filed with the Securities and Exchange Commission and in its other reports filed from time to time with the SEC.

SOURCE Cogent Communications

Inventure Foods to Participate in Upcoming Investor Conferences

Mon, 14 May 2012 09:12:00 -0400

May 14, 2012 09:12 ET

Inventure Foods to Participate in Upcoming Investor Conferences

PHOENIX, May 14, 2012 /PRNewswire/ -- Inventure Foods, Inc. (Nasdaq: SNAK), a leading specialty food marketer and manufacturer, today announced that Terry McDaniel, President and CEO, and Steve Weinberger, CFO, will present to the investment community at the Janney Capital Markets Consumer Conference and the 13^th Annual B. Riley & Co. Investor Conference this month.

Janney Capital Markets Consumer Conference
Date: Monday, May 21, 2012
Location: The State Room, Boston, MA
No Formal Presentation

13^th Annual B. Riley & Co. Investor Conference
Date: Tuesday, May 22, 2012
Location: Loews Santa Monica Beach Hotel, Santa Monica, CA
Presentation: 4:00 p.m. PT (7:00 p.m. ET)

The B. Riley conference presentation will be available to all interested parties through a live audio webcast accessible in the investor relations section of Inventure Foods' website at www.inventurefoods.com, where it will be archived for 90 days following the presentation.

About Inventure Foods, Inc.

With manufacturing facilities in Arizona, Indiana and Washington, Inventure Foods, Inc. (Nasdaq: SNAK) is a marketer and manufacturer of specialty food brands in better-for-you and indulgent categories under a variety of Company owned and licensed brand names, including Boulder Canyon Natural Foods™, Jamba®, Rader Farms®, T.G.I. Friday's®, Nathan's Famous®, BURGER KING™, Poore Brothers®, Tato Skins® and Bob's Texas Style®. For further information about Inventure Foods, please visit www.inventurefoods.com.

Statements contained in this press release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that may cause actual results to differ from the forward-looking statements contained in this press release and that may affect the Company's prospects in general include, but are not limited to, general economic conditions, increases in cost or availability of ingredients, packaging, energy and employees, price competition and industry consolidation, ability to execute strategic initiatives, product recalls or safety concerns, disruptions of supply chain or information technology systems, customer acceptance of new products and changes in consumer preferences, food industry and regulatory factors, interest rate risks, dependence upon major customers, dependence upon existing and future license agreements, the possibility that we will need additional financing due to future operating losses or in order to implement the Company's business strategy, acquisition-related risks, the volatility of the market price of the Company's common stock, and such other factors as are described in the Company's filings with the Securities and Exchange Commission.

SOURCE Inventure Foods, Inc.

Lantiq Visionaries Lend Expertise at Upcoming Conferences

Mon, 14 May 2012 04:00:00 -0400

May 14, 2012 04:00 ET

Lantiq Visionaries Lend Expertise at Upcoming Conferences

MUNICH and NEUBIBERG, Germany, May 14, 2012 /PRNewswire/ -- Lantiq, a leading supplier of broadband access and home networking technologies, will be participating in the following upcoming conferences and tradeshows with speaking engagements, booths and/or demonstrations:

Broadband-IP&TV Asia (Kuala Lumpur, Malaysia: May 15-16): The leading-edge technology exhibition featuring broadband technologies, equipment, applications, solutions, and services.
Computex (Taipei, June 5-9): The world's leading ICT procurement platform attracts ICT companies, buyers, journalists and observers from all over the world and has become the largest computer exhibition in Asia and the second largest in the world, next to CeBIT in Germany.
Conlife 2012 (Cologne, Germany; June 26-28): Congress and venue for the connected life and home.
Broadband World Forum Europe (Amsterdam, October 16-18): The indicator for the industry to recognize the market potential of the latest broadband content, entertainment, applications, and services for the enterprise and home, delivering the promise of the ultimate connected world.

(Logo: http://photos.prnewswire.com/prnh/20100930/NE71735LOGO )

During these tradeshows and conferences, Lantiq will be on-site to discuss the state of the industry, market trends, and future predictions. Lantiq will also be available to discuss recent advances in its own technology, including the world's smallest GPON solution, Lantiq FALC™ON, the industry's first VDSL2 vectoring chip, the XWAY™ IVE1000, enabling full system-level crosstalk noise cancellation, and its latest hybrid residential gateways bringing triple-wire and wireless connectivity to every corner of the home. Lantiq's next generation chipset solutions address gateway and central office system configurations ranging from cost-optimized fast Ethernet to feature-rich, high-performance Gigabit Ethernet systems. Lantiq has designed its products to enhance and extend telecom carriers' xDSL services in worldwide markets and enable carriers to meet the growing demand for triple-play services and in-home Gigabit throughput with significant cost, size and power savings at no system performance compromise.

Lantiq and carriers worldwide share the vision to make the Giga Home become reality, with the highest throughput and best quality of service (QoS) possible. Lantiq drives this vision with its innovative technologies, including vectoring with full system-level crosstalk noise cancellation, GPON and VDSL solutions, concurrent dual band Wi-Fi, G.hn chipsets for home networking applications, and broadband wireless LTE to home gateways.

To meet Lantiq's industry experts participating in these events, please contact us at: Media-Relations@Lantiq.com.

For news updates, visit Lantiq's News Center, follow our Twitter feed and/or, subscribe to our News Release RSS Feed.

About LANTIQ
Lantiq offers a broad and innovative product portfolio for next-generation networks and the digital home. The company specializes in broadband communications encompassing analog, digital and mixed-signal ICs along with comprehensive software suites. Lantiq is a fabless company and its semiconductor solutions are deployed by major carriers and in home networks in every region of the world. Further information is available at: www.lantiq.com and on Twitter at: https://twitter.com/lantiq.

SOURCE Lantiq

The Walking Dead Escape: San Diego Debuts at Petco Park to Celebrate Robert Kirkman's The Walking Dead Issue #100 During San Diego Comic-Con July 12-14, 2012

Wed, 16 May 2012 12:02:00 -0400

Multimedia Gallery

http://photos.prnewswire.com/prnc/20120516/NE08243

May 16, 2012 12:02 ET

The Walking Dead Escape: San Diego Debuts at Petco Park to Celebrate Robert Kirkman's The Walking Dead Issue #100 During San Diego Comic-Con July 12-14, 2012

Registration for The Walking Dead Escape: San Diego Opens May 16th

SAN DIEGO, May 16, 2012 /PRNewswire/ -- Robert Kirkman, the creator/writer of The Walking Dead comic book series and graphic novels and www.Skybound.com announce their first event, The Walking Dead Escape: San Diego. In conjunction with the release of the Eisner Award-winning The Walking Dead Issue #100 at San Diego Comic-Con, the event takes place July 12 -14 at Petco Park, centrally located near the San Diego Convention Center. Registration is now open at www.TheWalkingDeadEscape.com. There are three ways to participate in this epic adventure. Participants can be a Survivor and race through the zombie infested evacuation zone; a Walker who becomes one of the undead, embracing the inevitable; or a Spectator who watches the apocalypse from sidelines at the Escape Party.

(Photo: http://photos.prnewswire.com/prnh/20120516/NE08243)

The Walking Dead Escape: San Diego is unlike any obstacle course event in the U.S., expanding on the best-selling The Walking Dead comic book series and graphic novel storylines, allowing Survivors and Walkers to explore the initial days of the apocalypse.

"Our fans have been reading about it, watching it and now they get to live it with The Walking Dead Escape," said Robert Kirkman. "We are literally transforming Petco Park into the early days of society's collapse and San Diego is just the first city to fall."

Survivors will climb, crawl and slide in an effort to avoid confrontation by hordes of Walkers, while achieving the ultimate adventure on The Walking Dead-themed obstacle course. The Walking Dead Escape is not a race, and Survivors are not timed, but the end is near, and they must move swiftly. If they're lucky, Survivors will reach the decontamination zone at the end where it will be determined if they have been infected.

Whether taking part in the event as a Survivor, Walker or Spectator, participants will be amazed at the interactive displays and The Walking Dead references along the course. Early registration is strongly recommended, as walk-ups may not be available on event day. This summer The Walking Dead will be taking over Petco Park and fans will have a front row seat to the real-life action event of a lifetime.

For more information or to register for the event, please visit www.thewalkingdeadescape.com.

About Robert Kirkman

Robert Kirkman's success and passionate advocacy for creator-owned comics led him to become the first person invited to become a partner at Image Comics since the company's inception twenty years ago and he formed his own imprint there, Skybound, in 2010. Kirkman is the creator/writer of the Eisner Award-winning The Walking Dead, long-running Invincible, all-ages Super Dinosaur, The Astounding Wolf-Man, and new title Thief of Thieves, among many others. Kirkman has earned the respect of the comic, writing and television communities and topped the New York Times bestseller list for graphic novels in 2011 and in April 2012, he took the top five spots on both the hardcover and paperback lists. He's the creator/executive producer and writer of the hit television show, AMC's The Walking Dead, the highest-rated basic cable drama of all time in the U.S, also an international success in 120 countries and 250 million households. AMC just picked up Thief of Thieves as a series with Kirkman serving as creator/executive producer and writer. www.Skybound.com is your destination for all news and merchandise for Robert Kirkman, The Walking Dead and all Skybound titles.

SOURCE The Walking Dead Escape: San Diego

Stream TV Networks Partners With Unihan (Pegatron) To Manufacture Ultra-D

Wed, 16 May 2012 11:13:00 -0400

May 16, 2012 11:13 ET

Stream TV Networks Partners With Unihan (Pegatron) To Manufacture Ultra-D™

Stream TV announces a manufacturing partner for Ultra-D 3D without glasses technology

PHILADELPHIA, May 16, 2012 /PRNewswire/ -- Stream TV Networks, Inc. (www.StreamTVNetworks.com) is proud to announce a manufacturing partnership with Unihan (Pegatron) Corporation for Stream TV's 3D without glasses devices. The 3D without glasses devices will be equipped with Stream TV's proprietary Ultra-D™ technology.

The most exciting part of the Ultra-D technology is that it can be ported to displays of almost any size without any noticeable loss in brightness or resolution. Stream TV's initial manufacturing partnership with Unihan (Pegatron) will be to assemble 42-inch 3D without glasses displays and accompanying Ultra-D Seecube™ converter boxes that autoconvert 2D, 3D animation and stereoscopic 3D into 3D without glasses real-time. Other products in the partnership roadmap include tablets, smart phones, laptops, PCs, digital communicator and television sets of various sizes. Pegatron will be involved in helping to distribute Ultra-D devices worldwide. Stream TV and Pegatron will also collaborate to create a worldwide 3D without glasses format based on the Ultra-D technology as a standard for their customers and content and broadcasting companies.

"Unihan (Pegatron)'s enormous manufacturing and R&D capabilities will allow us to accelerate the release of Ultra-D products to reach consumers in 2012," said Mathu Rajan, CEO of Stream TV Networks, Inc. "Ultra-D is the next generation 3D technology designed to replace 3D with glasses and win preference over 2D devices."

Ultra-D is the gold standard when it comes to 3D without glasses technology. The new version of the devices gives a quality equal to the stereoscopic 3D but without the glasses. Ultra-D is the result of years of research and development in the field of optical delivery. The result is a state of the art display that allows the unassisted human eye to view live and recorded content in true 3D.

Ultra-D is a unique amalgam of hardware and software in perfect sync. It introduces a layer of lenses on display panels that directs light at an optimal angle to create a 3D image for the human eye. Behind the scenes, a matrix of sophisticated algorithms scans incoming feed to decipher the different layers that may be used to extrude and generate depth. This depth may be either user defined or computer generated and packaged into the Ultra-D format. Autoconversion happens in microseconds keeping video latency indiscernible to the human eye. Stream TV and its partners who have seen this technology at work predict that Ultra-D will be the standard for 3D displays and content.

The Seecube will convert any kind of content to Ultra-D eliminating the need to wait for the content world to start delivering 3D specific content. The autoconverter converts 2D content as well as 3D stereo content to Ultra-D content. Compatible content includes regular cable and satellite feeds including both 2D and with glasses 3D, Blu-ray, gaming devices like Xbox® and PS3®, websites like YouTube®, Netflix®, Hulu®, Facebook® and even video calls through services like Skype®. All pictures and home videos are now available with exceptional rendition of the content to 3D without glasses. Seecube supports iOS®, iPad®, iPhone® and Apple TV®, all of which can be connected to Seecube and all the content on iTunes® as well as apps from the Apple® app store will now be viewed in 3D without glasses. 3D without glasses adds a whole new dimension to the Apple ecosystem.

During the Computex show in Taiwan additional information and demonstration units will be available.

Additional partnerships and markets will be announced soon regarding Stream TV's 3D without glasses devices using the Ultra-D technology.

About Stream TV Networks, Inc.

Stream TV Networks, Inc. Is a Philadelphia-based new media company founded in 2009 to enhance entertainment and communications experiences through superior quality devices with unlimited accessibility. Through its brands and products, Stream TV Networks, Inc. intends to create a media landscape that supports on-demand access to content anytime and anywhere and nurture interactive user feedback, creative participation and community formation around media content. The company's mission is to redefine "new media" so that it reaches its true dynamic potential and real-time interactive relationship with the media consumer. For more information, please visit www.StreamTVNetworks.com.

About Pegatron

Founded in January 2008, Unihan (Pegatron) is a worldwide leader in electronic and computing dms (design and manufacturing service) with extensive experience in product development and vertically integrated capabilities. With equity of US$2.7 billion, Pegatron boasts a diversified product line, including motherboards, desktop pcs, notebooks, broadband, wireless systems, game consoles, networking equipment, set-top boxes, multimedia, LCD TVs, and more. Pegatron takes pride in its well-diversified product portfolio, unique designs, flexible manufacturing capabilities and reliable after-sale services.

SOURCE Stream TV Networks, Inc.

Lantiq Visionaries Lend Expertise at Upcoming Conferences

Mon, 14 May 2012 04:00:00 -0400

May 14, 2012 04:00 ET

Lantiq Visionaries Lend Expertise at Upcoming Conferences

Broadband-IP&TV Asia (Kuala Lumpur, Malaysia: May 15-16): The leading-edge technology exhibition featuring broadband technologies, equipment, applications, solutions, and services.
Computex (Taipei, June 5-9): The world's leading ICT procurement platform attracts ICT companies, buyers, journalists and observers from all over the world and has become the largest computer exhibition in Asia and the second largest in the world, next to CeBIT in Germany.
Conlife 2012 (Cologne, Germany; June 26-28): Congress and venue for the connected life and home.
Broadband World Forum Europe (Amsterdam, October 16-18): The indicator for the industry to recognize the market potential of the latest broadband content, entertainment, applications, and services for the enterprise and home, delivering the promise of the ultimate connected world.

(Logo: http://photos.prnewswire.com/prnh/20100930/NE71735LOGO )

To meet Lantiq's industry experts participating in these events, please contact us at: Media-Relations@Lantiq.com.

For news updates, visit Lantiq's News Center, follow our Twitter feed and/or, subscribe to our News Release RSS Feed.

SOURCE Lantiq

Consumers Slow to Embrace Cloud Services for Digital Media, Says Parks Associates

Thu, 17 May 2012 12:08:00 -0400

DALLAS, May 17, 2012 /PRNewswire/ -- International research firm Parks Associates reports 22% of U.S. broadband households currently would refuse to buy a "cloud copy" of digital media, while almost 30% would require a physical copy in addition to a cloud copy. Parks Associates and industry leaders will explore business models, profit strategies, and consumer interest for cloud services, storage, and computing at CONNECTIONS™ at TIA 2012, June 5-7, in Dallas, Texas. Cloud sessions feature executives from Catch Media, CSG Media, F-Secure, IBM, MediaNaviCo, Omnifone, Primadesk, and SugarSync.

(Logo: http://photos.prnewswire.com/prnh/20120308/DA66977LOGO)

"Roughly one-quarter of U.S. broadband households are interested in the 'cloud copy' concept, but for now, consumers in general are unwilling to pay a premium for cloud offerings, indicating a market still in its early stages," said Brett Sappington, Director, Research, Parks Associates. "Many companies are experimenting with business models around the personal cloud to find the path to profitability. At CONNECTIONS™, we will examine the lessons learned today that will allow tomorrow's personal cloud services to quickly become profitable and sustainable."

Cloud Sessions at CONNECTIONS™ at TIA 2012:

"The Media Cloud: Technology, Business, and the Consumer," June 5, 4:00 p.m., is sponsored by F-Secure. Speakers:

Marc Beckwitt, VP, Strategic Partnerships, MediaNaviCo, a Technicolor Company

Dean Bolte, Managing Director, The Americas, Omnifone

Nick Chakalos, President, Catch Media

Steve Levine, Director of Solutions, Content Cloud Ecosystem, F-Secure

Steve Samuels, SVP of Sales, CSG Media, LLC

"Industry Convergence and the Smarter Home Cloud," June 6, 2:30 p.m., is hosted and sponsored by IBM. Speakers:

Jerry Bruce, Consulting IT Specialist, IBM

Scott Burnett, Director, Global Consumer Electronics Industry, IBM Electronics Industry, IBM

Ted Connell, Senior Managing Consultant, IBM Global Business Services

Brian House, Senior Managing Consultant, IBM Strategy & Transformation

Eric Riddleberger, Vice President and Partner, IBM Global Business Services

"Personal Cloud - Path to Revenues," June 6, 3:30 p.m., examines solutions that allow consumers to store and access their personal content remotely. Speakers:

Srinivasa Venkataraman (Venky), CEO, Primadesk

Laura Yecies, CEO, SugarSync

CONNECTIONS™ at TIA, June 5-7 at the Gaylord Texan, is the leading event for service providers, device manufacturers, and advanced technology companies working on solutions for the connected consumer. The agenda features special research sessions on new growth markets and several sessions focused on digital content and entertainment services, including insights from executives at Best Buy, AT&T Digital Life, Starz Entertainment & Starz Media, TiVo, and Comcast.

More information about CONNECTIONS™ at TIA can be found at www.connectionsconference.com.

About CONNECTIONS™

The 16th annual CONNECTIONS™: The Digital Living Conference and Showcase, co-located with TIA 2012: Inside the Network on June 5-7 at the Gaylord Hotel, Dallas, Texas, focuses leading strategies to monetize digital content, mobile applications and services, value-added services, connected CE, and home systems.

For information, contact sales@parksassociates.com, call 972-490-1113, visit www.connectionsconference.com.

Mindi Sue Sternblitz-Rubenstein
Parks Associates
972-490-1113
mindi.sue@parksassociates.com

SOURCE Parks Associates

Parks Associates: Can "The Avengers" Save 3D TV?

Tue, 15 May 2012 11:25:00 -0400

DALLAS, May 15, 2012 /PRNewswire/ -- The record-breaking box office success of "The Avengers," in large part due to higher-priced 3D tickets, will increase consumer demand for access to 3D movies at home, according to analysts at Parks Associates. New research from the international firm shows U.S. 3D TV owners are satisfied with their TVs. A majority of them use their 3D TVs on a monthly basis, and 65% want access to more 3D movies.

(Logo: http://photos.prnewswire.com/prnh/20120307/MM66462LOGO)

Parks Associates recently released 3D TVs: Adoption, Use, and Purchase Intentions as part of its Connected CE and Platforms research service. The study includes a survey of over 600 3D TV owners and found 56% were "very satisfied" with their TV's 3D features. In addition to more 3D movies, 49% of consumers surveyed want more 3DTV program options, and 45% want more 3D games.

"People who have a 3D TV use it, like it, and want more content for it," said John Barrett, Director, Consumer Analytics, Parks Associates. The latest Parks Associates figures show just 6% of U.S. broadband households have a 3D TV. "Don't blame the technology. Prices are still too high, and the amount of content is still too low."

Barrett said expectations for 3D should be revised. "The industry needs to stop comparing 3D to HD. Consumers are never going to watch everything in 3D. They will watch the occasional program in 3D if the content is compelling, but 2D will always be the default."

Parks Associates will discuss 3D consumer research and other interactive technologies in the session "The Human TV Remote: Gesture and Voice Recognition" at CONNECTIONS™: The Digital Living Conference and Showcase, June 5-7, co-located with TIA 2012 in Dallas, Texas.

Information about CONNECTIONS™ at TIA can be found at www.connectionsconference.com.

Visit http://www.parksassociates.com or contact 972-490-1113, sales@parksassociates.com.

About Parks Associates
Parks Associates is an internationally recognized market research and consulting company specializing in emerging consumer technology products and services. Founded in 1986, Parks Associates creates research capital for companies ranging from Fortune 500 to small start-ups through market reports, primary studies, consumer research, custom research, workshops, executive conferences, and annual service subscriptions.

Each year, Parks Associates hosts industry webcasts, the CONNECTIONS™ Conference Series, and Smart Energy Summit: Engaging the Consumer. http://www.parksassociates.com

Holly Sprague
Parks Associates
720.987.6614
hsprague@gmail.com

SOURCE Parks Associates

Sagantec Announces nmigrate

Mon, 14 May 2012 12:00:00 -0400

SANTA CLARA, Calif., May 14, 2012 /PRNewswire/ -- Sagantec announced today its nmigrate layout migration and optimization tool specifically developed for 28nm and 20nm technology rules. nmigrate is based on the patented 2D dynamic compaction technology developed by NP-Komplete Technologies, whose acquisition Sagantec announced earlier this month. nmigrate has already been used successfully by several tier-1 semiconductor companies.

The nmigrate tool is based on two-dimensional, automated, dynamic layout compaction technology. It makes all necessary corrections to a layout to enforce complex, must-abide-by rules for 28nm and 20nm process technologies and below.

"Today's 28nm and 20nm technologies present many new and tougher challenges for physical implementation. A library that is competitive from density, routability, reliability and variability perspectives and at the same time respects all new technology design rules is very hard to design manually in a timely manner. Furthermore, frequent changes and updates to new technology design rules make it even more challenging to keep up with manually," explained Coby Zelnik, Sagantec's president and CEO. "nmigrate is an automatic layout migration, compaction and optimization solution that is proven to successfully handle all these requirements and updates, delivering optimal results that are design rule clean," Zelnik concluded.

Product Capabilities

nmigrate can migrate and DRC-correct cell layout and make sure the layout adheres to all advanced design rules, including coloring for double patterning. The key benefits offered by nmigrate are:

Higher quality layout, enabled by its 2d native engine and optimized handling of composite rules
Faster time to solution, enabled by scalable automatic optimization of all layout requirements

The nmigrate tool has already been used successfully by several tier-1 semiconductor companies, and used with multiple cell libraries targeting multiple leading-edge 28nm and 20nm foundry processes.

Availability

nmigrate is already available for customers who design or migrate libraries for 28nm and 20nm processes. Sagantec offers both software license model as well as a service model.

At DAC'12

Sagantec will present and demonstrate nmigrate at this year's Design Automation Conference, June 4-6 in San Francisco, CA at booth number 1402.

About Sagantec

Sagantec's process migration tools are used to retarget semiconductor designs to either the next technology node or to a different process at the same or previous technology node, down to 20 nm. Privately held and funded, its corporate headquarters is at 2075 De La Cruz Blvd., Santa Clara, CA 95050. Telephone: (408) 727-6290 Fax: (408) 727-6288. On the Web at: http://www.sagantec.com

note: nmigrate is a trademark of Sagantec North America, Inc.

For information, contact:

Coby Zelnik
Sagantec
coby@sagantec.com
408-727-6290, ext 105

Liz Massingill
Lee PR
liz@leepr.com
650-363-0142

SOURCE Sagantec

IGT spotlights localized, Asian themed games at G2E Asia

Wed, 16 May 2012 20:00:00 -0400

May 16, 2012 20:00 ET

IGT spotlights localized, Asian themed games at G2E Asia

LAS VEGAS, May 16, 2012 /PRNewswire/ -- International Game Technology (NYSE: IGT) will showcase a portfolio of games tailored to the specific demands of Asian markets during G2E Asia 2012 at The Venetian Macao in Macau, May 22 – 24.

"IGT is proud to introduce our newest Asian market-attuned games and industry-leading systems products that are designed to deliver performance and profitably for our customers," said Craig Churchill, IGT senior vice president International. "Our innovative line-up at G2E Asia highlights our continued commitment to customers in these rapidly expanding markets."

More than half of IGT games at this year's show are designed to focus on local markets with the themes, dual languages (Chinese and English), and math models that Asian casinos and players are seeking. The array of games contains legendary Chinese themes such as West Journey Treasure Hunt™ and Golden Three Kingdom™, as well as appealing titles such as Four Great Chinese Beauties®, Big Dragon Lounge™ and Pearl Dragon™.

The Company will spotlight the industry's first community play five-reel slot, Fast-Hit Progressives™, which is available in Chinese. Also showcased at G2E Asia are blockbusters The Dark Knight and Ghostbusters™ on the eye-catching Center Stage™. After installing Center Stage™, Operators can refresh content with the latest games featuring big, bold titles. These entertaining titles join a full lineup of IGT's games including MegaJackpots® Premium Products favorites, Sex and the City Fabulous™ MultiPLAY and Elvis The King® Multi-Level Progressives.

Industry-leading IGT cabinet designs will include the exclusive G23 and the Universal Slant models, which allow for personalised playing experiences and flexibility for Operators.

IGT's Systems products at G2E Asia 2012 include leading server-based gaming tools offering dynamic ways to communicate with players, unmatched flexibility and connectivity, and the critical tools needed to manage the floor, players, promotions and operations. Highlighted products include IGT's sbX™ server-based experience, IGT Advantage®, IGT Casinolink™. With more than 50 installs in 11 countries, G2E Asia attendees will experience the power a server-based floor can create.

Visit IGT at stand No. 700 at G2E Asia to see how IGT's global strength and locally focused solutions help customers succeed in Asian markets. For more information, visit www.igt.com.

About IGT
International Game Technology (NYSE: IGT) is a global leader in the design, development and manufacture of gaming machines and systems products, as well as online and mobile gaming solutions for regulated markets. More information about IGT is available at www.IGT.com or follow IGT on Twitter at @IGTNews or Facebook at www.facebook.com/IGT.

THE DARK KNIGHT and all related characters and elements are trademarks of and © DC Comics.

(s12)

SOURCE IGT

Table Trac, Inc. in Macau at G2E Asia to Showcase New Table Games Management and Casino Management Systems

Tue, 15 May 2012 17:46:00 -0400

MINNETONKA, Minn., May 15, 2012 /PRNewswire/ -- Table Trac, Inc. (OTCQB:Table Trac) will showcase its latest casino management and table games management system at the sixth annual Global Gaming Expo (G2E) Asia from May 22-24 at The Venetian Macau. Table Trac is a leading developer and provider of casino management and table game management systems for the global gaming industry.

"Not only is G2E Asia the largest gaming event in Asia, this is the ideal place for Table Trac to showcase its latest products and technologies," said Jeff Connor, Table Trac's Director of Sales and Marketing. "Our comprehensive casino management and table games management system solutions have been re-designed with a focus not only on increasing operational efficiencies for gaming operators, but more important in this challenging economy, our systems are designed to drive revenues through an exciting suite of marketing and promotional tools."

Table Trac will be exhibiting its latest products and technologies in booth #733 at the trade show and conference at The Venetian Macau.

"What if we could show you a way to pay for your casino management and table games management system using our promotional suite of tools, included in our system solutions; would you be interested?" asked Connor.

Table Trac Plans to Showcase a Host of Products

Table games are fueling the Asian gaming market's growth. Table Trac's new TTrac2 Pit Management System offers operators real-time, easy access to player information through quick and intuitive GUI-based applications; provides seamless interfaces to most other casino management systems; and delivers a comprehensive suite of player promotions using Table Trac's Reflexive Reward© system, a customized auto-tiering program designed to rank and reward players.

Complementing Table Trac's latest table games management system is the TiTa®, a micro ticket redemption and issuing device designed for table games. The TiTa is designed to increase optimization and efficiencies at the table games, while providing players with a cashless gaming experience. TiTa is an excellent operator tool for coordinating and measuring the impact of the ever-important junket market.

Table Trac will also showcase the CasinoTrac casino management system that gives operators the tools to retain loyal players, improve operations and increase profitability. The extensive built-in functionality of this total solution casino management system supports all casino operations including auditing, accounting and regulatory reporting features as well as a comprehensive player loyalty and bonusing suite with floor visualization and easy-to-use navigation tools.

"Ours is probably the most affordable suite of system solutions in the market today," said Connor, adding, "but in the end a casino management system is all about giving you more freedom to engage and connect with your players."

About Table Trac, Inc.

Founded in 1995, Table Trac, Inc. designs, develops and sells casino information and management systems. The company has systems installed in North, South, and Central America, as well as the Caribbean. More information is available at http://www.tabletrac.com/.

Forward Looking Statements

Statements made in this press release, including statements regarding events and financial trends that may affect our future operating results, financial position and cash flows, may constitute "forward-looking statements" within the meaning of the federal securities laws. These certain statements are based on our assumptions and estimates and are subject to risks and uncertainties. You can identify these forward-looking statements by words like "strategy," "expects," "plans," "believes," "will," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning. You can also identify them by the fact that they do not relate strictly to historical or current facts. For these statements, we claim the protection of the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995.

For further information on factors that could impact Table Trac and statements contained in this press release, reference should be made to Table Trac's filings with the Securities and Exchange Commission, including quarterly reports on Forms 10-Q, current reports on Form 8-K and annual reports on Form 10-K. You can access such filings at http://www.sec.gov.

For More Information

Glenn Goulet, CEO
Table Trac, Inc.
Phone: (952) 548-8877

SOURCE Table Trac, Inc.

Quintiq Announces CEO session at the Gartner Supply Chain Executive Conference

Thu, 17 May 2012 14:14:00 -0400

May 17, 2012 14:14 ET

Quintiq Announces CEO session at the Gartner Supply Chain Executive Conference

The world's most important gathering of Supply Chain leaders

PALM DESERT, Calif., May 17, 2012 /PRNewswire/ -- Quintiq today announced their CEO will present from the Gartner Supply Chain Executive Conference.

Gartner has long been recognized within the Supply Chain alumni as those in the know for advice and recommendations to guide your business with enterprising operations leading to higher profitability and lower costs, so it only makes sense that Quintiq also guiding your business with these goals would participate as Platinum Sponsors at their largest Supply Chain event of the year.

The 2012 Gartner Supply Chain Executive Conference will host executives from the global Supply Chain Leadership team, providing advice on topics such as, "How do you and your team maintain supply chain prowess in the face of today's challenges?"

Contributing his own Supply Chain Leadership expertise Quintiq's CEO Dr. Victor Allis will present on day two at the conference, discussing "All Planning Puzzles Solved Through One Strategic Planning Platform."

Senior Quintiq representatives will be onsite during the Conference, hosting a VIP dinner, one to one demonstrations in private executive suites, public demonstrations, open discussions with Supply Chain experts at the Quintiq Booth #6 and of course Dr. Allis' presentation. (Please contact Kelli Gatlin @ 610-964-8111 for invitation and details)

Visit the Quintiq booth to experience 'hands on' Quintiq applications by entering the planning challenge & raffle to win one of two new iPads: the raffle & challenge winners to be announced Tuesday May 22nd 4:45pm at the Quintiq Booth #6.

Personal tailored one to one meetings and demonstrations can be pre booked via the Quintiq website http://www.quintiq.com/events-2012/gartner-supply-chain-executive-conference-california.aspx

About the Gartner Supply Chain Executive Conference
The future direction of the supply chain industry will be examined at the Gartner Supply Chain Executive Conference where supply chain executives are looking ahead to a smarter, more-connected and more-sustainable physical and information infrastructure as they plan for the future. The Gartner Supply Chain Executive Conference provides a unique opportunity to collaborate and connect with the world's leading supply chain executives, all in one place at one time. For more information, please visit www.gartner.com/us/supplychain.

About Quintiq
Quintiq provides advanced planning, scheduling and supply chain optimization software solutions. This fast-growing company, established in 1997, offers and implements software for planning and optimizing complex business processes throughout the enterprise. The company's dual headquarters are located in The Netherlands and the USA with subsidiaries in Australia, China, Finland, Germany, Italy, Malaysia, and the United Kingdom. Quintiq systems are implemented in 76 countries worldwide. More at www.quintiq.com. Follow us on Twitter: www.twitter.com/quintiq

SOURCE Quintiq

US Company Premieres Netvision Surveillance Product Line in Canada

Mon, 14 May 2012 10:44:00 -0400

May 14, 2012 10:44 ET

US Company Premieres Netvision Surveillance Product Line in Canada

Digital Management Solutions revisits Calgary Stampede

GREENVILLE, S.C., May 14, 2012 /PRNewswire/ -- Digital Management Solutions (DMS), alongside Caterpillar Inc., DuPont, Honeywell, and Ingersoll Rand, will attend the Global Petroleum Show in Calgary, Alberta, Canada, June 12th-14th at Stampede Park. At the show, DMS plans to captivate the oil and gas industry by introducing security solutions that protect against vandalism, promote employee safety, and assist with project management.

At booth #8147, Netvision will feature two dissimilar surveillance products, a solar trailer and security camera solar pole mount system. Although both systems have the same communications, one is designed to be more mobile than the other. The 2130 Battery/ Solar Powered surveillance trailer has 365 watts of solar; whereas the pole mount system has been augmented with adequate amp hour batteries and solar panels to make it a stand-alone solution.

"From simple solutions to integration that involves an existing wireless mesh network, DMS has transformed the world of surveillance by captivating the ease of mobility," says Lauren Grogan, Sales and Event Marketing Specialist at DMS. At DMS, their design team is able to incorporate various brands of IP and analog cameras onto their trailer solutions, including infrared and thermal imaging. They also are able to add a Ubiquiti wireless Ethernet system for when 3G/4G cellular connectivity is a challenge.

DMS, certified on the GSA schedule, services military, homeland security, law enforcement and energy companies worldwide. To receive pricing or schedule an online demonstration, call Digital Management Solutions at 1-800-380-9365 or visit www.netvisionmobile.com to learn more.

www.netvisionmobile.com

SOURCE Digital Management Solutions

HBA Global Announces Finalists for the Beauty Industry's 2012 International Package Design Awards (IPDA)

Tue, 15 May 2012 10:00:00 -0400

NEW YORK, May 15, 2012 /PRNewswire/ -- HBA Global, the leading product development source for the beauty and personal care industry, has announced the finalists of its Annual International Package Design Awards (IPDA). The IPDA Finalists are displayed during the HBA Global Expo & Conference, June 19-21, and the IPDA Winners will be announced at the HBA 20th Anniversary Celebration on Tuesday, June 19 from 4:00 to 5:30 p.m. in the Special Events Hall of the Jacob K. Javits Convention Center in New York.

(Logo: http://photos.prnewswire.com/prnh/20120515/NY07313LOGO)

As the only design award to celebrate the year's most innovative packaging in all of beauty's product categories, the HBA IPDA received entries from major brands, niche players and indie companies from all over the world.

The Committee of 100, made up of packaging executives, designers, suppliers and media, selected the following finalists in 11 categories:

COSMETICS MASS

pH Matchmaker pH Powered Bronzer, Blush & Lip Gloss by Physicians Formula; submitted by Physicians Formula Holding Inc.
Shimmer Strips Custom Eye Enhancing Shadow & Liner, Universal Looks by Physicians Formula; submitted by Physicians Formula Holding Inc.
Voluminous False Fiber Lashes Mascara by L'Oreal Paris; submitted by Alison Brod PR
Willa Smile Shine by willagirl LLC; submitted by Project MM

COSMETICS PRESTIGE

Burberry Cosmetics Line by Inter Parfums; submitted by Topline Products Company, Inc
chocoholicks Lip Gloss by jane iredale; submitted by Iredale Mineral Cosmetics, Ltd.
Socializer's Can You Keep A Secret? Lip Exfoliator & Conditioning Balm by Elizabeth Grant Skin Care; submitted by Elizabeth Grant Skin Care
Stila Dream Catcher Palette by Stila; submitted by Stila

FRAGRANCE MASS

Embleme Fragrance by Zermat Internacional; submitted by Zermat Internacional S.A de C.V.
Seduttore by LBEL; submitted by Belcorp
XOXO Mi Amore by Five Star Fragrance; submitted by Five Star Fragrance

FRAGRANCE PRESTIGE

Arbonne Fragrance Trio: The Dreamer, The Dazzler, and The Dynamo by Arbonne International; submitted by Arbonne International
Beyonce Pulse by Beyonce Parfums; submitted by Coty Inc.
LH Beauty Fragrance Jewelry by Lisa Hoffman Beauty; submitted by Lisa Hoffman Beauty
Too Too by Betsey Johnson; submitted by Inter Parfums, Inc.

GREEN PACKAGING

Biao Beauty Rejuvenation Collection by Biao Skincare; submitted by Biao Skincare
Environmental Repair Plus by COOLA; submitted by Behrman Communications
MudPot by Black Rock Mud Company; submitted by Black Rock Mud Company

PERSONAL CARE MASS

Just For Men AutoStop by Combe, Inc; submitted by Combe, Inc.
L'Oreal Paris Sublime Sun Crystal Clear Mist (30/50+) by L'Oreal Paris; submitted by Alison Brod PR
Renpure Organics Color Protecting Line by Renpure Organics; submitted by Berlin Packaging / Studio One Eleven
Vatika Styling Hair Gel by Dabur International Limited; submitted by Dabur International Limited, Dubai-UAE

PERSONAL CARE PRESTIGE

Beautydrink by beauty'in; submitted by beautyin
ColorProof™ Evolved Color Care Collection by ColorProof™ Evolved Color Care; submitted by Creative Media Marketing
Garden Alchemy Lemon Geranium Bubbling Bath Elixir by Thymes; submitted by Thymes
Lea Journo Hair Care Line by Lea Journo Cosmetique; submitted by Lea Journo Cosmetique
Love. Lust. Light Body & Boudoir Candle by Naked Princess; submitted by Naked Princess

SAMPLING/TRAVEL SIZE PACKAGING

b.right! Radiant Skincare Samples by Benefit Cosmetics; submitted by Xela Pack
HEVIA SKIN SCIENCE™ by Hevia Cosmetic Dermatology; submitted by The Design Spot
It Kit by vbeaute; submitted by vbeaute

SKIN CARE MASS

bebe de foret by Yuhan-Kimberly; submitted by: Kimberly-Clark (KCWW)
Cure Solutions Eye Smoothing Roll-on by Yves Rocher; submitted by Yves Rocher North America Inc.
Dr. LeWinn by Kinerase by Valeant Pharmaceuticals International; submitted by Creative Media Marketing

SKIN CARE PRESTIGE

DermalQuench Liquid Lift™ Advanced Wrinkle Treatment by Kate Somerville Skin Care; submitted by Tina Thomson Communications
MAC Lightful Marine Bright by MAC; submitted by The Estee Lauder Companies, Inc.
Oasis Collection by H2O Plus; submitted by Behrman Communications
Re-Nutriv Recreation Face Cream and Night Serum by Estee Lauder; submitted by The Estee Lauder Companies, Inc.
SK-II Whitening Spots Specialist by SK-II (P&G Prestige); submitted by Nicosia Creative Expresso Ltd. - Nice Ltd.

TOOLS/AT HOME DEVICES PACKAGING

iCurl Twin Heated Lash Curler by Mirenesse; submitted by Mirenesse
Sephora Collection Brush Wand by Sephora; submitted by Anisa International, Inc.
Serum Permeation Enhancer (SPE) by Nanomed Skincare, Inc.; submitted by Nanomed Skincare, Inc.

To view photos of the 2012 IPDA Finalists go to: http://www.hbaexpo.com/ipda_2012finalists.

Visit http://www.hbaexpo.com for more information and to register for the HBA Global Expo & Conference. Beauty Packaging and HAPPI magazines are the media sponsors of the HBA IPDA Awards.

About HBA Global Expo & Conference

Celebrating its 20th year, HBA Global Expo & Conference (www.hbaexpo.com) produced by UBM Live, is the most important product development source—from concept to market—for the cosmetics, personal care, skin care, fragrance and wellness industries. Exhibitors include international suppliers of raw materials and ingredients, packaging materials and components, dispensing systems, private label and contract manufacturers and testing equipment. The three-day conference program is renowned for providing cutting-edge information on the latest industry trends, technologies and branding strategies as well as the latest in skin care, ingredients, customer engagement, package design, global markets, distribution, technical advancements, sustainability and natural products. Connect with the HBA Global communities on Facebook, Linkedin and Twitter.

About UBM Live

UBM Live is a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM Live offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to http://www.ubmlive.com.

Contact: Annie Scully, 845-369-6382, ascully@hbaexpo.com

SOURCE HBA Global

Spa & Resort/Medical Aesthetics Event Features Latest Trends, Tools & Techniques For Business Success

Mon, 14 May 2012 10:17:00 -0400

Multimedia Gallery

http://photos.prnewswire.com/prnc/20120514/NY06421

May 14, 2012 10:17 ET

Spa & Resort/Medical Aesthetics Event Features Latest Trends, Tools & Techniques For Business Success

Education will Inspire Skin Care & Industry Professionals

NEW YORK, May 14, 2012 /PRNewswire/ -- A full slate of complimentary leading industry education is on tap at the New York Spa & Resort/Medical Aesthetics Expo, June 19-20, at the Javits Center in New York, including the latest trends on health and wellness, skin brightening procedures and laser technologies. The Industry Education Theater on the Spa & Resort show floor will provide attendees with up to date access to the latest treatments, devices, trends, and marketing strategies for successful spa operations. Spa & Resort is co-located with HBA Global Expo & Conference and is part of the annual Beauty Week™, at New York's Jacob K. Javits Convention Center.

(Photo: http://photos.prnewswire.com/prnh/20120514/NY06421 )

Free educational programming for Spa & Resort attendees starts with "Creating a Successful Spa or Medical Practice," presented by Carrie Gross, President & CEO of Dr. Dennis Gross Skin Care, on Tuesday, June 19th at 11:00 a.m. A true leader in the medical aesthetics industry, Ms. Gross who currently runs the NYC medical practice, will share her valuable insight and knowledge on best practices with attendees.

"Spa Trends Focus on Health & Wellness" will be presented by industry veteran Joanne Berry, Director of Spa and Wellness, Bellus Academy, at 12 Noon on Tuesday, June 19th. She will talk about the new paradigm shift from 'pampering' to health 'prevention' and 'promotion' of a healthier lifestyle. This session delivers a glimpse into the future of the industry, giving attendees ideas on how to incorporate these key learnings to boost profitability, increases customer satisfaction, and attract new staffing talent.

Next in the theater will be "Trends in Skin Brightening Procedures, Products & Methods" by Ramona Ray, National Trainer and Educator, Strivection / NIA 24. This session will provide a comprehensive overview of the causes of visible skin pigmentation, the market and potential of new ingredient solutions, and current trends in this fastest growing skin care category.

"How To Become A Cosmetic Laser Technician & Build Your Business" will be taught by industry experts Louis Silberman, Founder, and Carolyn Heyland, Director of Education Development, of the National Laser Institute: School of Medical Aesthetics.  

Another business-building workshop on the "Evaluation of the Utility of Low-level Laser Therapy for Non-Invasive Body Contouring" will be presented by Ryan Maloney, Zerona. Tuesday's educational programming ends with "Slim Line System Featuring the Vevazz Lipo Light," a complete turnkey weight loss business system showcased by Dr. Jamie Fettig, CEO, Slim Line System.

A popular well-being offering, "Reflexology: A Step into the Future," kicks off the free sessions in the Spa & Resort Theater on Wednesday, June 20th. David Cook, Instructor, International Institute of Reflexology will discuss this unique modality in the health and wellness field and demonstrate the difference between massage and reflexology, and other kinds of manipulative procedure, as well as the history of reflexology, what is new in the field, and where the future is headed with reflexology.

A fun presentation of "Facial Exercise Techniques;" by Cynthia Rowland, Anti-aging Specialist and Creator, Facial Magic® will show attendees how to lift their face in seconds, renew skin tone, and see immediate results. Demonstrations on "Bella Contour by Real Aesthetics;" and "Laser Treatment in the MediSpa – Safe and Effective with Aerolase;"  will also be presented.

Spa & Resort attendees also have access to the Trends Spot Theater (part of the adjacent HBA Global Expo), highlighting the latest in makeup, color, packaging, ingredients, and consumer buying and featuring presentations by professional make-up artists like Eve Pearl, the Eyebrow King, Damone Roberts, Aging Backwards, Jackie Silver and Lady Emmy with Beauty Trends 101.

In addition, Spa & Resort attendees can register to attend the HBA Educational Conference, which includes sessions of high interest on "The Present and Future of Medical Aesthetics: Trends from the Clinic to the Jar," "Devices: The New Frontier for Skincare and Personal Care,"  "Novel Approaches to Modifying Rheology of Hair & Skin Products,"  "Social Influence in Skin Care & Beauty," "Sophisticated Technology & Techniques for Enhancing Beauty & Health of Skin & Nails," "New Ingredients for Skin Care," and several in-depth session on "Anti-Aging."

To register and for more information on the exhibitors and education at Spa & Resort/Medical Aesthetics Expo visit www.spaandresortexpo.com.

About Spa & Resort/Medical Aesthetics
Spa & Resort/Medical Aesthetics Expo (www.spaandresortexpo.com), produced by UBM Live, platforms unique and innovative suppliers and services to leading spa and resort management including owners, directors, senior aestheticians, and massage therapists. An incomparable education program including hands-on training and networking opportunities gives spa, aesthetic and wellness professionals the tools and products to move their business forward and connect in new ways with their customers. Join the Spa & Resort communities on: Facebook, LinkedIn and Twitter.

About HBA Global Expo & Conference
Celebrating its 20th year, HBA Global Expo & Conference (www.hbaexpo.com) produced by UBM Live, is the most important product development source—from concept to market—for the cosmetics, personal care, skin care, fragrance and wellness industries. Exhibitors include international suppliers of raw materials and ingredients, packaging materials and components, dispensing systems, private label and contract manufacturers and testing equipment. The three-day conference program is renowned for providing cutting-edge information on the latest industry trends, technologies and branding strategies as well as the latest in skin care, ingredients, customer engagement, package design, global markets, distribution, technical advancements, sustainability and natural products. Connect with the HBA Global communities on Facebook, Linkedin and Twitter.

About UBM Live
UBM Live is a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM Live offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to http://www.ubmlive.com.

SOURCE HBA Global

U.S. Consumers Become Cook Aware: New Research Details Desire for Cost-conscious, Home-cooked Meals

Wed, 16 May 2012 11:32:00 -0400

May 16, 2012 11:32 ET

U.S. Consumers Become Cook Aware: New Research Details Desire for Cost-conscious, Home-cooked Meals

DuPont™ Teflon® Brand Team Releases National Survey Results

WILMINGTON, Del., May 16, 2012 /PRNewswire/ -- A growing number of U.S. consumers are taking to their kitchens to cook more frequently, and trying new and more nutritious foods, in an effort to reduce food bills and perhaps their waistlines. These findings are among the results of a recent DuPont™ Teflon® brand Be Cook Aware consumer survey, conducted to understand how the past year's trends have impacted America's cooking and eating behaviors at home.

To view the multimedia assets associated with this release, please visit: http://www.multivu.com/mnr/55967-dupont-teflon-be-cook-aware-national-survey

"Societal and economic shifts such as the fluctuating economy, combined with evolving national demographics and the introduction of new nutritional guidelines, are likely to have heightened people's awareness of the need to evolve eating and cooking behavior," said Christa Kaiser, global segment manager, Teflon® nonstick coatings systems. "Consumers are living smarter and healthier, and having more fun in the process while seeking out resources to help them make these changes."

Compared to this time last year consumers have changed how they cook and eat in their home:

72 percent indicated ways in which they have changed how they cook and eat in their home:
- 37 percent reported they are cooking more often
- 26 percent are experimenting more with food
- 23 percent are eating more natural or organic foods
89 percent of consumers are paying more attention to price and nutritional value when making food decisions:
- 73 percent named price as a factor in grocery shopping
- 52 percent report fresh ingredients at the top of the list of what's important to them, 49 percent say foods with less fat

The DuPont™ Teflon® brand Be Cook Aware survey also indicates that increased attention to health and price are not limiting consumers' imagination in the kitchen:

59 percent have sought cooking inspiration from online recipes, cookbooks, recipes from family and friends, cooking shows and mobile apps.
40 percent say cleaning up after cooking is their biggest kitchen challenge followed by preparation time (26 percent)
The most commonly used cookware is nonstick (66 percent), followed by stainless steel (48 percent) and cast iron (23 percent).

"The Teflon® brand team is looking at the factors impacting decision making and we are using our experience to help empower cooks to bring out the best in themselves and their cooking," said Kaiser. Online advice, recipes and more are available at www.teflon.com/becomeaware.

The DuPont™ Teflon® brand Be Cook Aware survey was conducted by TNS, an independent research agency. The data were gathered from March 7 to March 11, 2012, among a national sample of 1,000 American adults ages 18 and older. Results were released by DuPont at a roundtable discussion during the International Association of Culinary Professionals (IACP) Culinary Expo on April 1, 2012 in New York City. DuPont, the nonstick category originator, invited several food and lifestyle celebrities to help introduce the findings, and to discuss solutions for consumers seeking advice for adapting to new ways of cooking and eating.

The roundtable at the IACP event was moderated by Kelsey Nixon, host of Kelsey's Essentials on the Cooking Channel. Tips and insights into the research were offered by the following food, family and nutrition experts and featured in the DuPont™ Teflon® brand Be Cook Aware video series:

Janice Newell Bissex, M.S., R.D., author of the new family cookbook, No Whine with Dinner, and co-Founder of MealMakeoverMoms.com;
Dr. Rovenia Brock, author and nutrition coach to the Dr. Oz Show;
Joscelyn Ramos Campbell, editor-in-chief of MamiOfMultiples, one of the nation's leading Hispanic American Mom blogs;
Lauren Braun Costello, renowned food stylist and host of AOL's hit cooking series Pantry Challenge; and
Dr. Kantha Shelke, food scientist, editor-at-large for Penton Media's Functional Ingredients and advisory board member for Nutrition Business Journal.

The origin of the DuPont™ Teflon® brand began with the discovery of polytetrafluoroethylene, (PTFE), in 1938 by DuPont chemist, Roy Plunkett. Teflon® nonstick coating systems were first commercialized for cookware more than 50 years ago in the United States. Cookware made with Teflon® nonstick coating systems makes cooking and clean up easier. DuPont has created a wide range of nonstick coating systems for cookware to meet the needs of a variety of end users – from those who are avid cooks to those who are professional chefs. For more information, please visit www.teflon.com.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.

The DuPont Oval Logo, DuPont™, and Teflon® are registered trademarks or trademarks of DuPont or its affiliates.

SOURCE DuPont

Uncooled Continuous Zoom, Extreme Long-Range Thermal Camera Introduced by Opgal

Mon, 14 May 2012 04:00:00 -0400

KARMIEL, Israel, May 14, 2012 /PRNewswire/ --

Opgal's EyeSec™ Zoom 225 offers the performance and reliability of a cooled camera; demonstration of Opgal's latest thermal camera set for the IFSEC International 2012

Opgal Optronic Industries, a leading global provider of innovative thermal imaging and near infrared illumination solutions for security and safety applications, has announced that it will introduce the long-range EyeSecZoom 225 as the latest addition to its advanced line of thermal security cameras at IFSEC 2012. With this launch, Opgal becomes the first camera manufacturer to offer an uncooled thermal camera with the continuous zoom performance and reliability of a cooled camera.

The EyeSecZoom 225 is equipped with a continuous zoom lens ranging from 25 to 225mm and provides an unparalleled human detection range of over 5km. Its high-sensitivity, uncooled 640 x 480 resolution detector with a 17μm pitch provides a detailed and clear picture, offering a superior visual assessment tool for a range of perimeter and homeland security applications, such as airports, correction facilities, transportation and many others. Secured inside a ruggedized enclosure, the camera can withstand the harshest weather and environmental conditions - including rain, direct sunlight, high humidity and dust.

In line with all of Opgal's innovative thermal imaging solutions, the EyeSecZoom 225 is best suited to video analytics and is recognized for its unparalleled image quality and strong signal-to-noise ratio (SNR). Available in multiple configurations, the EyeSecZoom 225 can be used as a stand-alone camera and/or as an OEM sensor integrated with the customer's surveillance system. The camera adheres to IP66 standards.

Opgal's ground-breaking solutions are based on 30 years of development and are field-proven by hundreds of customers in over 50 countries. With a keen focus on the needs of its customers, the company is offering one of the broadest product lines available in the perimeter security market. For more information about Opgal's products, visit us at Booth no. D115.

About Opgal

Opgal delivers advanced vision and surveillance solutions enabling accurate insight into suspicious situations in adverse and harsh visibility conditions. Using state-of-the-art thermal and active-imaging technologies, Opgal leverages advanced electro-optics and image processing expertise to create high performance, versatile visualization hardware and software products for the security and paramilitary markets. Founded 30 years ago, Opgal is a major supplier to some of the leading contractors and has hundreds of customers in over 50 countries. Opgal is co-owned by Elbit Systems and Rafael. http://www.opgal.com

For more information please contact:
Hadas Weizman
Weizman@opgal.com
+972-54-6077622

SOURCE Opgal Optronic Industries

NOVALinked™ System Combined with The Trolley™ E-Class Allows Complete Control of Classroom Computers

Thu, 17 May 2012 11:41:06 -0400

NOVA's iMod™ Keeps Cables and Cords Under Contro

Thu, 17 May 2012 11:40:09 -0400

NOVA Solutions' Introduces Collaboration Solution

Thu, 17 May 2012 11:38:48 -0400

NOVA Solutions Introduces Complete Line-up of Audio/Visual Lecterns

Thu, 17 May 2012 11:37:00 -0400

NOVA Solutions Launches New Website and Blog

Thu, 17 May 2012 11:36:05 -0400

AnyDATA Corporation ARD400-W Wins CTIA E-Tech Award

Fri, 18 May 2012 08:35:00 -0400

May 18, 2012 08:35 ET

AnyDATA Corporation ARD400-W Wins CTIA E-Tech Award

Recognized for Innovation in Consumer Electronics: Tablets and Embedded Devices

NEW ORLEANS, May 18, 2012 /PRNewswire/ -- The AnyDATA ARD400-W was named the winner in Consumer Electronics: Tablets and Embedded Devices category of CTIA's Emerging Technology (E-Tech) Awards. In its seventh year, the CTIA E-Tech Awards honor the industry's most innovative wireless products and services in the areas of mobile apps, consumer electronics, enterprise and vertical markets and infrastructure. Winners were announced at International CTIA WIRELESS® 2012 that took place May 8-10, 2012 at the Ernest N. Morial Convention Center in New Orleans.

The AnyDATA ARD400-W is a 3G-enabled dosimeter that automatically transmits the measured Cesium radiation level and its location to remote servers for data sharing and archiving. Users can also keep track of the current date, time, and radiation reading, as well as their lifetime exposure level. The integrated speakerphone and panic alert button provide one-touch connection to a Call Center operator in the event of an emergency. The ARD400-W connected radiation monitoring solution from AnyDATA can provide effective, real-time solutions for protecting residents and reconstruction workers in high radiation areas, such as Fukushima in Japan.

"CTIA is pleased to congratulate AnyDATA Corporation on winning the CTIA E-Tech Award for representing the best in wireless innovation for Consumer Electronics: Tablets and Embedded Devices," said Robert Mesirow, vice president and show director for CTIA.

Nearly 250 entries across 15 awards categories were judged by a panel of media and industry analysts and scored on innovation, functionality, technological importance, implementation and overall "wow" factor.

For more information on the CTIA E-Tech Awards, visit http://www.ctiashows.com/awards.

To learn more about International CTIA WIRELESS 2012, visit http://www.ctiawireless.com.

Follow CTIA Shows:

Facebook: http://www.ctiashows.com/facebook
LinkedIn: http://www.ctiashows.com/linkedin
Twitter: http://www.ctiashows.com/twitter (#CTIAW12)

About CTIA Shows

CTIA Shows bring together all industries advanced by wireless technology for intense business, learning and networking. International CTIA WIRELESS® takes place May 8-10, 2012 at the Ernest N. Morial Convention Center in New Orleans, La. CTIA ENTERPRISE & APPLICATIONS™ takes place Oct. 9-11, 2012 at the San Diego Convention Center in San Diego, Calif. Visit http://www.ctiashows.com.

About CTIA

CTIA-The Wireless Association® (http://www.ctia.org) is an international organization representing the wireless communications industry. Membership in the association includes wireless carriers and their suppliers, as well as providers and manufacturers of wireless data services and products. CTIA advocates on behalf of its members at all levels of government. The association also coordinates the industry's voluntary best practices and initiatives, and sponsors the industry's leading wireless tradeshows. CTIA was founded in 1984 and is based in Washington, D.C.

About AnyDATA Corporation:

AnyDATA Corporation (http://www.anydata.com), headquartered in Irvine, CA, USA, is a global leader in the design and manufacture of connected devices and solutions. AnyDATA provides a full range of device services from design and development to testing, certification, and manufacture. Leveraging its 17 years of experience in wireless connectivity, AnyDATA helps our partners, network operators and major brands deliver stylish, reliable, differentiated devices and solutions to consumers worldwide.

AnyDATA is providing wireless solutions for a smarter world.

This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE AnyDATA Corporation

Hottest New Technology Roll Out

Wed, 16 May 2012 12:50:00 -0400

May 16, 2012 12:50 ET

Hottest New Technology Roll Out

CEL-FACTOR ANTI-EMF DEVICE SUCCESS AT CTIA

HOLLAND, Mich., May 16, 2012 /PRNewswire/ -- During the CTIA convention held in New Orleans, LA, May 8 thru 10, 2012, von Hoffmann and Partner Technologies and CeL-Factor™, LLC introduced their line of EMF radiation protection devices to the industry and the public.

CeL-Factor's™ philosophy is one of better living for the entire family and calls for an all-encompassing protection of our bodies…inside and out. We now live in a world where wireless technology is an important part of our business and personal lives, to the point where wireless communications touches nearly every aspect of our daily existence even to the point of being status symbols and trophies of achievement. As our individual futures depend more and more on these technologies, von Hoffmann and Partner Technologies believes that it is necessary to protect our lives as well as enhance them. They believe that their technological advancement of Energetic Quanta Cymatics Communication Technology (EQCCT) optimizes and protects the quality of life for each wireless device consumer. Therefore, they continue to challenge the status quo.

The line of products released at CTIA, called CeL-Factor™ utilizes the Energetic Quanta Cymatics Communication Technology (EQCCT) that has demonstrated, after years of clinical testing, real benefits to wireless users. This technology especially helps cell phone users in two ways: 1) to help keep a person's head tissue temperature cooler when they use a cell phone and 2) help a cell phone user's blood remain in a more normal state.

November 14-18, 2011, von Hoffmann and Partner Technologies and in particular their new product, CeL-Factor™, participated in a comprehensive double-blind, randomized placebo based study conducted at the world renowned Jasper Clinical Research and Development, Inc. This comprehensive double blind study was conducted on the company's product, CeL-Factor™ to determine its effectiveness in diminishing the harmful effects of EMF radiation.

The study was conducted to validate and confirm the company's claim that when using a cell phone in conjunction with their product it would:

1. Help keep your head's tissue temperature cooler, and

2. Help keep your blood in a more normal state.

The clinic reviewed 68 separate performances on subjects who were both female and male (a mix of Caucasians and African Americans) whose ages ranged between 16 to 30 years of age, each using their own personal cell phones. Neither the subjects nor the researchers knew if the cell phone being used had a placebo product attached to it or if the cell phone had the actual CeL-Factor™ product attached to it.

The Jasper Clinic's doctors and staff (Dean W. Knuth, President and CEO, Jasper Research and Development, Inc.; Dr. Thomas Blok MD, Director of Research; Dr. Otto Linet, MD, Principal Investigator; Dr. James VanderLugt MD, Sub Investigator; Karen Klott RN, Study Coordinator; Julie McGonigal, Project Manager; Nabil Ghazal, IRB-Informed Consent; Diana Reist, Regulatory) Researchers: Dr. Robert Kane DC, DABCT, FIACT and Diane Victor N.D. determined the double blind study they conducted on the CeL-Factor™ product produced stunning and superior results. The clinic's protocol and analysis confirmed and validated that after reviewing all 68 separate performances only one performance did not show the expected analysis.

Additional testing has been conducted by such notable institutions as; The Royal Scientific Society of Amman, Jordan and the Holon Institute of Technology in Israel.

As a product line, CeL-Factor™ has undergone extensive testing since 2004.

The CeL-Factor™ device has no affect on the performance of the cell phone or other devices it is attached to. CeL-Factor™ does not "shield" or "block" the EMF radiation from the cell phone or other wireless devices. If it did, the wireless device would not function as designed. Rather, the CeL-Factor™ works with the human body by communicating on a cellular level to keep cells organized when distortion occurs from EMF emitting devices such as cell phones and other wireless devices. Consumer awareness of the potential dangers of EMF radiation has risen dramatically over the past several years. In 2011 The World Health Organization (WHO) placed cell phones on their list of carcinogens. Also, there have been scores of articles, studies and scientific papers from around the world pointing out the hazards of exposure to EMF radiation.

The risks from being exposed to EMF radiation effects everyone, but is far more pronounced on children. Dr. Om Gandhi of the University of Utah has done an extensive study regarding the penetration of EMF radiation into the skulls of children. As children, the bones in the skull have not fully knitted together or reached their final, adult thickness. Therefore, the younger or smaller the child the deeper the penetration of the radiation emitted from the cell phone. CeL-Factor™ is a simple to use, clinically proven, accessory that can be attached to any cell phone.

Executives from the wireless industry visited the CeL-Factor™ booth at the CTIA trade show and concur that a working relationship between CeL-Factor™ and the wireless world is the perfect partnership. Although the company's focus for CTIA was on cell phones as they are the most widely used device that consumers can't live without and they should be protected from the EMF they generate. The company also has individual products for baby monitors, laptop computers, tablets, televisions, home phone systems and other EMF emitting devices. There is specific CeL-Factor™ for each category of wireless devices. This is necessary so that the correct frequency is addressed in the various types of wireless devices.

"We believe CeL-Factor™ provides genuine consumer peace of mind when using a wireless device of any kind," stated CeL-Factor™ Director of R&D, Friedrich Gradl von Hoffmann.

As a product line, CeL-Factor™ has undergone extensive testing since 2004. For a complete report of the testing results, please visit the company's web site: http://cel-factor.com/the-science/clinical-studies/

SOURCE von Hoffmann

HOTTEST NEW TECHNOLOGY ROLL OUT

Tue, 15 May 2012 09:52:09 -0400

5.15.2012

HOTTEST NEW TECHNOLOGY ROLL OUT

CEL-FACTOR ANTI-EMF DEVICE SUCCESS AT CTIA
(Holland Michigan – Cel-Factor, LLC) - (Virtual Press Office) – During the CTIA convention held in New Orleans, LA, May 8 thru 10, 2012, von Hoffmann and Partner Technologies and CeL-Factor™, LLC introduced their line of EMF radiation protection devices to the industry and the public.

CeL-Factor’s™ philosophy is one of better living for the entire family and calls for an all-encompassing protection of our bodies…inside and out. We now live in a world where wireless technology is an important part of our business and personal lives, to the point where wireless communications touches nearly every aspect of our daily existence even to the point of being status symbols and trophies of achievement. As our individual futures depend more and more on these technologies, von Hoffmann and Partner Technologies believes that it is necessary to protect our lives as well as enhance them. They believe that their technological advancement of Energetic Quanta Cymatics Communication Technology (EQCCT) optimizes and protects the quality of life for each wireless device consumer. Therefore, they continue to challenge the status quo.

The line of products released at CTIA, called CeL-Factor™ utilizes the Energetic Quanta Cymatics Communication Technology (EQCCT) that has demonstrated, after years of clinical testing, real benefits to wireless users. This technology especially helps cell phone users in two ways: 1) to help keep a person's head tissue temperature cooler when they use a cell phone and 2) help a cell phone user's blood remain in a more normal state.
November 14-18, 2011, von Hoffmann and Partner Technologies and in particular their new product, CeL-Factor™, participated in a comprehensive double-blind, randomized placebo based study conducted at the world renowned Jasper Clinical Research and Development, Inc. This comprehensive double blind study was conducted on the company’s product, Cel-Factor™ to determine its effectiveness in diminishing the harmful effects of EMF radiation.

The study was conducted to validate and confirm the company’s claim that when using a cell phone in conjunction with their product it would:
1. Help keep your head’s tissue temperature cooler, and
2. Help keep your blood in a more normal state.

The clinic reviewed 68 separate performances on subjects who were both female and male (a mix of Caucasians and African Americans) whose ages ranged between 16 to 30 years of age, each using their own personal cell phones. Neither the subjects nor the researchers knew if the cell phone being used had a placebo product attached to it or if the cell phone had the actual CeL-Factor™ product attached to it.

The Jasper Clinic’s doctors and staff (Dean W. Knuth, President and CEO, Jasper Research and Development, Inc.; Dr. Thomas Blok MD, Director of Research; Dr. Otto Linet, MD, Principal Investigator; Dr. James VanderLugt MD, Sub Investigator; Karen Klott RN, Study Coordinator; Julie McGonigal, Project Manager; Nabil Ghazal, IRB-Informed Consent; Diana Reist, Regulatory) Researchers: Dr. Robert Kane DC, DABCT, FIACT and Diane Victor N.D. determined the double blind study they conducted on the CeL-Factor™ product produced stunning and superior results. The clinic’s protocol and analysis confirmed and validated that after reviewing all 68 separate performances only one performance did not show the expected analysis.

Additional testing has been conducted by such notable institutions as; The Royal Scientific Society of Amman, Jordan and the Holon Institute of Technology in Israel.

As a product line, Cel-Factor™ has undergone extensive testing since 2004.

The Cel-Factor™ device has no affect on the performance of the cell phone or other devices it is attached to. Cel-Factor™ does not “shield” or “block” the EMF radiation from the cell phone or other wireless devices. If it did, the wireless device would not function as designed. Rather, the Cel-Factor™ works with the human body by communicating on a cellular level to keep cells organized when distortion occurs from EMF emitting devices such as cell phones and other wireless devices. Consumer awareness of the potential dangers of EMF radiation has risen dramatically over the past several years. In 2011 The World Health Organization (WHO) placed cell phones on their list of carcinogens. Also, there have been scores of articles, studies and scientific papers from around the world pointing out the hazards of exposure to EMF radiation.

The risks from being exposed to EMF radiation effects everyone, but is far more pronounced on children. Dr. Om Gandhi of the University of Utah has done an extensive study regarding the penetration of EMF radiation into the skulls of children. As children, the bones in the skull have not fully knitted together or reached their final, adult thickness. Therefore, the younger or smaller the child the deeper the penetration of the radiation emitted from the cell phone. Cel-Factor™ is a simple to use, clinically proven, accessory that can be attached to any cell phone.

Executives from the wireless industry visited the Cel-Factor™ booth at the CTIA trade show and concur that a working relationship between Cel-Factor™ and the wireless world is the perfect partnership. Although the company’s focus for CTIA was on cell phones as they are the most widely used device that consumers can’t live without and they should be protected from the EMF they generate. The company also has individual products for baby monitors, laptop computers, tablets, televisions, home phone systems and other EMF emitting devices. There is specific Cel-Factor™ for each category of wireless devices. This is necessary so that the correct frequency is addressed in the various types of wireless devices.

“We believe Cel-Factor™ provides genuine consumer peace of mind when using a wireless device of any kind”, stated Cel-Factor™ Director of R&D, Friedrich Gradl von Hoffmann.
As a product line, Cel-Factor™ has undergone extensive testing since 2004. For a complete report of the testing results, please visit the company’s web site: http://cel-factor.com/the-science/clinical-studies/

###
Media Contact: Steve Edwards
Phone: (855) 363-2355, Ext. 20
Email: press@vonhoffmannundpartner.com or sedwards@cel-factor.com

EXFO Announces a Major Expansion to Its Copper-Access Test Offering, Adding Two Product Lines Enabling the Installation and Advanced Troubleshooting of Broadband Services

Tue, 15 May 2012 09:03:46 -0400

EXFO Announces a Major Expansion to Its Copper-Access Test Offering, Adding Two Product Lines Enabling the Installation and Advanced Troubleshooting of Broadband Services

The most powerful and cost-effective VDSL2 installation and repair testers on the market, the MaxTester 610 and 635 help service providers deploy and maintain the latest ADSL2+ and VDSL2 technology while meeting budget constraints.
QUEBEC CITY, CANADA, May 15, 2012 - (Virtual Press Office) — EXFO Inc. (NASDAQ: EXFO) (TSX: EXF) announced today the launch of the MaxTester 610 Copper Test Set and MaxTester 635 Copper, DSL and Multiplay Test Set, the most powerful, intelligent and cost-effective VDSL2 installation and repair testers currently on the market. The newest additions to EXFO’s expanding copper access test offering, the MAX-610 and MAX-635 help service providers deploy the latest ADSL2+ and VDSL2 technology while keeping costs in check.

Telecom service providers are continuously faced with the issue of remaining competitive in delivering broadband to subscribers. FTTH is still quite expensive to install, so reusing copper and maximizing its potential is what the new DSL technologies enable. Previously available installation testers lacked the wideband capabilities necessary for testing VDSL2 circuits. Perfectly aligned with the new technologies, the MaxTester series bridges this gap, addressing the needs of installers to more quickly identify and interpret circuit troubles and restore service.

Adding to the existing MAX-630 ADSL2+/VDSL2 Multiplay Tester, the MaxTester 610 and 635 provide full fault location capabilities (TDR, RFL) and true 30 MHz wideband copper testing in support of ADSL2+ and VDSL2 technologies. Featuring an integrated ADSL2+/VDSL2 modem, the MAX-635 supports bonding, vectoring and G.INP, the latest DSL technologies to extend the reach and rate of DSL—using two pairs to deliver high-speed multiplay services over longer distances and/or at higher data rates.

The new MaxTester units also include the unique SmartR™ test suite, which automatically runs key copper tests, and intelligently analyzes the results to enable technicians to quickly identify and locate faults more reliably than ever before. This EXFO innovation directly leads to a significant increase in operational efficiency by any level of technician and provides a critical tool to enable service providers to reduce their repeat report rates.

Now available on the handheld MaxTester units, these next-generation copper/DSL test functionalities will also be offered on two new copper access modules designed for the FTB-1 modular platform in Q4 of calendar 2012.

“With their unique SmartRTM test approach, the new handheld MaxTester 610 and 635 bring second-to-none simplification for next-generation technologies—such as VDSL2—which are becoming more and more complex to deploy,” said Étienne Gagnon, EXFO’s Vice-President—Wireline Division and Corporate Marketing. “These new test solutions will help network operators increase field-testing efficiency and reduce operating expenses by integrating more automation and intelligence into their test processes.”

Visit our website for more information on the MaxTester 635 Copper, DSL and Multiplay Test Set and MaxTester 610 Copper Test Set.

About EXFO
Listed on the NASDAQ and TSX stock exchanges, EXFO is among the leading providers of next-generation test and service assurance solutions for wireline and wireless network operators and equipment manufacturers in the global telecommunications industry. The company offers innovative solutions for the development, installation, management and maintenance of converged, IP fixed and mobile networks—from the core to the edge. Key technologies supported include 3G, 4G/LTE, IMS, Ethernet, OTN, FTTx, VDSL2, ADSL2+ and various optical technologies (accounting for an estimated 35% of the portable fiber-optic test market). EXFO has a staff of approximately 1800 people in 25 countries, supporting more than 2000 telecom customers worldwide. For more information, visit http://www.EXFO.com.

EXFO Brand Name
The corporate name of the company is EXFO Inc. The company requests that all media outlets and publications use the corporate name (“EXFO Inc.”) or abbreviated name (“EXFO”) in capital letters for branding purposes. EXFO would like to thank all parties in advance for their cooperation.

For more information
Marie-Anne Grondin
Media and Public Relations Specialist
(418) 683-0913, Ext. 23417
marie-anne.grondin@EXFO.com

Vance Oliver
Manager, Investor Relations
(418) 683-0913, Ext. 23733
vance.oliver@EXFO.com

Doro® Experience Software Won The Best of CTIA Wireless 2012 Award From Techlicious

Mon, 14 May 2012 15:05:00 -0400

May 14, 2012 15:05 ET

Doro® Experience Software Won The Best of CTIA Wireless 2012 Award From Techlicious

DORO EXPERIENCE SOFTWARE APPLICATION IS SIMPLY THE BEST FOR SENIORS

NEW YORK, May 14, 2012 /PRNewswire/ -- Doro, the European market leader in easy-to-use mobile phones and applications for seniors, is proud to announce that its innovative software the Doro Experience won the Best of CTIA Wireless 2012 Award from Techlicious.

The Doro Experience reflects the Techlicious mission to help Make Tech Simple for consumers. The Software combines a straightforward user interface that provides easy navigation with large clear icons and applications specifically developed for seniors, e.g. the DoroFriends App simplifies navigation of Facebook which enables seniors to participate in social media more easily. It can be installed onto any Windows PC or Android based smart device to make it easy-to-use.

Jerome Arnaud, CEO at Doro commented, "Doro team is excited and proud to receive the Best of CTIA 2012 Awards. It is a huge honor for us to get recognized by Techlicious. The next awards we are looking forward to receiving are our customers' appraisal and satisfaction."

"Even the most technically advanced of us sometimes get lost in the plethora of features and apps on today's smartphones," says Suzanne Kantra, Founder and Editor-in-Chief of Techlicious. "For seniors, who may not be familiar with the latest technology, this problem is even more daunting. Doro has done an excellent job at simplifying the smartphone interface to its core functions, while also giving family members a way to remotely manage the content and applications."

The awards were selected by the Techlicious editors for those products that truly excelled in their categories. After evaluating all the products, the magazine's editorial staff chose the winner based on a combination of: benefit to the consumer, innovation, value and availability. According to Techlicious, Doro is simply the best for seniors.

The review of the winning software application will be included in the awards coverage on Techlicious.com.

In addition to the Techlicious award, Doro Experience won third place at the awards ceremony for the 2012 CTIA Emerging Technology Awards in the Mobile Applications category.

For more information on Doro and its products please visit us online at www.doro.com.

About the Techlicious Best of CTIA Awards

The Techlicious Best of CTIA Awards recognize those products that truly excel in their categories – from cell phones to tablets to apps to accessories – and reflect the Techlicious mission to help Make Tech Simple. The 2012 list of winners can be seen at www.techlicious.com/guide/techlicious-2012-best-of-ctia-awards/. Founded in 2009, Techlicious is a technology media company focusing on the everyday lifestyle needs of women. In addition to our own properties, Techlicious content is syndicated through MSNBC.com, Today.com, USAToday.com and many other channels. To learn more, visit us at Techlicious.com or follow us on www.facebook.com/Techlicious or www.twitter.com/Techlicious.

SOURCE Doro

DORO® EXPERIENCE SOFTWARE WON THE BEST OF CTIA WIRELESS 2012 AWARD FROM TECHLICIOUS

Mon, 14 May 2012 14:20:37 -0400

PRESS RELEASE
New York, May 14, 2012

DORO® EXPERIENCE SOFTWARE WON THE BEST OF CTIA WIRELESS 2012 AWARD FROM TECHLICIOUS

DORO EXPERIENCE SOFTWARE APPLICATION IS SIMPLY THE BEST FOR SENIORS
(Virtual Press Office) - Doro, the European market leader in easy-to-use mobile phones and applications for seniors, is proud to announce that its innovative software the Doro Experience won the Best of CTIA Wireless 2012 Award from Techlicious.

The Doro Experience reflects the Techlicious mission to help Make Tech Simple for consumers. The Software combines a straightforward user interface that provides easy navigation with large clear icons and applications specifically developed for seniors, e.g. the DoroFriends App simplifies navigation of Facebook which enables seniors to participate in social media more easily. It can be installed onto any Windows PC or Android based smart device to make it easy-to-use.

Jerôme Arnaud, CEO at Doro commented, “Doro team is excited and proud to receive the Best of CTIA 2012 Awards. It is a huge honor for us to get recognized by Techlicious. The next awards we are looking forward to receiving are our customers’ appraisal and satisfaction.”

“Even the most technically advanced of us sometimes get lost in the plethora of features and apps on today’s smartphones,” says Suzanne Kantra, Founder and Editor-in-Chief of Techlicious. “For seniors, who may not be familiar with the latest technology, this problem is even more daunting. Doro has done an excellent job at simplifying the smartphone interface to its core functions, while also giving family members a way to remotely manage the content and applications.”

The awards were selected by the Techlicious editors for those products that truly excelled in their categories. After evaluating all the products, the magazine’s editorial staff chose the winner based on a combination of: benefit to the consumer, innovation, value and availability. According to Techlicious, Doro is simply the best for seniors.

The review of the winning software application will be included in the awards coverage on Techlicious.com.

In addition to the Techlicious award, Doro Experience won third place at the awards ceremony for the 2012 CTIA Emerging Technology Awards in the Mobile Applications category.

For more information on Doro and its products please visit us online at http://www.doro.com.

About the Techlicious Best of CTIA Awards
The Techlicious Best of CTIA Awards recognize those products that truly excel in their categories – from cell phones to tablets to apps to accessories – and reflect the Techlicious mission to help Make Tech Simple. The 2012 list of winners can be seen at http://www.techlicious.com/guide/techlicious-2012-best-of-ctia-awards/. Founded in 2009, Techlicious is a technology media company focusing on the everyday lifestyle needs of women. In addition to our own properties, Techlicious content is syndicated through MSNBC.com, Today.com, USAToday.com and many other channels. To learn more, visit us at Techlicious.com or follow us on http://www.facebook.com/Techlicious or http://www.twitter.com/Techlicious.

For more information about Doro, please contact:
Christopher Lundström, Executive Director North America, Doro: +1-212-300-6864 or christopher.lundstrom@doro.com

Ivette Almeida, Grayling (Media Relations): +1-917-302-9946 or ivette.almeida@grayling.com

###
About Doro
Doro, the leader in the telecom care market is a Swedish public company. With over 38 years of experience in the telecom industry, the company focuses on developing, marketing and selling products, software, TeleCare and mHealth solutions specially adapted to the growing worldwide population of seniors. Doro’s range of easy-to-use mobile phones is unmatched and its unique know-how has been recognized through several international design awards. The company’s products are sold in more than 30 countries on five continents. In FY 2011 revenue totaled SEK 745 million. Doro’s shares are quoted on the OMX Nasdaq Stockholm exchange, Nordic list, Small companies.

Click here to view UnboundID's CTIA WIRELESS 2012 online press kit

Mon, 14 May 2012 10:46:09 -0400

Click here to view PaymentOne's CTIA WIRELESS 2012 online press kit

Mon, 14 May 2012 10:45:10 -0400

Click here to view OneSimCard's CTIA WIRELESS 2012 online press kit

Mon, 14 May 2012 10:34:03 -0400

Click here to view NetNumber Inc.'s CTIA Wireless 2012 Online Press Kit

Mon, 14 May 2012 10:28:25 -0400

Click here to view Digi International's CTIA Wireless 2012 Online Press Kit

Mon, 14 May 2012 10:27:00 -0400

Click here to view COMPRION GmbH's CTIA Wireless 2012 Online Press Kit

Mon, 14 May 2012 10:24:39 -0400

Click here to view Antenova Limited's CTIA Wireless 2012 Online Press Kit

Mon, 14 May 2012 10:21:30 -0400

Huawei Successfully Previewed Next Generation Full-View Telepresence at Interop 2012

Wed, 16 May 2012 14:00:00 -0400

PLANO, Texas, May 16, 2012 /PRNewswire/ -- Huawei, a leading global information and communications technology (ICT) solutions provider, successfully previewed its next generation telepresence solution at the recently held Interop Spring 2012. The new solution features the first tri-camera, tri-screen full-view technology for an impressive 5760*1080p panoramic display to provide users with the most immersive viewing experience possible. The solution is planned to ship in the fourth quarter of 2012.

"We are excited to unveil our new generation of telepresence solutions that incorporates industry-leading innovations to provide businesses with better user experience while lowering operating costs," said Mr. Yiquan Chen, President, UC&C Product Line, Huawei Enterprise Business Group. "Huawei will continue to meet high-end client demands to deliver more realistic live videoconferencing experiences, as well as to develop products to help clients increase efficiency and competitiveness."

The next generation telepresence solution incorporates a co-optical-center camera system that creates a seamless full-view 5760*1080p high-definition video of unprecedented quality. In the video conferencing industry, gaps between screens are typically 12 centimeters, which interrupt the users' viewing experience. By using the latest borderless display, Huawei's full-view telepresence solution dramatically reduces the screen gaps to just 5.5 millimeters; one twentieth the size of gaps in products currently on the market.

Beyond superior technology, Huawei's full-view telepresence solution employs stringent environmental standards in order to help clients reduce carbon emissions and lower operating costs. Overall power consumption is 30 percent lower than the industry standard for a similar solution. This also reduces noise levels within the conference room.

In addition, Huawei's full-view telepresence solution leads the industry with an advanced table design that provides front access for easy maintenance. This feature uses 30 percent less space than similar products and requires only 200 square feet, thereby saving valuable conference room space.

Core features for an outstanding user experience
Huawei's next generation full-view telepresence solution is based on technology advances from the second generation Huawei telepresence TP3106 system, and holds a competitive advantage over similar products currently on the market by providing the clearest picture and smoothest video experience through its 1080p, 60fps (frames per second) high-definition technology. The stunning high-definition picture allows for more effective visual communication and drives better business results. Compared to similar products with high bandwidth requirements, full-view telepresence achieves the above-stated pixel and frame rate with 30 percent lower bandwidth, leading to significant operational expense savings.

Full-view telepresence also supports local meetings, which helps clients use their video conferencing room more efficiently. At the same time, full-view telepresence adapts automatically to interconnect with existing telepresence products and provide a more flexible video communication service to businesses.

Using three-channel hi-fi audio technology, accurate audio localization, reproduction, and lip syncing technology, full-view telepresence provides users with the capability to tell where the speaker is located, effectively supporting an exceptional live experience. Additionally, the wireless touch panel control application can be installed easily on an Android tablet allowing users to control the display, hidden full-view camera, hi-fi audio, light system, system configuration and conference controls all at the touch of a button.

As of December 2011, global shipments of Huawei's telepresence solution surpassed 2,100 sets. Currently, Huawei telepresence solutions are being used by 45 governments, over 100 CXOs and 13 major operators. Huawei is the leading telepresence provider in China and among the category leaders globally.

For more information on Huawei's participation at Interop please see http://www.huawei.com/en/about-huawei/newsroom/press-release/hw-131912-huaweienterpriseinterop.htm.

About Huawei Enterprise Business Group
Huawei Enterprise Business Group ("Huawei Enterprise") is one of the three business groups of Huawei, a leading global information and communications technology (ICT) solutions provider. Leveraging Huawei's strong R&D capabilities and comprehensive technical expertise, Huawei Enterprise provides a wide range of highly efficient customer-centric ICT solutions and services to global vertical industry and enterprise customers across government and public sector, finance, transportation, electric power, energy, commercial businesses, and ISPs. Huawei Enterprise's innovative and leading solutions cover network infrastructure, unified communications and collaboration (UC&C), cloud computing & data center, enterprise information security, and industry application solutions.

For more information, please visit http://enterprise.huawei.com
Follow us on Twitter: www.twitter.com/huaweiENT
Facebook: http://www.facebook.com/HuaweiEnterprise
LinkedIn: www.linkedin.com/groups/Huawei-Enterprise-4070523?home=&gid=4070523

Media contact:
Mark Burnworth
Director, Public Relations
(214) 919-6147
(214) 499-8036 (mobile)
mark.burnworth@huawei.com

Analyst contact:
Sarita Kincaid
Director, Enterprise Analyst Relations
(408) 330 5324
(408) 799-1109 (mobile)
sarita.kincaid@huawei.com

SOURCE Huawei

Mersen Joins the SunSpec Alliance

Wed, 16 May 2012 12:28:00 -0400

May 16, 2012 12:28 ET

Mersen Joins the SunSpec Alliance

NEWBURYPORT, Mass., May 16, 2012 /PRNewswire/ -- Mersen, formerly Ferraz Shawmut, recently became a member of the SunSpec Alliance.

The SunSpec Alliance is dedicated to establishing information standards for renewable energy. Its mission is to "accelerate the growth of the renewable energy industry by driving data- and communications interoperability standards." The Alliance is also working to "create a common language that renewable energy component manufacturers can use to achieve plug-and-play interoperability between the components and management systems that make up renewable energy power generation systems."

SunSpec is comprised of:

Components vendors (inverters, PV panels, string combiners, monitoring hardware, trackers, environmental sensors, and balance-of-system components)
Networking, software, computer hardware companies
Engineering Procurement Construction (EPC) firms
System integrators
Financial institutions
Utilities
Regulatory agencies
Energy consumers

"Mersen is thrilled to be a part of the SunSpec Alliance," states Stephen Colvin, VP of Marketing. "Mersen has been at the forefront of developing electrical protection solutions for the solar power industry. We're delighted to be part of the body developing interoperability standards for solar power."

For additional information about the SunSpec Alliance, visit www.sunspec.org. For more information and resources on Mersen's solar power electrical protection solutions, visit ep-us.mersen.com/solarpower.

About Mersen

Mersen, formerly Ferraz Shawmut, is worldwide expert in high-performance materials for extreme environments and in the reliability and safety of electrical installations. Drawing on a century of experience—and an ongoing commitment to critical research in electrical safety— it provides industrial, commercial, and OEM customers with innovative products and unsurpassed technical support. The electrical and circuit protection division provides a comprehensive line of current-limiting fuses (low voltage, general purpose, medium voltage, semiconductor, miniature and glass, and special purpose) and accessories, fuse blocks and holders, power distribution blocks, low voltage disconnect switches, surge protection, high power switches, heatsinks, thermal management, and more. Amp-Trap^® High-Speed Class J (HSJ) fuses, TPMOV^® Technology, and the SmartSpot^® open-fuse indicator are a few of the company's latest innovations. For more information, call (978) 462-6662 or visit http://ep-us.mersen.com.

SOURCE Mersen

NAPCO Reports Results For Three And Nine Months Ended March 31, 2012

Mon, 14 May 2012 07:30:00 -0400

AMITYVILLE, N.Y., May 14, 2012 /PRNewswire/ -- NAPCO Security Technologies, Inc., (NASDAQ: NSSC), one of the world's leading suppliers of high performance electronic security equipment for over 30 years, today announced financial results for its third quarter ended March 31, 2012.

Highlights:

Net sales for the third quarter decreased 3% to $17,236,000 as compared to $17,760,000 a year ago. Net sales for the nine months ended March 31, 2012 were up 1% to $51,056,000 from $50,695,000 in the prior year.

Adjusted EBITDA* for the third quarter was $1,247,000 as compared to $1,246,000 for the same period a year ago (see table attached). For the nine months ended March 31, 2012 Adjusted EBITDA* increased $576,000, or 23%, to $3,087,000 from $2,511,000 for the same period a year ago.

Net income for the third quarter decreased $392,000 to $303,000, or $0.02 per share, as compared to $695,000, or $0.04, per share for the same period a year ago. Net income for the nine months ended March 31, 2012 increased $727,000 to $445,000, or $0.02 per share, as compared to $(282,000), or $(0.01), per share for the same period a year ago. Per share results are based on 19,409,000 and 19,253,000 fully diluted weighted average shares for the three and nine months ended March 31, 2012, respectively, and 19,193,000 and 19,096,000 fully diluted weighted average shares for the three and nine months ended March 31, 2011, respectively.

Cash generated by operating activities was approximately $1.9 million for the quarter ended March 31, 2012 as compared to $1.0 million for the same period a year ago. For the nine months ended March 31, 2012, cash generated by operating activities was $3.0 million as compared to $2.3 million for the same period last year.

Debt, net of cash, has been reduced by $17.8 million from $35.9 million to $18.1 million since acquiring Marks USA in August of 2008.

In May 2012, NAPCO entered into a term sheet with its current primary bank. The term sheet anticipates consummation of an extension of the existing credit facilities for five years with terms and conditions that Management believes are similar to, or better than the existing facilities.

Gross Profit for the three months ended March 31, 2012 was $5,064,000, a decrease of 8% compared to $5,513,000 for same period a year ago. Gross Profit for the nine months ended March 31, 2012 was $14,115,000, an increase of 4% compared to $13,626,000 for same period a year ago.

Selling, general and administrative expenses for the three months ended March 31, 2012 decreased by 10% to $4,375,000 as compared to $4,856,000 for the same quarter a year ago. Selling, general and administrative expenses for the nine months ended March 31, 2012 decreased by 4% to $12,673,000 from $13,155,000 for the same period a year ago.

Operating income for the three months ended March 31, 2012 increased by $32,000 to $689,000 as compared to $657,000 for the same quarter a year ago. Operating income for the nine months ended March 31, 2012 increased by $971,000 to $1,442,000 as compared to $471,000 for the same period a year ago.

Richard Soloway, Chairman and President, stated, "We are very pleased to have agreed on a term sheet with our current bank regarding an extension and restructuring of our expiring credit facilities. While there is no guarantee that a definitive agreement will close, the contemplated five-year agreement offers more advantageous payment and interest terms than the existing facilities. Both the Company and our current bank are confident that this agreement will be finalized in the very near future. In addition, we were pleased that the Company's improving balance sheet resulted in offers from other banking institutions. However, management has concluded that remaining with our current bank is best for our Company."

Mr. Soloway added, "Income before taxes for the three and nine months improved over last year despite continued soft demand in the traditional mechanical door-locking products market. This market softness resulted in the 3% decrease in sales this quarter, and related primarily to the Marks door-locking products, as partially offset by increases in the Company's other divisions. We are cautiously optimistic that this business, which is primarily driven by commercial high rise construction, is improving as evidenced by the large percentage increases in new building permits issued in NYC, one of the largest areas for Marks products. In addition, we have greatly expanded the Marks range of new products to address all of the sales opportunities in the commercial building refurb market. Our goal is to supply all products for all entry and exit doors in this market."

"We continue to hold down our manufacturing overhead and SG&A expenses which contributed to our profitability. Net income for the nine months ended March 31, 2012 was up significantly while net income for the three months was down due to the tax benefit recognized in the third quarter of last year as a result of R&D credits relating to prior years. "

Mr. Soloway continued, "The Company continues to invest in the future with new software-driven and IP products in key, strategic market categories and the feedback from our network of security dealers has been very positive. Our award-winning, NAPCO Commercial™ product platform continues to build market share and gives us a strong entry in the high gross-margin, commercial intrusion and fire segments of the industry."

"We are also proud of our performance at the recent ISC West trade show, where NAPCO won Best of Show – Wireless Intrusion Product, for its innovative iBridge™, Wi-Fi, 7-inch touch-screen tablet. Consumers can control their security systems, video cameras, thermostats or lighting, from anywhere in the home, wirelessly, with this device. Additionally, we continue to generate awareness, trial and adoption of our recurring revenue product entries, such as the Starlink 2™ wireless GSM communicator and the iSeeVideo™ remote viewing system. As a leader in the nascent category of wireless access control locking systems, our Networx™ product is progressing well. The product is being adopted and installed for use in many hospital and school applications. This product is cost-effective versus other access control options and enables dealers to install a system with minimal labor costs."

"In conclusion, with these exciting, new products and the stability offered by the proposed extension of our bank loans, we are laser-focused on maximizing the return on our expansive product lines. While returning to profitability over the past few years has certainly been a challenge, we feel that we have not only succeeded in that but are also poised to take full advantage of the security market as the economic conditions improve and revenue from our new products increases."

NAPCO will host a conference call for the investment community today, May 14, 2012, at 11:00 AM ET. Interested parties may participate in the call by dialing 877-407-8291; international callers dial 201-689-8345 about 5-10 minutes prior to 11:00 AM ET. The conference call will also be available on replay starting at 1:00 PM ET on May 14, 2012 and ending on May 28, 2012. For the replay, please dial 877-660-6853 (replay account # 405, replay conference #394347). The access number for the replay for international callers is 201-612-7415 (replay account # 405, replay conference #394347).

About NAPCO Security Technologies, Inc.

NAPCO Security Technologies, Inc. is one of the world's leading manufacturers of technologically advanced electronic security equipment including intrusion and fire alarm systems, access control and door locking systems. The Company consists of NAPCO plus three wholly-owned subsidiaries: Alarm Lock, Continental Instruments, and Marks USA. The products are installed by security professionals worldwide in commercial, industrial, institutional, residential and government applications. NAPCO products have earned a reputation for technical excellence, reliability and innovation, poising the Company for growth in the rapidly expanding electronic security market, a multi-billion dollar market.

For additional information on NAPCO, please visit the Company's web site at www.napcosecurity.com.

This press release contains forward-looking statements that involve numerous risks and uncertainties. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements as a result of certain factors, including those set forth in the Company's filings with the Securities and Exchange Commission.

NAPCO SECURITY TECHNOLOGIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
ASSETS	March 31, 2012		June 30, 2011
	(unaudited)		(audited)
	(In thousands except share data)
CURRENT ASSETS
Cash and cash equivalents	$ 2,997		$ 3,077
Accounts receivable, net of reserves	13,737		17,640
Inventories	19,806		19,986
Prepaid expenses and other current assets	791		950
Income tax receivable	133		--
Deferred income taxes	543		528
Total Current Assets	38,007		42,181
Inventories - non-current, net	4,466		4,201
Deferred income taxes	1,853		2,083
Property, plant and equipment, net	7,373		7,741
Intangible assets, net	11,517		12,316
Other assets	277		273
TOTAL ASSETS	$ 63,493		$ 68,795
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Current maturities of long-term debt	$ 12,172	*	$ 3,572
Accounts payable	3,309		4,649
Accrued expenses	1,658		2,553
Income tax payable	--		437
Accrued salaries and wages	1,426		1,785
Total Current Liabilities	18,565		12,996
Long-term debt, net of current maturities	8,926		20,205
Accrued income taxes	120		165
Total Liabilities	27,611		33,366
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Common Stock, par value $0.01 per share; 40,000,000 shares authorized; 20,095,713 shares issued; 19,095,713 shares outstanding	201		201
Additional paid-in capital	14,080		14,072
Retained earnings	27,216		26,771
	41,497		41,044
Less: Treasury Stock, at cost (1,000,000 shares)	(5,615)		(5,615)
TOTAL STOCKHOLDERS' EQUITY	35,882		35,429
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 63,493		$ 68,795

* Our existing revolving line of credit expires in August 2012. The Company has signed a term sheet with its primary bank which provides for extending both this line and the Company's term loan through 2017. However, there is no guarantee that this agreement will close. Accordingly, we have classified its balance as a current liability as of March 31, 2012.

NAPCO SECURITY TECHNOLOGIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
	Three months ended March 31,			Nine months ended March 31,
	2012	2011		2012	2011
	(In thousands, except share and per share data)
Net sales	$ 17,236	$ 17,760	$ 51,056		$ 50,695
Cost of sales	12,172	12,247	36,941		37,069
Gross Profit	5,064	5,513	14,115		13,626
Selling, general, and administrative expenses	4,375	4,856	12,673		13,155
Operating Income	689	657	1,442		471
Other expense:
Interest expense, net	287	328	889		1,333
Other, net	15	14	42		41
	302	341	931		1,374
Income (Loss) before Provision (Benefit) for Income Taxes	387	316	511		(903)
Provision (Benefit) for income taxes	84	(379)	66		(621)
Net Income (Loss)	$ 303	$ 695	$ 445		$ (282)
Income (Loss) per share:
Basic	$ 0.02	$ 0.04	$ 0.02		$ (0.01)
Diluted	$ 0.02	$ 0.04	$ 0.02		$ (0.01)
Weighted average number of shares outstanding:
Basic	19,096,000	19,096,000	19,096,000		19,096,000
Diluted	19,409,000	19,193,000	19,253,000		19,096,000

NAPCO SECURITY TECHNOLOGIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
	Nine months ended March 31,
	2012	2011
	(in thousands)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income (Loss)	$ 445	$ (282)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	1,638	1,703
Provision for doubtful accounts	--	32
Charge to obsolescence reserve	--	500
Deferred income taxes	215	(134)
Stock based compensation expense	8	52
Changes in operating assets and liabilities:
Accounts receivable	3,903	2,261
Inventories	(85)	(404)
Prepaid expenses and other current assets	159	81
Income tax receivable	(133)	(440)
Other assets	(44)	(32)
Accounts payable and accrued expenses	(3,077)	(1,086)
Net Cash Provided by Operating Activities	3,029	2,251
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant, and equipment	(430)	(454)
Net Cash Used in Investing Activities	(430)	(454)
CASH FLOWS FROM FINANCING ACTIVITIES
Principal payments on long-term debt	(2,679)	(3,679)
Net Cash Used in Financing Activities	(2,679)	(3,679)
Net Decrease in Cash and Cash Equivalents	(80)	(1,882)
CASH AND CASH EQUIVALENTS - Beginning	3,077	5,522
CASH AND CASH EQUIVALENTS - Ending	$ 2,997	$ 3,640
SUPPLEMENTAL CASH FLOW INFORMATION
Interest paid, net	$ 938	$ 1,247
Income taxes paid	$ 467	$ 5

NAPCO SECURITY TECHNOLOGIES, INC.
NON-GAAP MEASURES OF PERFORMANCE* (Unaudited)
(in thousands)
	3 months ended March 31,		9 months ended March 31,
	2012	2011	2012	2011
Net income (loss) (GAAP)	$ 303	$ 695	$ 445	$ (282)
Add back provision (benefit) for income taxes	84	(379)	66	(621)
Add back interest and other expense	302	341	931	1,374
Operating income (GAAP)	689	657	1,442	471
Adjustments for non-GAAP measures of performance:
Add back amortization of acquisition-related intangibles	266	290	799	866
Add back stock-based compensation expense	--	14	8	52
Add back costs relating to Marks acquisition and consolidation	--	--	--	216
Add back costs associated with waivers and amendments to credit facilities	--	--	--	69
Adjusted non-GAAP operating income	955	961	2,249	1,674
Add back depreciation	292	285	838	837
Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization)	$ 1,247	$ 1,246	$ 3,087	$ 2,511

* Non-GAAP Information. Certain non-GAAP measures are included in this press release, including EBITDA, non-GAAP operating income and Adjusted EBITDA. We define EBITDA as GAAP net income (loss) plus income tax expense (benefit), net interest expense and depreciation and amortization expense. Non-GAAP operating income does not include impairment of goodwill, amortization of intangibles, restructuring charges, stock-based compensation expense and other infrequent or unusual charges. These non-GAAP measures are provided to enhance the user's overall understanding of our financial performance. By excluding these charges our non-GAAP results provide information to management and investors that is useful in assessing NAPCO's core operating performance and in comparing our results of operations on a consistent basis from period to period. The presentation of this information is not meant to be a substitute for the corresponding financial measures prepared in accordance with generally accepted accounting principles. Investors are encouraged to review the reconciliation of GAAP to non-GAAP financial measures included in the above.

INVESTOR INQUIRIES:
Brett Maas
Hayden IR
(646) 536-7331
brett@haydenir.com

James Carbonara, Regional Vice President
Hayden IR
(646)-755-7412
Email: james@haydenir.com

Donald Weinberger
Wolfe Axelrod Weinberger Assoc. LLC
(212) 370-4500
don@wolfeaxelrod.com

SOURCE NAPCO Security Technologies, Inc.

V&A at Licensing International Expo 2012

Wed, 16 May 2012 08:24:11 -0400

€99 million investment activity in the first quarter of 2012, with the office sector accounting for 93% of the total volume

Tue, 15 May 2012 10:39:54 -0400

Croydon ready to get a great new vibe

Mon, 14 May 2012 12:36:19 -0400

May 14th, 2012

Croydon ready to get a great new vibe
(Virtual Press Office) - Croydon’s is set to become a vibrant place to live, work and play thanks to the raft of new housing developments being planned in the Town Centre.

That is the view of Bob Hay, managing director of Streets Ahead estates agents, who has just been secured as the latest speaker at the Live Croydon housing seminar, to be held at Fairfield Halls, on Tuesday, May 22nd.

Mr Hay said: “Having attended the Develop Croydon conferences in 2010 and 2011, we have been telling developer clients for the past two years about the benefits of investing in Croydon and the general buzz that will be created once the Ruskin Square and Saffron Square schemes are completed.

“As well as boosting an area that is currently void of residential homes, first class new office developments, shops, restaurants and coffee shops will provide a new leisure area which will encourage the workers who commute to Croydon to say in the central area after they finish work.

“It will create the type of work/leisure environments which are popular around areas such as Canary Wharf, Central London, Camden, Victoria and Clapham and will dramatically change the first impressions of Croydon for those arriving at East or West Croydon stations.

“Even for those sitting on trains just passing through East Croydon it is very likely to improve their perception of Croydon as a place to visit, work and live.”

At the conference, Streets Ahead will provide statistics to demonstrate the numbers of new enquiries from businesses expressing interest in relocating to East Croydon, as well as interest from homebuyers and tenants wishing to rent in the town.

Mr Hay added: “We are able to provide invaluable market knowledge for the developers committed or interested in investing in this exciting future of Croydon development.
“Streets Ahead is working with Berkeley Homes and Fairview New Homes as well as with other clients at sites with or about to obtain planning permission.”

The Live Croydon event is aimed at developers and investors, registered social landlords, housebuilders, architects, contractors and housing associations, will also explore ways in which the authority is looking to work in partnerships to continue its strong record of housing delivery across the borough.

Other confirmed speakers include London Borough of Croydon chief executive Jon Rouse, director of planning and building control Mike Kiely and head of housing development and growth partnerships Beverley Nomafo and deputy service head for spatial planning Steve Dennington plus Richard De Cani, director of strategy and policy of TFL London.

The private sector will also be well represented with Charles Holland, director of FAT Architects; Sue Riddlestone, chief executive and co-founder of BioRegional; Harry Lewis, land and planning director of Berkeley Homes; and Daren Nathan, director of new business and development of Durkan Homes; among the speakers. The event will be hosted by Robert Gordon Clark, executive chairman of the London Communications Agency.

Topics for conversation will include collaborative working for building new sustainable communities and affordable housing; the London Borough of Croydon’s relaxation of planning rules and regulations; funding opportunities and challenges including the introduction of a Community Infrastructure Levy (CIL) to help fund infrastructure and conversion schemes from redundant offices and other buildings to residential properties.

Tickets priced £90-plus VAT, to include refreshments and a buffet lunch, are available at http://www.participant.co.uk/livecroydon2012

For more details on the event visit http://www.livecroydon.co.uk

For further press information please contact:
John Payne
White Label Consultants
Tel: 020 8726 7968 (office)
Tel: 07976 436433 (mobile)
Email: john@whitelabelconsultants.org.uk

RAUSCH CREATES A DRINKING CHOCOLATE FIRST

Fri, 18 May 2012 15:07:05 -0400

CARL BRANDT MARKS 100TH ANNIVERSARY YEARS OF GROWTH AND ACCOMPLISHMENT

Fri, 18 May 2012 15:01:11 -0400

CARL BRANDT OFFERS NEW MICRO MINIS

Fri, 18 May 2012 14:58:30 -0400

NIEDEREGGER MARZIPAN DEBUTS WHITE BOXED SERIES

Fri, 18 May 2012 14:49:59 -0400

Mountain Valley Spring 2012 Summer Fancy Food Show Press Kit

Thu, 17 May 2012 17:15:10 -0400

Keeping it Fresh: Natural Ingredients, Classic Southern Recipes and Homemade Baking Make Up The Sweetery's Recipe for Success

Thu, 17 May 2012 11:52:43 -0400

For Immediate Release
May 17, 2012

Contact:
Ryan Jarahian
864-276-7969
ryjarahian@gmail.com

Belly Up to the Booth to Try The Sweetery's Unique Confection, Wine Sticks, At the Fancy Food Show June 17-19

Thu, 17 May 2012 11:46:11 -0400

For Immediate Release
May 17, 2012

Contact:
Ryan Jarahian
864-276-7969
ryjarahian@gmail.com

WOLFGANG PUCK'S ICED COFFEE RIDES WAVE OF DEMAND FOR THIS SUMMER'S HOTTEST BEVERAGE

Thu, 17 May 2012 09:04:13 -0400

WOLFGANG PUCK'S ICED COFFEE RIDES WAVE OF DEMAND FOR THIS SUMMER'S HOTTEST BEVERAGE

Now Available Online for Ordering Within the United States
May 2012

Beverly Hills, Calif. - (Virtual Press Office) - With people making the seasonal switch from hot to cold coffee, Wolfgang Puck Iced Coffee (WPIC) is looking forward to another sizzling summer growth spurt in sales, especially with the launch of its online ordering.

In response to the significant growth in Facebook fans and requests where the product can be purchased, WPIC is now available online to be shipped anywhere in the United States. Online ordering can be done via the website at http://www.wolfgangpuckicedcoffee.com.

"Summer is the perfect time for a refreshing iced coffee," said Wolfgang Puck, the renowned master chef who created his cold brew in Spago's kitchen in 2009. "Our iced coffee is different from bottled frappuccino drinks because it is less sweet with only 120 calories. We use a cold-brewed process that provides a smoother, cleaner, less acidic coffee drink that tastes like an iced coffee should."

Single serve iced coffee sales in K-cups are also on the rise and coffee consumer packaged goods dollars sales increased 20.1% in 2011. Mimicking the growth in the overall marketplace, WPIC has increased its retail availability and is now sold in 38 states.

The product comes in four flavors: Café au Lait, Vanilla Fusion, Crème Caramel and Double Blend Mocha. All flavors are organic, gluten free and kosher with no artificial ingredients. Although the cold-brewing process is more costly, a bottle of WPIC sells for around $2.29, which is less than what people pay for flavored iced coffee beverages sold in coffee shops and restaurants.

More information can be found on wolfgangpuckicedcoffee.com, or through Woodway Beverage Partners, Houston, Texas, licensee of the product. Information about Wolfgang Puck can be found on wolfgangpuck.com.

Media Contacts:
Woodway Beverage Partners
713.960.6635
Stephen@wpicedcoffee.com

Summer Communications
323.547.2747
jane@janesummerpr.com

Wolfgang Puck Cold Brewed Iced Coffee
"120 Calories Never Tasted So Delicious!"
http://www.wolfgangpuckicedcoffee.com

Béquet Confections to Introduce Cinnamon Swirl Caramel at 2012 Summer Fancy Food Show (Booth #5544)

Wed, 16 May 2012 16:52:52 -0400

Venus Wafers launches Non-GMO certified Water Cracker

Wed, 16 May 2012 12:27:03 -0400

May 16, 2012

For information, please contact:
Michael Thompson, Venus Wafers, Inc.
800-545-4538 • mthompson@venuswafers.com

Venus Wafers launches Non-GMO certified Stoned Wheat crackers

Wed, 16 May 2012 12:22:44 -0400

May 16, 2012

For information, please contact:
Michael Thompson, Venus Wafers, Inc.
800-545-4538 • mthompson@venuswafers.com

Coach Farm to Unveil Trimmed Down Goat Milk Yogurt at Summer Fancy Food

Tue, 15 May 2012 14:22:17 -0400

Busy Bee Apiaries partners with Sitti Restaurant to Bring rooftop Honeybees to Downtown Raleigh

Mon, 14 May 2012 17:32:21 -0400

Cadbury Cookies Expanded Gift Assortment

Mon, 14 May 2012 15:41:10 -0400

Cadbury Cookies are now Kosher

Mon, 14 May 2012 15:28:33 -0400

Acme Import Co. announces the addition of Coronet Danish Cookies

Mon, 14 May 2012 15:17:08 -0400

Bold, New Look for Rising Sun Farms

Mon, 14 May 2012 14:36:54 -0400

SUBWAY® Restaurant Chain to Open 1,200 North American Locations in 2012

Fri, 18 May 2012 12:00:00 -0400

Multimedia Gallery

http://photos.prnewswire.com/prnc/20120518/NY09737

May 18, 2012 12:00 ET

SUBWAY® Restaurant Chain to Open 1,200 North American Locations in 2012

-World's Largest Restaurant Franchise Wants Your Sites-

MILFORD, Conn., May 18, 2012 /PRNewswire/ -- With more than 2,000 franchisees actively searching for locations, the SUBWAY® sandwich chain has aggressive growth plans for 2012.

(Photo: http://photos.prnewswire.com/prnh/20120518/NY09737 )

According to an article in the Wall Street Journal, the SUBWAY® franchise system is the world's largest restaurant chain, in terms of number of locations. In order to reach the company's development goals, a contingent of SUBWAY® representatives will be manning the SUBWAY® booth in South Hall 3 & 4, S2600 N Street & 28th Avenue at the ICSC RECon convention, May 21st thru May 23rd, in Las Vegas.

"To continue to provide career opportunities to entrepreneurs and offer our world famous submarine sandwiches, which includes a wide range of healthier meal options, to an ever increasing consumer base, more than 100 Subway developers, field staff and leasing specialists from all across North America will be attending the event," says Chris Kan, Training and Business Promotion Specialist for Subway Real Estate, LLC. "We will be looking for sites and ready to make deals."

The SUBWAY® chain is growing and continues to forge ahead with new opportunities in traditional shopping centers, mall and free standing locations as well as non-traditional venues such as hospitals, colleges, sports arenas and airports. Since this past January, the SUBWAY® chain has opened nearly 900 new stores in 58 countries, 42 U.S. states and 7 Canadian provinces, which equates to more than one million square feet of prime commercial retail space. In total, SUBWAY® franchisees lease more than 43 million square feet of property around the globe.

Most recently, the SUBWAY® chain reached the milestones of 25,000 U.S. locations and restaurants open in 100 countries.

From 100 to 5,000 square feet, SUBWAY® restaurants come in all shapes and sizes. Because of the chain's unique business model, which has minimal equipment and space requirements, a SUBWAY® restaurant can operate just about anywhere.

To illustrate how flexible the SUBWAY® concept is, unique locations include an automobile assembly plant in Ohio; a new car showroom, and a brewery in California; a church in upstate New York; a combination laundry and tanning salon in Wisconsin; several high schools in Virginia; and a floating restaurant aboard a river boat in Germany.

Real estate professionals interested in submitting property information, or learning more about what the SUBWAY® chain is looking for in new sites, can contact Chris Kan at the Subway Real Estate office at 800-888-4848 extension 1434, or e-mail at kan_c@subway.com.

About SUBWAY® Restaurants

Headquartered in Milford, Connecticut, and with regional offices in Amsterdam, Beirut, Brisbane, Miami and Singapore, the SUBWAY® chain was co-founded by Fred DeLuca and Dr. Peter Buck in 1965. Their partnership, which continues today, marked the beginning of a remarkable journey — one that has made it possible for thousands of individuals to build and succeed in their own business.

In the 2011 Zagat® Fast Food Survey, the SUBWAY® brand was ranked "number one" by consumers in the "Most Popular," "Top Service" and "Healthy Options" categories for food brands with 5,000 or more locations.

For more information about the SUBWAY®chain, visit www.subway.com.
Find us on Facebook: Facebook.com/subway
Follow us on Twitter: twitter.com/subway
SUBWAY®is a registered trademark of Doctor's Associates Inc.

SOURCE SUBWAY Restaurants

Colliers International Retail Report Highlights Upbeat First Quarter, Consumer Confidence

Mon, 14 May 2012 08:00:00 -0400

May 14, 2012 08:00 ET

Colliers International Retail Report Highlights Upbeat First Quarter, Consumer Confidence

Discounters, Restaurants, and Auto Parts Rank Among the Top Vertical Markets for Retailers

SEATTLE, May 14, 2012 /PRNewswire/ -- The U.S. retail real estate industry, boosted by higher consumer spending, experienced a better-than-expected first quarter in 2012, according to a new nine-page report just published by Colliers International's Retail Services Group. Colliers International released its Spring 2012 United States Retail Highlights report, which looks closely at industry trends and a series of retail market performance indicators such as vacancies, net absorption, construction, and rental rates.

Key Findings
Colliers' key takeaways from the report include:

Technology Trends: Retailers are allocating additional capital expenditure dollars to technology upgrades expected to improve omnichannel integration, better automate merchandise assortment planning, and enhance the interactive aspects of both the online and in-store experience.
Consumer Confidence: Consumer spending has increased but may not be sustainable until personal after-tax incomes increase.
Top-Performing Categories: According to the Colliers Retailer Report Card, discounters, restaurants, and auto parts retailers currently rank the highest in overall performance for the first quarter of 2012.
2012 Predictions: Six of the nine predictions that Colliers International made at the beginning of 2012 are playing out as expected. Among them: continuing growth in the U.S. manufacturing sector is driving the economy; retailers are offering more exclusive, limited edition products and promotions to generate excitement and revenue; and high-profile acquisitions, such as last week's Bed Bath & Beyond offer to Cost Plus, are on the rise as companies flush with capital seek out higher-yield investment opportunities.

In the report, Ann Natunewicz, National Manager of Retail Research for Colliers International's Retail Services Group, and author of the report, explains: "Definitive signs of a self-sustaining recovery continue to elude us . . . but we remain cautiously optimistic that retail performance in 2012 will exceed the muted expectations predicted for the year."

"The 2012 retail industry has benefitted from a combination of pent-up demand that has spurred consumer spending, a slight easing in underwriting standards that has begun to move lending, and historically low interest rates that have attracted investment capital from yield-seeking investors," said Natunewicz.

Additional data and insights are available in a complete PDF version of the nine-page report at http://www.colliers.com/content/Colliers_US_Retail_Report_Q12012.pdf.

For more information about Colliers International, visit us at Booth #S243 R Street at the upcoming ICSC Annual RECon Convention in Las Vegas, May 20-22.

Further, connect with us on Facebook, LinkedIn, Twitter, YouTube and SlideShare.

About Colliers International
Colliers International is the third-largest commercial real estate services company in the world, with over 12,300 professionals operating out of more than 522 offices in 62 countries. A subsidiary of FirstService Corporation (NASDAQ: FSRV; TSX: FSV and FSV.PR.U), it focuses on accelerating success for its clients by seamlessly providing a full range of services to real estate users, owners and investors worldwide, including global corporate solutions, brokerage, property and asset management, hotel investment sales and consulting, valuation, consulting and appraisal services, mortgage banking and research. Commercial Property Executive and Multi-Housing News magazines ranked Colliers International the top U.S. real estate company. The latest annual survey by the Lipsey Company ranked Colliers International as the second-most recognized commercial real estate firm in the world.

SOURCE Colliers International

SAP Further Extends Real-Time Data Platform With "Big Data" Capabilities

Wed, 16 May 2012 08:49:00 -0400

ORLANDO, Fla., May 16, 2012 /PRNewswire/ -- SAP AG (NYSE: SAP) today announced advanced support and integration with Hadoop environments including an expanded "big data" partner council and customer showcases. These "big data" integration capabilities are planned in SAP® Data Services and SAP® Information Steward software with the release of service pack 4 for the SAP HANA® platform. SAP also showcased game-changing business results among customers, made possible by "big data" implementations based on the SAP real-time data platform. The announcement was made at SAPPHIRE® NOW, being held in Orlando, Florida, May 14-16, 2012.

(Logo: http://photos.prnewswire.com/prnh/20110126/AQ34470LOGO)

The SAP real-time data platform, based on the flagship SAP HANA platform, includes data management capabilities from SAP Sybase IQ, SAP Sybase ESP, SAP Sybase ASE and SAP Enterprise Information Management. It unlocks business value from "big data" by providing for real-time decision support within the window of opportunity with extreme capabilities to ingest, store and process big data in real-time.

"Groundbreaking innovations like SAP HANA help our customers access and deliver information at unprecedented speeds — up to 100,000 times faster than before — and empower them with fundamentally new ways to run their businesses and master 'big data,'" said Steve Lucas, global executive vice president and general manager, Database & Technology, SAP. "The SAP real-time data platform delivers an information value chain that uncovers and harnesses the right information at the right moment by moving data among SAP HANA, SAP Sybase IQ and Hadoop file systems."

Customer Showcases "Big Data" Results Powered by SAP HANA

MITSUI KNOWLEDGE INDUSTRY analyzes genomes for cancer research and treatment. By building an information value chain that uses SAP HANA with R, open source programming language and software environment for statistical computing and graphics, for real-time analysis and Hadoop for preprocessing DNA sequences, the company found a way to shorten the genome analysis time from several days down to only 20 minutes.

"Going from a process measured in days to one measured in minutes is radically transforming our customer relationships," said Yukihisa Kato, CTO and director, MITSUI KNOWLEDGE INDUSTRY. "Using the SAP real-time data platform with SAP HANA at its core will be critical to our DNA going forward and to future business growth."

SAP Enterprise Information Management Solutions to Power Access to All "Big Data" Sources

SAP envisions SAP Data Services and SAP Information Steward as the industry's first and only unified solution for data quality, data integration, text data processing, data profiling and metadata management. The company aims to allow users to unlock the full business potential of "big data" by making it easier to integrate and synthesize information across an enterprise's SAP and non-SAP applications. SAP Data Services and SAP Information Steward are intended to provide both business users and IT with an intuitive and comprehensive information management solution with planned enhancements that include:

Hadoop integration: reading from and loading to Hive and Hadoop Distributed File System (HDFS), rapid batch updating and loading to SAP HANA, SAP® Sybase® IQ server and any other data store, resulting in faster performance
Text data processing: extending the data view to analyze data sources by performing linguistic analysis and extracting relevant content from files, Web logs and social media
Authoritative and trustworthy data: helping users understand, assess and improve the quality of data by integrating data quality scorecards directly within business intelligence (BI) and enterprise applications so users can immediately determine the accuracy of the data and if necessary take corrective action

"Our goal is to help organizations access build and govern information value chains across all data sources," said Lucas. "With our enterprise information management solutions, customers will have the ability to easily understand and access any data source — be it from an SAP, custom or partner application, enterprise database or new data sources such as Hadoop — so they can now better manage information throughout the organization."

SAP Extends "Big Data" Partner Ecosystem

SAP has set up a "big data" partner council that will co-innovate to produce solutions uncovering use cases and architectures that leverage the SAP real-time data platform and Hadoop. The council will include a cross-section of companies, including startups, hardware vendors, software providers and technology services organizations that will collaborate together with SAP on select projects in the SAP® Co-Innovation Lab. The cornerstone of this strategy is building a strong integration with the Hadoop ecosystem, starting with Cloudera, the leading provider of enterprise-grade Hadoop data management software, services and training. By co-innovating with Cloudera, the top contributor to the Hadoop development community, SAP plans to enable customers to go beyond business analytics and into the world of next-generation applications that innovate on data and open the door to myriad new possibilities.

"We are very excited to work with SAP to provide customers with real-time insights from their Hadoop environments using our complementary solutions," said Mike Olson, co-founder and CEO, Cloudera. "The SAP real-time data platform, combined with the Cloudera Hadoop Distribution, will deliver unmatched capabilities in next-generation 'big data' applications and analytics to the enterprise."

SAP today also announced a number of innovations on the SAP HANA platform. For more information, see "SAP Continues to Expand Capabilities and Scale of SAP HANA Platform."

For announcements, blog posts, videos and other coverage during SAPPHIRE NOW, visit the Events Newsroom.

SAPPHIRE® NOW

With SAPPHIRE® NOW, SAP offers its customers, partners and prospects even more opportunities to engage in dialogue with peers, participants and thought leaders around the globe. Being held in Orlando, Florida, May 14-16, 2012, this enhanced, real-time event connects attendees on site with global participants through state-of-the-art broadcast studios and an online experience that incorporates the latest social media and community functionality. Whether on site or online, participants can gain insight as to how SAP is delivering on its product strategy and helping organizations around the world to run better. For more information, visit www.sapphirenow.com. Follow SAPPHIRE NOW on Twitter at @SAPPHIRENOW and visit the Events Newsroom at www.events.news-sap.com.

About SAP

As market leader in enterprise application software, SAP (NYSE: SAP) helps companies of all sizes and industries run better. From back office to boardroom, warehouse to storefront, desktop to mobile device – SAP empowers people and organizations to work together more efficiently and use business insight more effectively to stay ahead of the competition. SAP applications and services enable more than 190,000 customers (includes customers from the acquisition of SuccessFactors) to operate profitably, adapt continuously, and grow sustainably. For more information, visit www.sap.com.

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions as they relate to SAP are intended to identify such forward-looking statements. SAP undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. The factors that could affect SAP's future financial results are discussed more fully in SAP's filings with the U.S. Securities and Exchange Commission ("SEC"), including SAP's most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.

SAP and the SAP logo are registered trademarks of SAP AG in Germany and other countries. Business Objects and the Business Objects logo are trademarks or registered trademarks of Business Objects Software Ltd. Business Objects is an SAP company. Sybase and the Sybase logo are registered trademarks of Sybase Inc. Sybase is an SAP company. Crossgate is a registered trademark of Crossgate AG in Germany and other countries. Crossgate is an SAP company.

Hadoop is a trademark of the Apache Software Foundation.

For customers interested in learning more about SAP products:
Global Customer Center: +49 180 534-34-24
United States Only: 1 (800) 872-1SAP (1-800-872-1727)

For more information, press only:
Samantha Finnegan, +1 (650) 276-9350, samantha.finnegan@sap.com, PDT
Jeff Neal, +1 (925) 236-5035, jeff.neal@sap.com, PDT
SAP Press Office, +49 (6227) 7-46315, CET; +1 (610) 661-3200, EDT; press@sap.com
Anthony Suarez, Burson-Marsteller, +1 (212) 614-4331, anthony.suarez@bm.com, EDT

During SAPPHIRE NOW (from May 14 to 16), to speak with press contacts on site, please dial the SAP press room: +1 (610) 661-0469.

SOURCE SAP AG

SAP Continues to Expand Capabilities and Scale of SAP HANA® Platform and Ease Developer Adoption

Wed, 16 May 2012 08:32:00 -0400

ORLANDO, Fla., May 16, 2012 /PRNewswire/ -- SAP AG (NYSE: SAP) today announced innovations on the SAP HANA® platform, including the release of service pack 4, new access to a development sandbox for SAP HANA in the cloud via Amazon Web Services (AWS) and the next step in a program encouraging startups to develop on SAP HANA. SAP and HP also unveiled the first results on enhanced mixed load benchmark that highlights speed of ad-hoc analysis on detailed and fresh data. The announcement was made at SAPPHIRE® NOW, being held in Orlando, Florida, May 14-16, 2012.

(Logo: http://photos.prnewswire.com/prnh/20110126/AQ34470LOGO)

"SAP HANA is seeing widespread adoption and customer success. With SAP HANA SP4 we continue to raise the bar on breakthrough performance and extensive scale," said Dr. Vishal Sikka, member of the SAP Executive Board, Technology & Innovation. "We are committed to an open real-time platform for developers and end-users and will continue to provide this non-disruptively to our partners and customers."

Service Pack 4 for SAP HANA Now Generally Available

With the SAP HANA platform, customers can easily add new capabilities with service packs instead of costly upgrades. The newest service pack for SAP HANA also offers native text searching capabilities on structured and unstructured content, seamless and optimized interoperability with the R open-source statistical environment and additional in-database predictive and business functions for rapid deployment and faster processing. SAP HANA also expands the interoperability of platform support for "big data" by providing interoperability with the open source Apache™ Hadoop™ technologies.

Native text searching: The additional native predictive and business functions within the SAP HANA database allow for developers, partners and customers to build powerful and fast predictive applications on the platform. Native text searching on structured and unstructured content offers the ability to procure, process, model and search text content directly in the real-time SAP HANA database, so results can run lighting fast and be called by business intelligence (BI) tools, applications or the forthcoming, planned SAP® BusinessObjects™ Predictive Analysis software. The functions can also be easily implemented, resulting in rapid application deployment and faster development. Several SAP business applications, such as SAP® Smart Meter Analytics software, and partner solutions utilize these functions for fast in-database predictive processing.
R interoperability with SAP HANA: Furthermore, the interoperability of R with SAP HANA opens up all the statistical functions available in one of the world's most popular open source projects to business analysts and data scientists who want to use the power of the SAP HANA platform. This new interoperability relies on a highly optimized and secure connection between SAP HANA and R to solve business-critical problems in real time. Analysts and developers can quickly and easily connect to and call R functions from within SAP HANA and make the results available for consumption by end users within seconds.
Interoperability of SAP HANA with open source Apache™ Hadoop™: SAP Data Services software will provide capabilities to use Hadoop as a data store and be interoperable with the "big data" Hadoop framework.
In addition, this service pack supports the general availability of the SAP NetWeaver® Business Warehouse (SAP NetWeaver BW) application, which has become the most successful early adoption program in SAP history.

SAP HANA Now Available for Developers on Amazon Web Services (AWS)

Developer instances of SAP HANA are now available on the Amazon Web Services (AWS) platform. For the first time, developers can get access to the ground-breaking in-memory technology from SAP through a highly-scalable and low-cost infrastructure-as-a-service (IaaS). Developers who sign up are able to run their own pre-configured HANA instance to create their data analysis application. Along with a host of third-party development tools already available on AWS, this compelling and attractive solution is a major step for SAP to build-out the global ecosystem of SAP HANA developers. Developers can sign-up through the "SAP HANA Developer Center" page of SAP Community Network.

"SAP HANA on AWS for developers is an important milestone in our relationship with SAP," said Terry Wise, director, Worldwide Partner Ecosystem, Amazon Web Services. "With this offering, we are providing customers the ability to begin developing enterprise business applications leveraging the power of SAP HANA in a matter of minutes. The large scale in-memory capabilities on our scalable, flexible, pay-as-you-go platform will reduce the barrier of entry for many developers."

Startup Focus Program Enables Further Innovation on SAP HANA

The SAP Startup Focus program is designed to enable startups to innovate on SAP HANA as their underlying platform of choice. The ten startups currently in the accelerator program focus on areas as diverse as social media analytics from NextPrinciples and Passenger, to industry-specific solutions from Optessa, Nexvisionix, Basis Technologies and AlertEnterprise. Space-Time Insight and Ankhor Software offer new ways of visualizing data while Zettaset offers an integration solution for SAP HANA and Hadoop. For specific reports, the performance improvements the startups have seen with SAP HANA have ranged from 300 times to cases as extreme as Taulia's, which managed to reduce risk analysis business process from two to five days to under three seconds.

These startups are showcasing their applications at SAPPHIRE NOW onsite in the "SAP HANA Test Drive" area. To further underscore the company's intention to deliver SAP HANA as a platform for development, the SAP Startup Focus program is closely aligned with the new US$155 million "SAP HANA Real-Time Fund" to identify and foster such startups on an ongoing basis. For more information, visit the SAP Startup Focus program page on sap.com.

SAP Defines New Benchmark for SAP NetWeaver Business Warehouse

In order to reflect evolving customer requirements which demand greater ad-hoc query capabilities on real-time data, SAP has developed a new standard application benchmark for the SAP NetWeaver® Business Warehouse (SAP NetWeaver BW) application called the enhanced mixed load (EML) benchmark. This standard performance benchmark is the first to provide a standard performance measurement of near real-time, ad-hoc analysis and reporting on continuously updated data.

HP is the first partner to deliver a certified result for this new EML benchmark. This benchmark showcases the ability of SAP NetWeaver BW on SAP HANA running on HP AppSystem for SAP HANA, to exceed customer expectations for high-performance analytics with near real-time data sets. For a detailed independent white paper describing the testing environment and business value, visit experiencesaphana.com.

SAP and HP to Help Organizations such as Hilti Corporation to Rapidly Deploy Large-Scale solutions on SAP HANA Platform

SAP and HP have partnered to help companies process and analyze higher volumes of data from business-critical applications to drive innovation with HP AppSystems for SAP HANA. The new scale-out solution of HP AppSystems for SAP HANA is a pre-integrated, tested and supported converged system featuring servers, storage, networking and management software. It is the first enterprise-class real-time analytics solution optimized to run SAP business application workloads while offering a completely automated failover mechanism for high availability and disaster tolerance technology. It includes HP ProLiant BladeSystem BL680c servers and the HP X9300 IBRIX Network Storage System with HP P6500 Enterprise Virtual Array (EVA).

Hilti Corporation, a leading provider of technology for the global construction industry, is one of the first organizations planning to run 30 terabytes of data from SAP NetWeaver BW powered by SAP HANA on the HP AppSystem for SAP HANA.

"SAP and HP are helping Hilti to provide better customer service and develop innovations in the global construction industry with SAP HANA and HP Converged Infrastructure, said Christian Ritter, head of Performance Competency Center, Finance, HR and Reporting, Global IT, Hilti. "We look forward to deploy our 30 TB of SAP NetWeaver BW on the SAP HANA platform and benefiting from SAP and HP's close collaboration in scale-out architecture."

To help organizations implement their roadmaps for SAP HANA in a more timely and cost-effective manner, HP and SAP are partnering to develop new rapid deployment solutions for SAP HANA.

"Exabytes of digital information are created, captured and replicated every day around the world, making it complicated and time-consuming for organizations to manage and exploit the data," said Martin Fink, senior vice president, Business Critical Systems, HP. "With HP AppSystems and rapid-deployment solutions for SAP HANA, organizations should be able to achieve real-time insight from their data, speeding and simplifying the decision-making process across the enterprise."

For announcements, blog posts, videos and other coverage during SAPPHIRE NOW, visit the Events Newsroom.

SAPPHIRE® NOW

About SAP

All other product and service names mentioned are the trademarks of their respective companies.

For customers interested in learning more about SAP products:

Global Customer Center: +49 180 534-34-24
United States Only: 1 (800) 872-1SAP (1-800-872-1727)

For more information, press only:

Samantha Finnegan, +1 (650) 276-9350, samantha.finnegan@sap.com, PDT
Jason Loesche, +1 (484) 437 0015, j.loesche@sap.com, EDT
SAP Press Office, +49 (6227) 7-46315, CET; +1 (610) 661-3200, EDT; press@sap.com
Anthony Suarez, Burson-Marsteller, +1 (212) 614-4331, anthony.suarez@bm.com, EDT

During SAPPHIRE NOW (from May 14 to 16), to speak with press contacts on site, please dial the SAP press room: +1 (610) 661-0469.

SOURCE SAP AG

Newsbyte: SAP HANA® Offers Multi-Node Capabilities to Help Customers Scale Out

Wed, 16 May 2012 07:30:00 -0400

ORLANDO, Fla., May 16, 2012 /PRNewswire/ -- A company's ability to grow with its data is critical. Increasingly, organizations are challenged to draw deeper insights from larger data sets in shrinking windows of time. To empower customers in this regard, SAP AG (NYSE: SAP) offers scale-out capabilities with the SAP HANA® platform so that customers can grow their deployments to multiple nodes, supporting multi-terabyte data sets to provide real-time insights on big data. More than 50 percent of the original equipment manufacturers (OEMs) that offer x86 servers now deliver servers certified to run SAP HANA in a scale-out environment, including leading SAP technology partners Fujitsu, HP and IBM. In addition, SAP and Intel have collaborated to optimize SAP HANA to run optimally on Intel processors, enabling greater business agility and innovative usage models that let customers respond to changing conditions in real time. The announcement was made at SAPPHIRE® NOW, being held in Orlando, Florida, May 14-16, 2012.

"Our ongoing, joint engineering collaboration allowed SAP HANA to take full advantage of the powerful performance, reliability and availability features of the Intel Xeon processor E7 family," said Diane Bryant, vice president and general manager of Intel's Datacenter and Connected Systems Group. "The optimization of SAP HANA for Intel processors allows customers to achieve much more efficient results, increasing their record-breaking performance and scalability for mission-critical applications for increased business value."

SAP HANA delivers scale-up and scale-out solutions for clients to run big data, growth-oriented applications and analytics — including high-volume instances of the SAP NetWeaver® Business Warehouse application — by rapidly scaling to many nodes in high-performance and high-availability configurations. Other key benefits include:

Ability to handle large volumes of data: In addition to compression of data that fundamentally reduces the amount of memory required, SAP HANA grows with the number of data volumes across multiple nodes. SAP has validated 16 nodes and has not seen limitations on a large number of nodes now certified on demand for partners and customers.
Better failover and high availability: High availability enables the failover of a node within a distributed SAP HANA database. With cluster configurations, failover uses a cold standby node and gets triggered automatically. If a node fails, the database on a standby server can be cold-started and returns to its last consistent state by replaying the log since the last save point from shared storage. Distributed processing of data allows systems to scale beyond one server and can remove the single point of failure.
End-to-end improvement in performance: Increasing nodes of SAP HANA clusters enables distribution of data loading and analysis utilizing massively parallel processing (MPP) capabilities.

"With the scale out of SAP HANA, we see almost linear improvement in performance with additional computing nodes," said Dr. Vishal Sikka, member of the SAP Executive Board, Technology & Innovation. "Recently, in our research labs, we have assembled the largest SAP HANA system that scales to 100 nodes, 4000 computing cores and 100 TB in DRAM. Now CIOs can adopt in-memory databases for large deployments with peace of mind that it can grow with their data and provide breakthrough improvement in end-to-end performance."

The business value of SAP HANA was demonstrated recently through scalability testing performed by SAP on SAP HANA with a 16-node server cluster. During the testing, SAP HANA allowed SAP NetWeaver BW-like queries to be executed on 100 billion rows of sales and distribution data with sub-second performance results, without any indexing or tuning required. The results of this testing highlights the ability of SAP HANA to enable customers to perform real-time analytics directly on raw transactional data without going through traditional extract, transform and load (ETL) processes and building of aggregates or materialized views. Details on the testing can be found in a recently released SAP HANA performance white paper.

For additional information regarding SAP HANA and in-memory computing technology, visit the Experience SAP HANA website. For announcements, blog posts, videos and other coverage during SAPPHIRE NOW, visit the Events Newsroom.

SAPPHIRE® NOW
With SAPPHIRE® NOW, SAP offers its customers, partners and prospects even more opportunities to engage in dialogue with peers, participants and thought leaders around the globe. To be held in Orlando, Florida, May 14-16, 2012, this enhanced, real-time event connects attendees on site with global participants through state-of-the-art broadcast studios and an online experience that incorporates the latest social media and community functionality. Whether on site or online, participants can gain insight as to how SAP is delivering on its product strategy and helping organizations around the world to run better. For more information, visit www.sapphirenow.com. Follow SAPPHIRE NOW on Twitter at @SAPPHIRENOW and visit the Events Newsroom at www.events.news-sap.com.

Media Contacts:
Samantha Finnegan, +1 (650) 276-9350, samantha.finnegan@sap.com, PDT
Cindy McKendry, +1 (503) 231-7274, cindy.mckendry@sap.com, PDT

During SAPPHIRE NOW (from May 14 to 16), to speak with press contacts on site, please dial the SAP press room: +1 (610) 661-0469.

SOURCE SAP AG

SAP Broadens Analytics Reach With New Stake in Data Discovery and Visualization Market

Wed, 16 May 2012 07:30:00 -0400

ORLANDO, Fla., May 16, 2012 /PRNewswire/ -- SAP AG (NYSE: SAP) today announced intuitive software that turns data into answers for people across organizations. SAP® Visual Intelligence software allows employees, departments and lines of business to creatively visualize and analyze information and apply it to individual and group decision-making. A desktop version of SAP BusinessObjects Explorer® software, SAP Visual Intelligence is powered by the SAP HANA® platform and empowers users to perform data discovery regardless of technical skill level. With the new application, business users can take advantage of existing data investments that their IT organizations have built and maintained without tasking IT to produce reports. The announcement was made at SAPPHIRE® NOW, being held in Orlando, Florida, May 14-16, 2012.

(Logo: http://photos.prnewswire.com/prnh/20110126/AQ34470LOGO)

No matter where users sit in a company, they want a way to easily explore, mash up and share information to make better decisions and find new opportunities — without having to task IT to deliver reports. Companies are also looking to maximize existing business intelligence (BI) investments; expanding access allows more people to take advantage of a wealth of existing data and systems to make better-informed decisions.

"The category of visual data discovery has become a must-have component of the BI tool portfolio and SAP has upped its capabilities with its latest product, SAP Visual Intelligence," said Cindi Howson, founder, BI Scorecard. "Ease of use, time to insight and business agility are key reasons for the rapid growth of visual data discovery that provides users with greater self service with minimal IT support. SAP BusinessObjects Explorer provided ease of use, but the release of SAP Visual Intelligence brings greater flexibility and richer analysis."

"3M is a diversified company consisting of six different businesses units operating across various industries globally. As a result, we are a data-rich organization that relies on SAP to deliver intuitive BI solutions," said Jeff Robinson, IT manager, Global Business Intelligence, 3M. "SAP Visual Intelligence puts our people in the driver's seat because they can truly discover data on the fly. And because SAP handles the work of combining multiple data sources backed by in-memory technology, self-service analysis hits our users' screens in seconds."

Empowering Users in Any Industry or Line of Business to Explore Data and Find Answers

SAP Visual Intelligence draws upon the company's expertise in 24 industries, 10 lines of business and global footprint to deliver a product that any company can use to deliver answers to users everywhere. For example:

A loan officer at a bank might wonder how the bank is performing regionally across multiple categories of loans and demographics. Typically this would involve intensive efforts downloading and bringing together information from corporate as well as public data sources to find answers, which would be done manually each time a refresh is needed. SAP Visual Intelligence enables the loan officer to create an automated routine to download census information, combine it with regional loan data as well as additional region and state details to enrich the data. The information could be immediately plotted on a map to discover that loan business had increased 25 percent in the past two years for high-income earners in a specific zip code but new loan applications had slowed significantly. At the next meeting, the team could put together a new campaign targeting sales of loans in the high income areas.
A regional manager for a healthy snack company might be tasked with increasing sales of a new health bar in the western region. Working with a business analyst and SAP Visual Intelligence, the regional manager could easily access sales numbers for the last three years and combine this with point of sale data to see that the majority of sales were coming from small stores running a new campaign. On the spot, the regional manager and business analyst could expand the campaign to a broader market and eliminate poorly performing campaigns.
Responsible for analyzing the numbers of defects across plants and suppliers, a business analyst at a global manufacturing firm could use SAP Visual Intelligence to pull enterprise data as well as external data files sent by suppliers. A mash up of the data might reveal that specific parts and one particular supplier are responsible for 80 percent of the defects. As a result, the engineering team could work with the supplier on correcting the issues.

Fast, Engaging Way of Finding Answers Buried in Massive Amounts of Data

Building on SAP BusinessObjects Explorer, SAP Visual Intelligence leverages SAP HANA to help users ignite their creativity with beautiful and interactive visualizations, allowing them to ask any question without the need for predefined queries, reports or dashboards. SAP Visual Intelligence removes roadblocks to information so business users can find real-time answers on any volume of data. The engaging interface increases the usage of data and ability to derive answers and make better decisions. SAP Visual Intelligence enables ad-hoc discovery everywhere, across all data — from spreadsheets to sales, finance, marketing, customer, social, geo-location, third-party and other business data.

Analytics Innovations Revolutionize the Decision-Making Process

Recognized as the BI market share leader by Gartner, today's announcement is another of example of SAP's commitment to investing and expanding its analytics portfolio to respond to the needs of customers and the market. Recently announced SAP® BusinessObjects™ Predictive Analysis software is intended to help users improve decision-making by predicting future outcomes. Additional planned enhancements to SAP BusinessObjects BI solutions aim to deliver more mobile analytics options, richer insight, improved collaborative decision-making and deeper SAP applications integration. The improved capabilities are planned to help companies extract the most business value from the massive amounts of data that are generated today.

"SAP Visual Intelligence revolutionizes decision-making by offering every person in an organization a fast and extremely easy to use way of discovering answers from any data," said John Schweitzer, senior vice president and general manager, Analytics, SAP. "SAP solutions for analytics empower people with precise information anytime and anywhere using beautiful visualizations, enabling rapid response to events as they unfold. SAP delivers a powerful and comprehensive analytics portfolio that helps companies adapt to constant change so they can achieve remarkable results."

For more information and demos about SAP Visual Intelligence, visit www.experienceexplorer.com. For a closer look, see: "Screenshots: SAP Broadens Analytics Reach."

For announcements, blog posts, videos and other coverage during SAPPHIRE NOW, visit the Events Newsroom.

SAPPHIRE® NOW

About SAP

For customers interested in learning more about SAP products:
Global Customer Center: +49 180 534-34-24
United States Only: 1 (800) 872-1SAP (1-800-872-1727)

For more information, press only:
Susan Miller, SAP, +1 (610) 661-9225, susan.miller@sap.com, EDT
SAP Press Office, +49 (6227) 7-46315, CET; +1 (610) 661-3200, EDT; press@sap.com
Jeff Shadid, Burson-Marsteller, +1 (214) 224-8419, jeff.shadid@bm.com, CDT

During SAPPHIRE NOW (from May 14 to 16), to speak with press contacts on site, please dial the SAP press room: +1 (610) 661-0469.

SOURCE SAP AG

SAP Delivers New Applications Built on the SAP HANA® Platform

Wed, 16 May 2012 07:30:00 -0400

ORLANDO, Fla., May 16, 2012 /PRNewswire/ -- SAP AG (NYSE: SAP) continues to deliver on its innovation agenda and announced today a new wave of solutions built on the SAP HANA® platform. These real-time solutions aim to help customers drive new business value with advanced reporting, analysis and planning capabilities in the context of their lines of business and industries. The announcement was made at SAPPHIRE® NOW, being held in Orlando, Florida, May 14-16, 2012.

(Logo: http://photos.prnewswire.com/prnh/20110126/AQ34470LOGO)

"SAP's innovation continues with the delivery of these new applications that are simple to use, easy to implement and are built on an open real-time platform," said Dr. Vishal Sikka, member of the SAP Executive Board, Technology & Innovation. "These applications take advantage of detailed and fresh data, doing complex analysis on-the-fly to power interactive decision-making on mobile devices and in the cloud."

The solutions announced today are:

SAP® Sales and Operations Planning application
SAP® Cash Forecasting analytic application
SAP® Planning and Consolidation application
SAP® Collections Insight analytic application
SAP® Sales Pipeline Analysis analytic content
SAP® Bank Analyzer rapid-deployment solution for financial reporting with SAP HANA
SAP® Deposits Management rapid-deployment solution for transaction history analysis with SAP HANA
SAP® Supplier InfoNet site

Next Generation Planning Applications powered by SAP HANA

SAP Sales and Operations Planning is a cloud-based application powered by SAP HANA and designed to help companies become more demand-driven by enabling them to rapidly translate demand fluctuations into actionable plans for manufacturing, procurement and logistics. With the new application, companies can engage stakeholders from sales, marketing, finance, supply chain and other functions in a truly integrated and collaborative planning process. SAP Sales and Operations Planning brings together the real-time computing power of SAP HANA and the social collaborative paradigm of the SAP® Streamwork® application to enable:

Planning, using a unified model of demand, supply chain and financial data, which can be analyzed in real time at any level of granularity or dimension
Rapid simulations and scenario comparison on a complete, detailed sales and operations planning model against multiple criteria such as demand fluctuations, product mix changes and capacity constraints
Collaboration, using an embedded, context-aware social platform to accelerate planning and decision-making across the company

More details on SAP Sales & Operations Planning, Powered by SAP HANA can be found in this video.

"In relatively short period of time, we were able to model a significant portion of our business in the pilot environment and perform what-if scenario analysis," said Richard Komm, director, Advanced Micro Devices. "We could adjust demand volumes and the capacity resource allocations and immediately see their impact on revenue and margins in the solution. This is something that used to take multiple spreadsheets, numerous emails and phone calls and meetings to develop an aligned plan. We feel that this solution has great potential to improve our sales and operations planning process management and accelerate decision-making and the overall responsiveness of our teams."

"Today, our sales and operations planning process is largely manual, managed over disconnected spreadsheets, spans multiple internal teams and contract manufacturers, and it takes too much time and effort to respond to demand and supply variations," said James Smith, director, McKesson. "We were able to assess the impact of fluctuations in capacity positions at contract manufacturers on our sales forecasts in real time, model alternative scenarios and cut our planning cycle time in half. We are excited about the solution and look forward to rolling it out at McKesson."

SAP Cash Forecasting is an on-premise analytic application built on the SAP HANA platform that helps companies better navigate today's volatile financial environment by providing advanced capabilities for cash forecasting and analysis in a heterogeneous system landscape. The application is available via an early adoption program. With SAP Cash Forecasting, companies can:

Create accurate cash forecasts based on financial data from SAP and non-SAP systems such as ERP
Develop an effective foreign exchange hedging strategy based on real-time visibility into exposure across multiple currencies
Perform ex-post variance analysis on cash forecasts with the ability to explain variance down to the cash flow statement item-level
Manage the forecast process centrally, tracking subsidiaries' planning status and consolidating forecasts from across the company

"BSH Bosch und Siemens Hausgerate GmbH co-innovated with SAP on the new SAP Cash Forecasting analytic application, which is built on the SAP HANA platform," said Marco Dockweiler, enterprise architect, BSH Bosch und Siemens Hausgerate GmbH. "This application has the potential to improve cash forecast accuracy and to optimize our processes in the treasury department. The results we have seen are very compelling, and we look forward to our continued collaboration with SAP."

SAP Planning and Consolidation helps organizations dramatically accelerate their planning processes, giving financial professionals more analytics power and smarter insights, as well as time savings. Powered by SAP HANA, the application enables companies to accelerate budgeting and forecasting by speeding up the retrieval of queries, pull in large data sets and get a real-time view of what's happening in the business. As a result, people can plan faster, input data back into systems faster and shrink planning cycles, enabling organizations to more quickly respond to capitalize on opportunities or avoid risks. This also provides simplicity for IT as the application is optimized in real-time with SAP HANA.

Empowering Sales and Marketing Users With Real-Time Solutions

SAP Collections Insight provides sales teams with the real-time customer insights they need to optimize their collections strategy and the collaborative tools to execute that strategy. The application is available via an early adoption program. Powered by SAP HANA and accessible via an easy-to-use Web or mobile app, SAP Collections Insight helps companies:

Develop rich, dynamic profiles of their customers, including real-time visibility and analysis of payment history and trends
Equip users to quickly make and act on collection calls — anytime, anywhere
Empower users to collaborate rapidly and effectively to track and resolve collections issues

The capabilities delivered by SAP Collections Insight can enable companies to increase collections yield, accelerate the conversion of revenue to cash and strengthen their customer relationships.

SAP Sales Pipeline Analysis, powered by SAP HANA, helps sales organizations to get instant insights into massive volumes of pipeline data in the SAP® Customer Relationship Management (SAP CRM) application while performing on-the-fly calculations and in-depth analysis on any business dimension. Sales managers can react more quickly to changing sales conditions with real-time information and accelerate deals through the pipeline with powerful and user-driven analytics. As a result, companies can unlock hidden revenue opportunities as well as significantly increase profits and sales effectiveness. To help ensure a quicker time-to-value for customers, the content can be deployed as a rapid-deployment solution with the SAP® rapid-deployment solution for sales pipeline analysis with SAP HANA.

Taking Advantage of "Big Data" in the Banking Industry

SAP Bank Analyzer rapid-deployment solution for financial reporting with SAP HANA is designed to help organizations quickly analyze large volumes of data, enabling them to automate lean banking processes and make decisions in near real time. The solution enables banking organizations to rapidly generate detailed financial reports on assets and accounting performance, offering immediate answers to their business questions.

SAP Deposits Management rapid-deployment solution for transaction history analysis with SAP HANA helps retail banks boost performance through improved transaction history analysis. It makes it easy for employees to access up-to-date account information, while powerful in-memory data platform and business intelligence (BI) software helps organizations process multi-year information for real-time insights.

Drive Greater Visibility and Stronger Performance Across the Business Network

SAP Supplier InfoNet is an information network that brings together the power of SAP HANA and the cloud to help companies gain real-time insights from 'big data" and rapidly respond to changing conditions across their multi-tier supply networks. With this solution, companies are able to effectively manage their complex supply chains by:

Proactively monitoring and predicting risks across the multi-tier supply network with real-time alerts and leading-edge machine learning and statistical analysis tools
Gaining instant insights into the operational health of the supply network by aggregating and analyzing supplier data from enterprise systems and thousands of external data sources
Benchmarking supplier performance on quality and delivery and identifying significant shifts and trends in their performance

The capabilities delivered by SAP Supplier InfoNet empower companies to minimize supply chain disruptions before they impact the business, drive stronger performance of their suppliers and save time and operational costs of managing the supplier base.

For announcements, blog posts, videos and other coverage during SAPPHIRE NOW, visit the Events Newsroom.

SAPPHIRE® NOW

About SAP

For customers interested in learning more about SAP products:

Global Customer Center: +49 180 534-34-24
United States Only: 1 (800) 872-1SAP (1-800-872-1727)

For more information, press only:

Samantha Finnegan, +1 (650) 276-9350, samantha.finnegan@sap.com, PDT
Cathrin Wolf, +49 6227 7 63908, cathrin.wolf@sap.com, CET
SAP Press Office, +49 (6227) 7-46315, CET; +1 (610) 661-3200, EDT; press@sap.com

During SAPPHIRE NOW (from May 14 to 16), to speak with press contacts on site, please dial the SAP press room: +1 (610) 661-0469.

SOURCE SAP AG

Stefanini Announces New Support Services for SAP

Tue, 15 May 2012 10:04:00 -0400

May 15, 2012 10:04 ET

Stefanini Announces New Support Services for SAP

SOUTHFIELD, Mich., May 15, 2012 /PRNewswire/ -- Stefanini (www.stefanini.com/en) – a global provider of onshore and nearshore IT consulting, integration and development, and outsourcing services, today announced that it has expanded its Application Services portfolio by adding SAP Application Management Services (AMS+).

Stefanini is promoting its SAP solutions at the SAPPHIRE NOW + ASUG Annual Conference, May 14-16, at the Orange County Convention Center, Orlando, Florida.

Application Management Services provide comprehensive support for customers' SAP deployments. Stefanini AMS+ Services include:

SAP Application Help Desk – levels 1, 2, 3
Application monitoring and performance management
Ongoing SAP maintenance services

The new support services complement Stefanini's existing SAP offerings. The SAP service portfolio includes support for launches, optimizations, enhancements and performance tuning for existing deployments. SAP consulting includes current assessments and business process improvement recommendations leveraging the company's RUN SAP certification.

"Since 1987, we have been providing offshore, onshore and nearshore IT services, specializing in application development outsourcing," said Antonio Moreira, CEO, Stefanini North America. "With our new AMS+ services, we are able to offer our SAP clients a broader portfolio of support services, which leverage our extensive experience developing, implementing and supporting SAP deployments."

These solutions from Stefanini will focus on customers that are looking to improve performance and increase return on their SAP investment.

About Stefanini
Stefanini is a global IT services company with over 16,000 employees across 71 offices in 28 countries across the Americas, Europe, Africa, Australia, and Asia. Since 1987, Stefanini has been providing offshore, onshore and nearshore IT services, including application development and outsourcing services, IT infrastructure outsourcing (help desk support and desktop services), systems integration, consulting and strategic staffing to Fortune 1000 enterprises around the world.

With a base of over 500 active clients, including more than 300 multinationals, Stefanini maintains a strong presence in industries such as financial services, manufacturing, telecommunications, chemical, services, technology, public sector, and utilities. Clients benefit from Stefanini's financial stability, sustained year-over-year growth, and zero net debt. The corporate global headquarters is located in Sao Paulo, Brazil with European headquarters in Brussels and North American headquarters in metropolitan Detroit.

SOURCE Stefanini

itelligence Launches Rapid Deployment Solution for CRM, Providing Fast Time to Value, Defined Scope and Predictable Cost

Mon, 14 May 2012 16:51:00 -0400

ORLANDO, Fla., May 14, 2012 /PRNewswire/ -- itelligence announced today the availability of itelligence Rapid Deployment Solution for CRM, an SAP-qualified rapid deployment solution based on SAP® CRM that combines software and services to provide essential CRM functionality quickly and affordably, while reducing risk and putting customers on a predictable path to attain their CRM vision. The announcement was made at SAPPHIRE® NOW, being held in Orlando May 14-16.

Within the framework of a calculable investment, the functionality in itelligence's Rapid Deployment Solution for SAP CRM provides a fast, simple and future-proof package for effectively supporting customer relationships within medium-sized companies. This places best practice processes for supporting marketing, sales and services at your disposal.

"SAPPHIRE NOW is very appropriate for today's announcement because we're not just announcing great new solutions for customers that offer a lower total cost of implementation and predictable costs, but also demonstrating the strategic importance our SAP-qualified rapid deployment solutions will have in 2012 and beyond," said Andrew Powers, practice manager for CRM, itelligence. "While businesses certainly have a choice for SAP solutions, providing a clear difference and better solutions is part of itelligence's DNA. Our proven methodologies and expert knowledge of, and adherence to, SAP best practices are at the heart of what elevates and separates itelligence as the choice for medium-sized businesses."

itelligence's Rapid Deployment Solution for CRM delivers preconfigured software to support essential sales, service, and marketing processes, together with corresponding implementation services. The software can provide a permanent solution to most basic customer care requirements. For more extensive CRM needs, the solution can lay the foundation for an incremental evolution toward the comprehensive SAP CRM application suite.

"Using the integrated functionality in Rapid Deployment Solution for SAP CRM, users can support their company's strategic business initiatives, increase sales, and optimize operating expenses while achieving greater growth. We believe the solution explores the potential of CRM to the fullest—with the added value of enabling users to adapt the solution to meet future, individual requirements," said Powers.

Based on a company's requirements, Rapid Deployment Solution for CRM users can select one module such as Sales for the implementation project or a combination such as Sales and Marketing. Also, within a module users are free to choose what to implement and what not to implement on a process level (e.g. Opportunity and Pipeline Performance Management, but not Lead Management). The solution also provides an integration option with each customer's existing SAP ERP system. Integration touch points exist for business partner master records, account hierarchy, organizational units, pricing conditions, product master records, ERP quotations, and ERP sales orders.

While the scope of Rapid Deployment Solution for CRM is limited to selected core processes of Sales, Service, and Marketing, users are ultimately not limited to this process scope. Instead, they can add additional CRM processes from the vast solution portfolio of SAP CRM at a later stage such as a separate implementation project.

For more information about Rapid Deployment Solution for CRM, please visit itelligence's booth (#1909) and the SAP EcoHub.

An SAP partner for more than 20 years, itelligence is an SAP gold channel partner, an SAP global services partner and a global value-added reseller. itelligence offers best-run businesses the SAP software and solutions needed to address increasingly critical business issues, including the need for better access to valuable business intelligence to inform their decisions.

About itelligence

itelligence Inc. is a wholly owned subsidiary of itelligence AG, an international full-service solution and consulting company with a global presence in 20 countries. itelligence provides a broad range of consulting and customer support services to maximize SAP solutions, including implementations, business intelligence, application management services and hosting. itelligence is a gold-level SAP channel partner authorized to resell SAP Business All-in-One and SAP BusinessObjects solutions and is one of only 6 SAP global services, global hosting and global application management services partners. itelligence also holds global quality accreditation by SAP Active Quality Management organization for demonstrating clear quality standards and processes. For more information please visit http://www.itelligencegroup.com.

Contacts:
Brent Curry	Laure Poquette
Hill+Knowlton Strategies	itelligence
312-255-3086	630-725-3346
brent.curry@hkstrategies.com	laure.poquette@itelligencegroup.com

SAP, SAPPHIRE and all SAP logos are trademarks or registered trademarks of SAP AG in Germany and in several other countries.

SAP Forward-looking Statement

SOURCE itelligence

Newsbyte: SAP Teams Up With Amazon Web Services to Offer Customers Cloud-Based Option for Mobile Device and Application Management

Mon, 14 May 2012 15:00:00 -0400

ORLANDO, Fla., May 14, 2012 /PRNewswire/ -- SAP AG (NYSE: SAP) today announced that the industry-leading SAP® Afaria® mobile device management solution is now available on Amazon Web Services (AWS) Marketplace, providing a convenient, reliable and cost-effective way for customers to effectively manage and secure their enterprise mobile applications and corporate-liable and personally-owned devices. The announcement was made at SAPPHIRE® NOW, being held in Orlando, Florida, May 14-16, 2012.

(Logo: http://photos.prnewswire.com/prnh/20110126/AQ34470LOGO)

The AWS Marketplace is an online store that helps customers easily find, purchase and deploy software and services they need to help them run their businesses. The availability of the fully configured SAP Afaria 7.0 server on the AWS Marketplace gives customers the ability to immediately take advantage of a comprehensive mobile management platform with the click of a mouse.

"As the cloud rapidly becomes the IT deployment model of choice for business of all sizes, Amazon Web Services is excited to be working closely with SAP in bringing enterprise solutions to the cloud," said Andy Jassy, senior vice president, Amazon Web Services. "Adding SAP Afaria to AWS Marketplace provides customers a fast, simple and trusted way to shop for and implement an enterprise-ready mobile solution."

The decision to offer SAP Afaria on the AWS Marketplace is in response to increasing customer demand for software that can deliver centralized control of all mobile devices and instantly be deployed in the cloud. A July 2011 Aberdeen study found that 75 percent of organizations permit the use of employee-liable mobile devices for business purposes. With the growing trend of employees using personally-owned mobile devices in the workplace, regulating these devices is essential for protecting sensitive data and enhancing employee productivity.

SAP Afaria is a long-standing solution that has evolved over the last decade into a complete platform that manages and secures mobile data, devices and applications across the enterprise from a single console. The 7.0 release of SAP Afaria brings a new user interface for simplified app and expense management, a consumer-like app portal with SAP® Store integration and mobile analytics dashboards for business intelligence (BI) reporting with powerful drill-down analysis capabilities.

SAP Afaria can now be found in the AWS Marketplace. Customers with licenses for earlier versions of SAP Afaria can use the same license to experience SAP Afaria 7.0 on Amazon Web Services. Customers without existing licenses can receive a license that enables a 14-day free trial. The evaluation includes help from SAP mobile experts, who will guide customers throughout the test-drive process. SAP Afaria can be found by visiting http://aws.amazon.com/marketplace.

"By offering SAP Afaria on the secure, scalable AWS cloud infrastructure, we are extending our existing close relationship with AWS and making it as easy as possible for customers and partners to test and deploy the industry's leading mobile device management solution in an economical and reliable fashion," said Sanjay Poonen, president, Product Go-to-Market, and head of Mobile Division, SAP. "This announcement is just a sneak preview of what's coming from SAP as we lay the ground work for long-term innovation around our comprehensive, unmatched B2B and B2C mobile platform – both on premise and in the cloud."

For announcements, blog posts, videos and other coverage during SAPPHIRE NOW, visit the Events Newsroom.

SAPPHIRE® NOW
With SAPPHIRE® NOW, SAP offers its customers, partners and prospects even more opportunities to engage in dialogue with peers, participants and thought leaders around the globe. Being held in Orlando, Florida, May 14-16, 2012, this enhanced, real-time event connects attendees on site with global participants through state-of-the-art broadcast studios and an online experience that incorporates the latest social media and community functionality. Whether on site or online, participants can gain insight as to how SAP is delivering on its product strategy and helping organizations around the world to run better. For more information, visit www.sapphirenow.com. Follow SAPPHIRE NOW on Twitter at @SAPPHIRENOW and visit the Events Newsroom at www.events.news-sap.com.

Media Contact:
Jason Loesche, + 1 (610) 661 8541, j.loesche@sap.com, EDT

SOURCE SAP AG

CyberSafe Announces Support for FDA 21 CFR Part 11 Compliance

Mon, 14 May 2012 10:00:00 -0400

Multimedia Gallery

http://photos.prnewswire.com/prnc/20120514/CG05641

ORLANDO, Fla., May 14, 2012 /PRNewswire-iReach/ -- CyberSafe, a leading security software vendor and SAP partner, today announced that the latest version of its TrustBroker™ Secure Client product delivers Active Directory-based Single Sign-On and Multiple Sign-On, with full support for the FDA 21 CFR Part 11 (FDA) Compliance features in the SAP® ERP application. The announcement was made at the SAPPHIRE® NOW and ASUG Annual Conference being held in Orlando, May 14-16, where CyberSafe is exhibiting in booth 207.

(Photo: http://photos.prnewswire.com/prnh/20120514/CG05641)

"Our customers were looking for our Secure Client product to co-exist with their FDA compliance needs, as non-compliance with FDA regulations can lead to fines and cost millions of dollars," said Tim Alsop, CEO, CyberSafe. "The risk of ignoring these issues is high, so we made this a top priority."

Version 4.3.3 of the TrustBroker Secure Client includes new features that allow users to re-authenticate when signing and approving electronic documents. They can use the same Active Directory credentials that they used when they logged onto SAP ERP. Previously, CyberSafe customers were required to use an SAP user ID and password for re-authentication, and use TrustBroker and Active Directory credentials via Single Sign-On for the initial application log on.

When using TrustBroker Secure Client, FDA compliance can co-exist with Active Directory authentication and Single Sign-On for SAP ERP without any need for additional hardware - saving on capital investment and operational costs. Installation and deployment is both quick and easy, and complexity is further reduced, as no Public Key Infrastructure (PKI) is required, keeping costs down and allowing a quick ROI.

Users can have a single Active Directory identity and a single set of credentials for authentication. This reduces costs, boosts user productivity and improves security and compliance. Users who must sign and approve electronic records for FDA compliance can now complete the electronic signature process more easily and effectively.

"Part 11 Section 11.10 requires that the possibility that a signer would repudiate an approval be minimized," added Alsop. "TrustBroker does this by asking the user to re-authenticate using their existing Active Directory credentials when approving any type of document. The user has a single unique identity and a single set of authentication credentials, so he or she doesn't need to remember multiple credentials, thereby reducing the chance of a repudiation."

In addition, TrustBroker includes many advanced features compared to typical SSO products, such as enhanced auditing, which reduces the time to troubleshoot authentication issues; automatic encryption key renewal, which improves overall application security; and support for a wide range of authentication methods, including X.509 Certificate, RSA SecurID, Active Directory Account and Password.

TrustBroker goes beyond Single Sign-On by ensuring compliance with FDA regulations using a simple, easy-to-use re-authentication process that streamlines approvals and boosts user productivity.

To find out more about TrustBroker products, visit:

· The CyberSafe booth #207 at SAPPHIRE NOW

· The SAP EcoHub solution marketplace, where you can find information on TrustBroker Secure Client

· The CyberSafe website at http://CyberSafe.com or email: Info@CyberSafe.com

About CyberSafe
Global security software vendor CyberSafe provides proven, standards-based solutions that enable true enterprise-class security for mission-critical business applications – on the intranet or in the cloud. CyberSafe's TrustBroker products for use with SAP business applications leverage two decades of Kerberos expertise and existing infrastructures, such as Active Directory – for authentication and key management – to lower costs and deliver exceptional return on investment. TrustBroker integrates with solutions from leading vendors, including SAP AG, to reliably deliver strong authentication, single sign-on access and end-to-end protection of application data in transit.

CyberSafe was the first company to offer a commercial Kerberos-based security product in 1991, and the first to provide critical security interoperability between Microsoft Windows 2000 and non-Microsoft operating systems and applications. This experience and expertise in commercially supported Kerberos-based authentication systems is unsurpassed.

TrustBroker is a trademark of CyberSafe Limited.

SAP, SAPPHIRE and all SAP logos are trademarks or registered trademarks of SAP AG in Germany and in several other countries. All other product and service names mentioned are the trademarks of their respective companies.

To view this video on YouTube, please visit: http://www.youtube.com/watch?v=dXITEJzsuIU

Media Contact: Press Only CyberSafe North America, LLC, +1 (678) 824-4411, PR@CyberSafe.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE CyberSafe North America, LLC

SAP® Mobile Apps Connect Businesses and Consumers - from the Boardroom to the Shopping Center

Mon, 14 May 2012 08:00:00 -0400

ORLANDO, Fla., May 14, 2012 /PRNewswire/ -- Extending its commitment to drive mobile innovation from the enterprise to consumers, SAP AG (NYSE: SAP) today announced a new wave of mobile apps designed to help people be more efficient whether at work, at home or pursing leisure activities. With the help of a thriving partner ecosystem, the new SAP® mobile apps lay the foundation for growth by providing real-time mobile access to human resources (HR), sustainability, finance, sales and mobile commerce functions. This includes updated versions of existing SAP mobile apps available on more mobile platforms, including Android and RIM BlackBerry. The announcement was made at SAPPHIRE® NOW, being held in Orlando, Florida, May 14-16, 2012.

(Logo: http://photos.prnewswire.com/prnh/20110126/AQ34470LOGO)

Mobile apps are transforming devices into useful productivity tools that enable people to save time, whether they are entering travel expenses, meeting with a customer, investigating a potential safety hazard, treating a patient at his bedside or purchasing an out-of-stock item at their favorite store. Innovations from SAP and its partners make it possible for people to quickly access a wide range of simple mobile apps to help them make informed decisions, any time and from anywhere.

"SAP is following through on its commitment to deliver innovative, engaging mobile apps for millions of people," said Sanjay Poonen, president, head of Mobile Division, SAP. "With mobile serving as a major part of daily life, it is a top priority for most businesses that seek to simplify daily tasks for employees and their customers. SAP is leading the charge for businesses to run better with stunning, easy-to-use mobile apps that can manage and analyze today's explosion of data—bringing business to people."

Mobilizing Work Tasks for Employees On the Go

Entering travel expenses is a necessary evil for many workers. Most travel and expense systems require an employee to log onto back-office systems from a computer. SAP is empowering mobile workers to easily enter expenses while on the road, freeing them from tedious re-entry at a later date. The SAP® Travel Expense Report mobile app allows business travelers to easily create expense reports from a mobile device. For example, users can save time by adding corporate credit card charges or quickly taking a photo of a receipt to submit expenses with a few clicks directly from a restaurant.

With the new SAP® Learning Assistant mobile app, SAP helps learners explore and consume learning content anywhere and anytime. The app accesses SAP® Learning Solution and allows learners to explore available learning content, manage course bookings and download and play e-learning content online in a range of formats right from their iPads. Learners can view personal notifications for expiring and required qualifications, as well as the recommended courses to fulfill them on time. Employees who to consume learning content off-site can now do so quickly and easily even in unconnected mode.

For sales executives the SAP® Customer Briefing mobile app provides a real-time dashboard to help prepare them for customer interactions. This allows immediate access to critical client data in an easily consumable format. The app provides real-time visibility to internal customer relationship management (CRM) data, as well as external business, and news sources, while on the road. Sales professionals can easily view customer information in a visual format, helping ensure they are exceptionally well prepared for every customer meeting.

Companies focused on improving safety will have faster visibility to problems with the SAP® EHS Safety Issue mobile app. Workers can log issues from their mobile device with a photo or video, as well as an audio recording, and send it directly to an incident or safety manager for corrective action. The app makes it easy for everyone to participate in creating a safer, more sustainable work environment and proactively reduce operational risks.

Bringing Mobile Commerce to Consumers and Businesses

With billions of mobile apps downloaded to date and hundreds of millions of mobile commerce users worldwide, what people do with their mobile devices is changing. SAP is supporting this monumental shift through its award-winning mobile customer engagement and commerce platform for banking, telecommunications, utilities, retail and consumer packaged goods. The mobile commerce portfolio from Sybase 365 has already been widely deployed by banks and mobile operators for mobile banking, mobile payments and mobile money services in both developed and emerging markets. This mobile commerce portfolio from Sybase 365 is a key component of the industry-leading SAP mobile platform for powering highly productive business-to-business (B2B) and business-to-consumer (B2C) mobile apps and services, including:

Sybase 365 Mobile Banking, which enables subscribers to pay, buy, bank and remit money with any mobile device. It allows an end user to use his mobile phone as a micro bank, performing all banking tasks where instant information is important, such as inquiring about account balances, configuring notifications to receive account activity, paying bills, person-to-person (P2P) money transfers and applying for new products. This solution is available in retail, small to midsize business and corporate mobile banking editions.
Sybase 365 Mobile Payments, which enables people to leverage a mobile wallet solution to pay bills and loans, make domestic P2P payments to known and unknown beneficiaries, remit money, top-up and pay for goods and services. The solution includes all the tools and services for managing merchants and for emerging markets managing agent networks.
Sybase 365 Mobile Money, which enables financial institutions to offer a branchless financial inclusion service that allows them to offer financial products to un-banked and under-banked customer segments in a highly cost-effective manner, entirely through the mobile device. For the end user, mobile money supports money transfers, balance inquiries, bill payments, cash in/cash out via agents and self-service machines, as well as micro-payments and loan repayments. For bank agents, it offers a full suite of customer enrollment, KYC (Know Your Customer) details, reports, fee tracking and much more.

Numerous leading financial institutions and mobile operators, including Dutch Bangla-Bank, First Tennessee Bank and Telefonica, are providing their customers with live mobile commerce apps and services built on top of the Sybase 365 mobile commerce portfolio.

Mobilizing Across Industries

SAP is extending the value of key systems of record by mobilizing business processes across healthcare, insurance and retail industries:

Retail shoppers and employees can benefit from the SAP® In-Store Product Lookup mobile app, which creates a new experience for retail shoppers and employees by helping store managers and associates on the floor better assist customers. For example, store employees can locate the availability of an item with current stock information in real-time, eliminating the need for shoppers to wait at the checkout counter. The app also displays product details and stock levels both in-store and in nearby stores, as well as the ability to adjust inventory.
Insurance companies can improve customer service with the SAP® Policyholder Lookup mobile app, which allows insurance sales agents to access policy and claim details of policyholders anywhere and anytime. The app provides increased sales insight and service with up-to-date customer information, decreasing call volume for claim status and policy coverage.

SAP® Store and Mobile App Ecosystem Growth

SAP offers a carefully curated mobile platform and enterprise application portfolio designed to expand and accelerate any business' ability to run better with mobile. With the introduction of more than 70 apps from SAP and its partners, SAP continues to expand a network of industry-leading developers, with companies such as Advent Global and Principal Consulting making it possible for complex mobile solutions to become a simple reality.

Advent Global's Go Sell mobile app is a comprehensive sales force automation app that enables sales professionals to be connected and sell on the go. With instant access to their handheld devices, sales professionals can log calls, respond to hot leads, and access vital information such as opportunities and dashboards across the complete order-to-cash process wherever they are. The app not only saves precious time, but also eliminates the process overhead of carrying physical reports/forms and dependency on sales office for real-time information. The app runs on Android, iPhone, iPad, Blackberry and Windows Mobile devices and utilizes data from the SAP® ERP Central Component (SAP ECC) component and SAP® CRM application.

The Principal Consulting Group successfully runs an app called the Project Manager, which allows users to effectively manage their projects while out of the office. The app provides customers with a complete end-to-end project management functionality including: the ability to review and update projects, review work-breakdown-structures, coordinate team members and project assignments, capture time for project tasks to be completed and review dashboards and critical KPIs. The app saves time and cost, while providing all the information needed for a project manager to run the task on time and on budget. The app is available for all major mobile devices.

An HTML5 version of SAP Store for iPad and tablets is now available, delivering a dynamic user experience. New versions of SAP Store native mobile application for iOS ("SAP Mobile Apps" in iTunes) and Android ("SAP Store" in Google Play Store) platforms have also been made available for an end-to-end buying process for mobile solutions, including credit card enablement for payment.

Expanding SAP apps Across Platforms

SAP is continuing to evolve and build the mobile app ecosystem with updated features and expanded platform availability to existing apps, including:

SAP® Customer Financial Fact Sheet mobile app, allowing sales representatives or account executives to check the system financial status of their customers anywhere and anytime, is now available on iPad and Android 2.2 or later.
SAP® Payment Approvals mobile app, helping ensure the liquidity of a company by approving payments anywhere and anytime, is now available on Android 2.2 or later.
SAP® Electronic Medical Record mobile app, putting critical patient information in the hands of doctors, providing them with instant access to the electronic medical records at a patient's bedside, is now available on Android 3.2 and iPhone.
SAP® GRC Policy Survey mobile app, allowing employees to receive, complete and submit governance, risk and compliance (GRC) policy surveys, quizzes and acknowledgements, is now available on iPad.

For a closer look, see: "Screenshots: SAP Mobile Apps Connect Businesses and Consumers." For announcements, blog posts, videos and other coverage during SAPPHIRE NOW, visit the Events Newsroom.

SAPPHIRE® NOW

About SAP

For customers interested in learning more about SAP products:
Global Customer Center: +49 180 534-34-24
United States Only: 1 (800) 872-1SAP (1-800-872-1727)

For more information, press only:
Amisha Gandhi, +1 (415) 341-7101, amisha.gandhi@sap.com, PDT
Scott Malinowski. +1 (978) 287-1793, scott.malinowski@sap.com, EDT
SAP Press Office, +49 (6227) 7-46315, CET; +1 (610) 661-3200, EDT; press@sap.com

During SAPPHIRE NOW (from May 14 to 16), to speak with press contacts on site, please dial the SAP press room: +1 (610) 661-0469.

SOURCE SAP AG

RSCC and Hughes Sign Technology Cooperation Memorandum of Understanding

Mon, 14 May 2012 11:08:00 -0400

May 14, 2012 11:08 ET

RSCC and Hughes Sign Technology Cooperation Memorandum of Understanding

Companies to Explore Innovative Multi-Media Satellite Networks and Services in Russia

MOSCOW and GERMANTOWN, Md., May 14, 2012 /PRNewswire/ -- Today, at the Sviaz-ExpoComm Exhibition in Moscow, the Russian Satellite Communications Company (RSCC), Russia's largest satellite communications operator, and Hughes Network Systems, LLC (Hughes), the world's leading provider of broadband satellite solutions and services, signed a technology cooperation memorandum of understanding (MOU) under which the companies will explore the development of multi-media video and broadband Internet services via RSCC satellites in Russia.

(Logo: http://photos.prnewswire.com/prnh/20110112/NE29456LOGO )

RSCC expects to apply the experience gained by Hughes, the U.S. market leader in high-speed satellite Internet services, to the development and management of satellite communications networks in Russia. RSCC is furthermore willing to consider providing Hughes with the necessary ground and space infrastructure at RSCC's Space Communication Centres to conduct testing and develop new solutions.

Hughes, in turn, will thoroughly examine the possibility of deploying its research and production capabilities on Russian territory in the immediate vicinity of one of RSCC's Space Communication Centres. RSCC and Hughes expect to develop in the following year a full-scale partnership cooperation program that would offer cost-effective solutions for public and private entities interested in multiple-system services.

"We are happy to expand cooperation with Hughes," said Yuri Prokhorov, the RSCC Director General. "RSCC seeks to implement state-of-the-art technological solutions and innovative practices in the global satellite communications market, and Hughes brings unique technology and market experience in addition to that of other RSCC industry partners from abroad. "

"The Russian market is growing rapidly and is strategically important to Hughes," commented Arunas Slekys, vice president and GM, Russia/CIS, Hughes. "We look forward to working with RSCC in exploring new value-added broadband data and video solutions in Russia, leveraging the complementary experience of both companies in satellite technologies and service delivery."

About Russian Satellite Communications Company
The Russian Satellite Communication Company (RSCC) is the Russian state satellite operator whose spacecraft provide global coverage. RSCC was founded in 1967 and is one of the ten largest satellite operators in the world in terms of satellites and orbital slots. The company owns the largest satellite constellation in Russia, located in the geostationary orbital arc from 14 West to 140 East and cover the whole territory of Russia, CIS, Europe, the Middle East, Africa, the Asia Pacific region, North and South America, and Australia. The company includes five Satellite Communications Centers (SCC) at Dubna, Bear Lakes, Skolkovo, Zheleznogorsk and Khabarovsk and the Shabolovka Technical Centre in Moscow, as well as its own high-speed optical-fiber digital network.

As the national satellite operator, RSCC fulfills the important state tasks of providing mobile presidential and governmental communications, and federal television and radio signal transmission over the territory of Russia and most countries of the world. The company pays serious attention to implementing national projects. RSCC closely interacts with the Russian state authorities in the field of informational and telecommunications and broadcast systems development. RSCC provides a full range of communications and broadcasting services using its own terrestrial engineering facilities and satellite constellation including up-to-date spacecraft of Express-AM, Express-A, Bonum-1, Ekran-M series and a part of the French W4 satellite capacity. The company's satellites offer wide opportunities to establish television and radio broadcasting inclusive DTH, IPTV, MPEG-4 services, broadband Internet access, data transmission, videoconferencing, VSAT network deployment, departmental, and enterprise communications networks worldwide. The company has its own satellite TT&C system. At present, RSCC controls and monitors Eutelsat, Intelsat, etc. satellites using its engineering facilities. The more detailed information is available on Web site: www.rscc.ru

About Hughes Network Systems
Hughes Network Systems, LLC (Hughes) is the world's leading provider of satellite broadband for home and office, delivering innovative network technologies, managed services, and solutions for enterprises and governments globally. HughesNet® is the #1 high-speed satellite Internet service in the marketplace, with offerings to suit every budget. To date, Hughes has shipped more than 2.8 million systems to customers in over 100 countries, representing over 50 percent market share. Its products employ global standards approved by the TIA, ETSI and ITU organizations, including IPoS/DVB-S2, RSM-A, and GMR-1.

Headquartered outside Washington, D.C., in Germantown, Maryland, USA, Hughes operates sales and support offices worldwide, and is a wholly owned subsidiary of EchoStar Corporation (NASDAQ: SATS), a premier global provider of satellite operations and digital TV solutions. For additional information about Hughes, please visit www.hughes.com

Hughes and HughesNet are registered trademarks of Hughes Network Systems, LLC, an EchoStar company.

SOURCE Hughes Network Systems, LLC

TechConnect World 2012 Attracts Leading Corporations for Technology-to-Business Matchmaking in Silicon Valley

Thu, 17 May 2012 13:28:00 -0400

SANTA CLARA, Calif., May 17, 2012 /PRNewswire/ -- The annual TechConnect World conference is North America's largest multi-sector conference and marketplace for innovators, technology business developers, and investors. The next TechConnect World will take place June 18-21, 2012, at the Santa Clara Convention Center, Santa Clara, CA, US.

 TechConnect's innovative Corporate Partnering Forum features executives from Fortune 1000 corporations presenting strategic technical and investment areas of interest. The corporations are looking for technology solutions for potential partner and funding opportunities.

More than twenty Corporate Partners will present at TechConnect World in Santa Clara, CA, including: Applied Materials, BASF, Bayer MaterialScience, bp, Dow, DuPont, Honda, Hyundai, IBM, Intel, Johnson Controls, Lockheed Martin, MeadWestvaco, Panasonic, PPG Industries, Samsung, Schlumberger, Shell, SK Innovation, Siemens, and Toray.

"The mission of TechConnect aligns directly with The White House directive to strengthen technology commercialization and entrepreneurial initiatives by accelerating investment and industry exposure to the nation's top innovations. TechConnect and its growing number of corporate partners speaks to the importance of having matchmaking programs to increase the innovation pipeline and bring the most promising technologies to the marketplace," notes Matthew Laudon, TechConnect CEO.

TechConnect World also features the world's largest showcase of top-vetted innovations, IP and early stage companies from multiple industrial sectors including: advanced materials, energy, defense, biotech, electronics, sensors, transportation, environment and medical.

One early stage company participating at the Conference "is currently working with numerous technology leaders and Fortune 1000 companies that are incorporating our nanocrystal additives into their product development efforts enabling them to develop their next generation of products," said Craig Bandes, president and CEO of Pixelligent Technologies. "TechConnect has proven to be our most productive conference in terms of meeting potential customers and partners. It provides Pixelligent with a great opportunity to get in front of our target customers and partners in the electronics and industrial markets."

To learn more about TechConnect World 2012 and how to participate, please visit:
http://www.techconnectworld.com/World2012/.

About TechConnect (www.techconnect.org):

TechConnect is a global technology outreach & development organization. Through our innovative programs and conferences, we deliver the most promising technologies to the world's top corporate, investment, and government professionals. TechConnect is headquartered in Austin, Texas, with offices in Cambridge, Massachusetts and Danville, California.

Contact:
Jennifer Rocha
Director, Strategic Development
774-249-8514
jrocha@techconnect.org

Laura Benold
Media Relations
press@techconnect.org

SOURCE TechConnect

Architectural Record Announces 2012 Excellence in Advertising Awards

Fri, 18 May 2012 12:38:00 -0400

NEW YORK, May 18, 2012 /PRNewswire/ -- Architectural Record (http://www.ArchitecturalRecord.com), McGraw-Hill Construction's prestigious publication, has presented its 16th Annual Excellence in Advertising Awards to 66 companies and agencies. The awards breakfast hosted more than 250 manufacturers, agencies, and architects in Washington, D.C. today during the AIA 2012 National Convention & Design Exposition.

More than 170 advertisements were judged. Advertisements were considered from the first quarter of 2012 in Architectural Record (in print and online) and in the January/February issue of GreenSource. Winners were judged for content and graphic presentation by a jury of 10 esteemed architects from across the country, representing the breadth of the profession.

"There is no single ad type that appeals to every architect. Our audience is highly visual and attractive images are an important characteristic of an effective ad. I'm thrilled for our winners and wish them, and all of our advertisers, continued success," said Laura Viscusi, vice president, McGraw-Hill Construction Media and publisher, Architectural Record.

This year's winners included:

Best in Class:

Campaign:

Armstrong Ceiling Systems – Zban Advertising
The Modern Fan Co.
Hunter Douglas Contract – Post & Beam
Rocky Mountain Hardware - Burchiellaro Design
Valspar – Periscope

Single Page:

Bobrick Washroom Equipment, Inc. –KleinMickaelianPartners
Holcim – Ricochet Partners

Winners:

Technical Glass Products – Brandner Communications, Inc.
CertainTeed Gypsum – Think Tank Studio
Decoustics – Interrupt Marketing
Forms+Surfaces
Kawneer Company, Inc. – Function
Louis Poulsen Lighting
Morin – A Kinspan Group Company
Simpson Strong-Tie – Function
Soil Retention Products, Inc. – Drop Dead Design

Honorable Mention:

Centria – Pipitone Group
Construction Specialties, Inc. – Brian J. Ganton & Associates
Lutron Electronics
Western Red Cedar Lumber Association – Hunter Consulting International, Inc.
The Collins Company – DHX Advertising
Kornegay Design
Pella Corporation – The Integer Group

Online Ad Awards:

Best in Show – Online

Alcoa – Elevation Advertising
Georgia Pacific Gypsum – OMD Atlanta
FSB

Winners – Online:

Centria – Pipitone Group
ClimateMaster
Forms+Surfaces
Mitsubishi Plastics Composites America, Inc. – The Ludlow Group
Rethink Wood

Honorable Mention – Online:

Schindler – Point to Point Communications

User Engagement –Awards:

Winners:

Autodesk
Mitsubishi Plastics Composites America, Inc. – The Ludlow Group
PPG Glass – Pipitone Group

Honorable Mention:

Centria
Ceramic Tiles of Italy
Forestry Innovation Investment
Guardian
Merchant Evans
Rite Hite
Technical Glass Products
The Wester Red Cedar Lumber Association

Continuing Education –Awards:

Winners – Article Sponsors:

BRAE
Electrolux Home Products, Inc.
Forestry Innovation Investment – Hunter Consulting International, Inc.

Honorable Mention:

Bonded Logic Inc.
Cool Roof Rating Council
Manko Windo Systems
Mitsubishi Electric
NanaWall Systems, Inc.
Tournesol Siteworks
Vetrazzo

Winners – Interactive Sponsors:

Jenn-Air
Pilkington Fire Protection Glass North America
Smith & Fong, Plyboo

Honorable Mention:

ECOsurfaces Commercial Flooring
Feeney, Inc.
Glidden Professional
Guardian Industries Corp.
Lapeyre Stairs
National Gypsum Company
Sage Glass

For more information or photos of the awards, advertisements, or winners, visit http://archrecord.construction.com/adawards.

About McGraw-Hill Construction:
McGraw-Hill Construction's data, analytics, and media businesses—Dodge, Sweets, Architectural Record, and Engineering News-Record— create opportunities for owners, architects, engineers, contractors, building product manufacturers, and distributors to strengthen their market position, size their markets, prioritize prospects, and target and build relationships that will win more business. McGraw-Hill Construction serves more than one million customers through its trends and forecasts, industry news, and leading platform of construction data, benchmarks, and analytics, including Dodge BuildShare and Dodge SpecShare. To learn more, visit www.construction.com.

About The McGraw-Hill Companies:
McGraw-Hill announced on September 12, 2011, its intention to separate into two public companies: McGraw-Hill Financial, a leading provider of content and analytics to global financial markets, and McGraw-Hill Education, a leading education company focused on digital learning and education services worldwide. McGraw-Hill Financial's leading brands include Standard & Poor's Ratings Services, S&P Capital IQ, S&P Indices, Platts energy information services and J.D. Power and Associates. With sales of $6.2 billion in 2011, the Corporation has approximately 23,000 employees across more than 280 offices in 40 countries. Additional information is available at http://www.mcgraw-hill.com/.

Media Contact:
Kathy Malangone, Senior Director, Marketing Communications,
McGraw-Hill Construction, +1 212-904-4376, kathy_malangone@mcgraw-hill.com

SOURCE McGraw-Hill Construction

LG Electronics Brings New, Innovative Energy-Efficient Commercial HVAC Solutions To LEED-Focused Architects

Thu, 17 May 2012 10:00:00 -0400

May 17, 2012 10:00 ET

LG Electronics Brings New, Innovative Energy-Efficient Commercial HVAC Solutions To LEED-Focused Architects

Marrying innovative design with higher efficiency, Multi V III VRF technology delivers AHRI certified ratings, fast response cooling and space-saving smaller footprint

WASHINGTON, May 17, 2012 /PRNewswire/ -- Addressing the needs of architects seeking more energy efficiency and flexibility in HVAC solutions, LG Electronics is highlighting its award-winning variable refrigerant flow VRF product line, as well as new high Seasonal Energy Efficiency Rated (SEER) models for residential and light commercial applications at this week's American Institute of Architects National Convention & Design Expo (booth # 4126).

Catering to LEED®*-focused architects, these commercial climate control products from the worldwide HVAC solutions provider deliver aesthetic versatility and energy-saving technologies for a quicker return on investment, according to Kevin McNamara, vice president of Commercial Air Conditioning, LG Electronics USA.

"The architecture and design community is an important audience for LG Electronics, and the AIA Convention presents an ideal forum for demonstrating LG's ongoing partnership with, and product innovations developed for, this influential group," said McNamara. "Today's architects and design experts are setting the pace for more energy efficient, cost-effective and creative commercial and residential dwelling solutions. As evidenced by the products showcased at AIA this year, LG's new HVAC solutions are designed to both meet and exceed these needs."

Multi V III
Harnessing the power of the next-generation of VRF technology has enabled Multi V III to achieve a breakthrough with energy efficiency standards in both Heat Pump and Heat Recovery models with an increase in condenser heat transfer surface area and a new compressor. The Multi V III Heat Pump allows occupants to choose either to air-condition or heat all zones in use, while the Heat Recovery model allows for synchronous cooling and heating in different zones at the same time. Units are available from 6-36 tons and 208-230V or 460V. Multi V III is LG's flagship commercial HVAC system as demand for energy-saving HVAC technology continues to grow.

Multi V III's key benefits for building owners include:

Cost Savings: Lower lifecycle costs compared with traditional HVAC systems on the market today.**
Excellent Energy Efficiency:
- With AHRI Standard 1230 Certification®, Multi V III is one of the first performance certified VRF systems. This ensures building owners receive verified ratings.
- Strong AHRI Certified® ratings and an Integrated Energy Efficiency Ratio (IEER) of up to 21.8 solidify LG's position as a market leader.
LEED® Certification*: Allows building designers the opportunity to claim LEED®, points.
Longer Piping Distances: Owners can reach extra zones that are further away from the Multi V III unit. With up to 3,280-feet of total equivalent length, a maximum run length of 738 equivalent feet and elevation difference of up to 360-feet, Multi V III reduces the need to invest in extra systems and saves on installation.
Rapid Start Cooling: The fast response cooling or heating feature delivers conditioned air faster than previous systems.

Compact Footprint: Multi V III supports more indoor zones and takes up less outdoor space than previous models. When space or access is at a premium, this equates to significant cost advantages for the owner on large projects.

Newest Addition to the Art Cool Family
LG's new High SEER Art Cool wall-mounted models have increased Art Cool's already high SEER ratings vastly. The 12K BTU/h offers SEER up to 26 and the 9K model offers up to 28, a rating currently unmatched by competitors. The new product offers many unparalleled features for those needing a duct-free system:

Effective Air Dispersal -- an optimized 4-way swing airflow, 39ft of air throw and a 16° to 70° airflow outlet range disperse air throughout the space.
Efficiency – optimized 3 row coil and supply fan compliment the digitally controlled compressor and fan motors
Peace and Quiet – the fan size has been increased by 25% and utilizes a 15° blade angle to reduce buffeting, reducing noise levels.

In addition to the newest member of the Art Cool family, popular LG Art Cool Mirror wall mounted units have style to fit any decor are also on display. Similar to the standard wall mounted unit, the Art Cool Mirror hangs on an easily installed factory supplied wall bracket, making installation simple. Energy efficiency for the Art Cool Mirror units range from 18.9 SEER to 20 SEER. Also on display this week, LG's Art Cool Gallery model provides a three dimensional air flow system with the look and feel of a stylish photo frame.

Expanded Product Line
Also highlighted at the AIA Convention this week is LG's expanded product line, including the new Multi V Water II, a new high-efficiency inverter water source heat pump that enables capacity to vary based on load fluctuation. This eco-friendly heating and cooling system can also be used in geothermal applications.

LG's Multi V Mini is a two pipe heat pump system that is available in capacities of 3, 4 and 4.4 tons. This system is best suited for applications with up to 9 zones that require either heating or cooling with indoor units totalling up to 5.7 tons of capacity. Multi V Mini outdoor units are available in 208/230V single phase which suits small buildings and residences.

With today's concern for maintaining a comfortable indoor environment, the new LG Eco V is an integral component of any HVAC system. This high efficiency air-to-air heat exchanger allows introduction of tempered outdoor air to ducted and cassette indoor units or directly to the space while connecting to LG's controls system or operating standalone.

LG's high static ducted units offer a full range of capacities from 7,000 to 96,000 Btu/h. With short supply and return ducts, static pressure losses are minimized when compared to conventional ducted systems. Ducted units can be installed in schools, offices, conference rooms, homes and residence retrofits, hallways and lobbies or anywhere a unit must be concealed.

More information on Multi V III, VRF technology and additional LG commercial air conditioning solutions can be found at www.LG-VRF.com and www.LG-DFS.com.

Designs, features and specifications subject to change without notice.

*LEED, or Leadership in Energy and Environmental Design, is an internationally-recognized green building certification system developed by the U.S. Green Building Council (USGBC). LEED provides building owners and operators with a framework for identifying and implementing practical and measurable green building design, construction, operations and maintenance solutions.

** White paper available for review at http://www.lg-vrf.com/engineering-resources.aspx

About LG Electronics USA
LG Electronics USA, Inc., based in Englewood Cliffs, N.J., is the North American subsidiary of LG Electronics, Inc., a $48 billion global force and technology leader in consumer electronics, home appliances and mobile communications. In the United States, LG Electronics sells a range of stylish and innovative home entertainment products, mobile phones, home appliances, commercial displays, air conditioning systems and solar energy solutions, all under LG's "Life's Good" marketing theme. For more information, please visit www.lg.com.

LG Electronics USA Air Conditioning
The LG Electronics USA Commercial Air Conditioning business is based in Alpharetta, Ga. LG is a leading player in the global air conditioning market, manufacturing both commercial and residential air conditioners and providing total sustainability and building management solutions. From consumer and individual units to industrial and specialized air conditioning systems, LG provides a wide range of products for heating, ventilating and air conditioning.

LG Electronics Air Conditioning & Energy Solutions Company
The LG Electronics Air Conditioning & Energy Solutions Company (LG AE) is a complete heating, ventilation and air conditioning (HVAC), and energy solution company providing Residential Air Conditioning, Commercial Air Conditioning Solar Energy and LED Lighting around the world. Bringing technology leadership from the worldwide HVAC market and incorporating technologies from throughout LG, LG AE is increasingly expanding into specialized B2B solutions as an integrated energy solutions company. Through its innovative technology, heavy investments in R&D and effective marketing strategies, LG AE has broken its own sales records every year since 2000.

SOURCE LG Electronics USA, Inc.

UL Environment Collaborates with Perkins+Will and Interface to Develop 'EPD Transparency Brief

Thu, 17 May 2012 09:06:00 -0400

New tool enables specifiers, purchasers, and other EPD users to access critical product impact information quickly, easily, and consistently

MARIETTA, Ga., May 17, 2012 /PRNewswire-USNewswire/ -- UL Environment, a business unit of UL (Underwriters Laboratories), announced today the launch of its EPD Transparency Brief, an innovative, single-page supplement to the Environmental Product Declaration (EPD) that provides an at-a-glance look at a product's most critical lifecycle-based environmental impact information.

(Logo - http://photos.prnewswire.com/prnh/20120209/MM50987LOGO)

Developed with creative and technical input from architecture firm Perkins+Will, carpet tile manufacturer Interface, and a consortium of market-leading EPD users (including DPR Construction, Gensler, HOK, SERA, and Webcor Builders), UL Environment's EPD Transparency Brief is available for use by any manufacturer whose product has earned a UL Environment Certified EPD.

"We realized that what the marketplace needed wasn't just information -- but, rather, information that's easy to find, easy to understand, and easy to use. We call this notion 'accessible transparency,'" says Heather Gadonniex, part of the strategy and innovation team at UL Environment. "Our EPD Transparency Brief allows for accessible transparency by making it inherently simpler and quicker for specifiers and purchasers to glean key facts about a product's lifecycle-based impacts. And that helps them make more informed product choices."

Benefits of the EPD Transparency Brief
The result of many months of collaboration between UL Environment and a cross-section of experts in green building, design, products, and business, the EPD Transparency Brief:

Condenses the complex information presented within the many pages of an EPD into a concise, easy-to-understand, "nutrition label-like" document that takes up no more than one page front-and-back
Acts as a "quick reference guide" to a product's EPD, enabling specifiers to readily access the EPD's most relevant information -- thus saving time and effort
Serves as a unique sales, marketing, and specification tool that -- in a single page, front to back -- discloses a product's most relevant environmental impacts while also showcasing a manufacturer's commitment to transparency

"Offering more information about the human and environmental health of materials and buildings will drive change in the marketplace," says Chris Youssef, designer at Perkins+Will. "At Perkins+Will, we have been working alongside partners such as Interface and UL Environment to help drive this change, and we are thrilled to see transparency taking root."

A Complementary Tool: The New UL Certified EPD Badge
To complement the EPD Transparency Brief, UL Environment has also introduced a new UL Certified Environmental Product Declaration badge -- an easily recognizable mark that manufacturers can use on marketing collateral to help further differentiate their products. The badge -- a green-colored, soft-cornered rectangle bearing a modified UL mark, a leaf, and the words CERTIFIED ENVIRONMENTAL PRODUCT DECLARATION -- also helps specifiers identify products that have a trusted, third-party certified EPD.

Among the first manufacturers to receive the new EPD Transparency Brief and Certified Environmental Product Declaration badge are Kingspan, CertainTeed Saint-Gobain, and Interface.

"Interface is proud to continue our leadership in the transparency movement," says Lindsay James, director of strategic sustainability at Interface. "The 'accessible transparency' of the EPD Transparency Brief fills a critical need for busy specifiers who are eager to make choices based on lifecycle environmental impacts, with the reassurance of third-party verified data."

Both transparency tools will be on display at UL Environment's booth (#3717) at the AIA National Conference in Washington, D.C., which runs today through Saturday, May 19, 2012.

About UL Environment
UL Environment's mission is to advance global sustainability, environmental health, and safety by supporting the growth and development of environmentally preferable products, services, and organizations. We help companies achieve their sustainability goals -- and help purchasers, specifiers, retailers, governments, and consumers find products they can trust. UL Environment offers environmental claim validations, multi-attribute product certifications, environmental product declarations, indoor air quality certification, product emissions testing, organizational sustainability certification, and consulting. For more information, visit www.ul.com/environment.

About UL
UL is a premier global safety science company with more than 100 years of proven history. Employing nearly 9,000 professionals in 46 countries, UL is evolving the future of safety with five distinct business units – Product Safety, Environment, Life & Health, Verification and Knowledge Services – to meet the expanding needs of customers and the global public. For more information on UL's family of companies and network of 95 laboratory, testing, and certification facilities, go to www.UL.com.

SOURCE UL Environment

Construction Industry's Workforce Shortage Brings Concerns, but Green Jobs Bring Promise, According to New McGraw-Hill Construction Report

Thu, 17 May 2012 09:00:00 -0400

NEW YORK, May 17, 2012 /PRNewswire/ -- The construction industry is concerned about skilled worker shortages, according to a new SmartMarket Report from McGraw-Hill Construction entitled "Construction Industry Workforce Shortages: Role of Certification, Training and Green Jobs in Filling the Gaps." It is the first study to focus exclusively on design and construction professionals and trade workers. Skilled workers have left the industry as a result of the economic downturn, an aging workforce and an insufficient pipeline of younger workers, according to the new study released at the AIA 2012 National Convention and Design Exposition this week in Washington, DC. The study shows that 69% of architect, engineer, and contractor (AEC) professionals expect skilled workforce shortages in next three years; 32% of AEC are concerned about a shortage of specialty trade contractors by 2014; 49% of the general contractors are concerned about finding skilled craft workers by 2017, and 37% of architect and engineering firms are concerned about finding experienced workers. Skilled green workers are in even more demand; 86% of architects and engineers and 91% of contractors are finding too few green skilled employees.

Facing the loss of employees in the construction professions, industry professionals are worried they may have lost those skills, and uncertainty about interest by the next generation raises concerns about being able to fill gaps in the future. In a separate but related survey McGraw-Hill Construction conducted for the American Institute of Architects (AIA), 79% of architecture firms are not sure the U.S. student pipeline will be sufficient to replace those leaving the profession, a problem exacerbated by the 76% of U.S. architecture students/recent graduates who would consider working abroad.

"The downturn in construction activity may be masking a serious problem in the construction industry workforce," said Harvey Bernstein, vice president, Industry Insights and Alliances for McGraw-Hill Construction. "But the rise of green jobs and more availability of training and professional certifications can help to attract interest in the professions and make firms more competitive."

Green jobs, in particular, represent a transformational shift in the construction industry. McGraw-Hill Construction found that 35% of architects, engineers and contractors report having green jobs today, representing nearly 650,000 jobs. That share is expected to increase over the next three years, with 45% of all design and construction jobs being green by 2014.

McGraw-Hill Construction defines "green jobs" as those involving more than 50% of work on green projects (defined by McGraw-Hill Construction as projects meeting LEED or another credible green building certification program, or one that is energy- and water-efficient and also addresses indoor air quality and/or resource efficiency) or designing and installing uniquely green systems. Focusing on the construction professions exclusively, this definition excludes support or administrative professionals and manufacturing, production or transportation-related services.

This growth of green may help draw more young professionals into the industry. For example, the study also reveals that 62% of trade firms are concerned their profession does not appeal to the younger generation and 42% of architects report the same. However, the younger generation reports a strong commitment to sustainability, with 63% of architecture students saying they would engage in sustainable design out of a personal responsibility. This suggests that as green rises, so too may interest by young professionals in the design and construction fields of practice.

"Green buildings are a clear-cut smart investment in the current economic climate because they create financial returns, have environmental benefits and positively impact job creation. USGBC is excited to be releasing this new report with McGraw Hill Construction and the AIA that directly addresses these findings," says Roger Platt, senior vice president of global policy and law at USGBC. "Job creation and economic stability are crucial to supporting resilient and strong communities, and green buildings support the jobs of the future."

The survey also demonstrates that by requiring professional certifications of employees for different skills, firms are more apt to maintain a competitive advantage while also benefiting individual workers. 71% of firms find that having certified employees increases the competitiveness of their firms to win contracts; 68% believe certified employees help them grow their green business; 77% of individuals feel certification helps them gain valuable knowledge they can use on the job, and 75% believe it brings them more job opportunities, which are key in this time of high unemployment.

"These findings should serve as a huge wakeup call for the entire design and construction industry," said AIA EVP/Chief Executive Officer, Robert Ivy, FAIA. "But they also present an opportunity to showcase the tremendous opportunity for architecture students and emerging professionals since there will be such a heavy demand for architects in the coming years."

The premier partners on the project include the American Institute of Architects and the U.S. Green Building Council. Other contributing partners include the Society for Marketing Professional Services, National Association of the Remodeling Industry, Building & Construction Trades Department of the AFL/CIO, ACE Mentor Program, American Institute of Constructors & Constructor Certification Commission, and National Center for Construction Education and Research.

Further results and insights will be shared by Bernstein at the AIA National Convention session "Workforce Transformations: Creating a Bridge between the Needs of Today and the Construction Workforce of Tomorrow." The session will be held on Friday, May 18, at 2:00 p.m. at the Washington, DC Convention Center. Highlights from the report will also be offered on Thursday, May 17 at 10:00 a.m. at McGraw-Hill Construction's booth #2603.

A copy of the McGraw-Hill Construction SmartMarket Report "Construction Industry Workforce Shortages: Role of Certification, Training and Green Jobs in Filling the Gaps" can be downloaded at http://analyticsstore.construction.com/index.php/smartmarket-report-construction-industry-workforce-shortages-2012.html

About McGraw-Hill Construction:
McGraw-Hill Construction's data, analytics, and media businesses -- Dodge, Sweets, Architectural Record, and Engineering News-Record -- create opportunities for owners, architects, engineers, contractors, building product manufacturers, and distributors to strengthen their market position, size their markets, prioritize prospects, and target and build relationships that will win more business. McGraw-Hill Construction serves more than one million customers through its trends and forecasts, industry news, and leading platform of construction data, benchmarks, and analytics. To learn more, visit www.construction.com.

About The McGraw-Hill Companies:
McGraw-Hill announced on September 12, 2011, its intention to separate into two public companies: McGraw-Hill Financial, a leading provider of content and analytics to global financial markets, and McGraw-Hill Education, a leading education company focused on digital learning and education services worldwide. McGraw-Hill Financial's leading brands include Standard & Poor's Ratings Services, S&P Capital IQ, S&P Indices, Platts energy information services and J.D. Power and Associates. With sales of $6.2 billion in 2011, the Corporation has approximately 23,000 employees across more than 280 offices in 40 countries. Additional information is available at http://www.mcgraw-hill.com/.

Media Contact:
Kathy Malangone, Senior Director, Marketing Communications,
McGraw-Hill Construction, +1 212-904-4376, kathy_malangone@mcgraw-hill.com

SOURCE McGraw-Hill Construction

ArchiCAD 16 Debuts at AIA 2012 National Conference

Tue, 15 May 2012 09:15:00 -0400

May 15, 2012 09:15 ET

ArchiCAD 16 Debuts at AIA 2012 National Conference

BOSTON, May 15, 2012 /PRNewswire/ -- GRAPHISOFT introduces ArchiCAD® 16, the latest version of its premium BIM software, at booth #2209 at the AIA 2012 National Convention and Design Exposition in Washington DC, May 17-19, at the Walter E. Washington Convention Center.

Architects are invited to join GRAPHISOFT for software demonstrations that will focus on design freedom, accessibility to BIM components and sustainable design, which make ArchiCAD 16 the best architectural modeling tool available today.

"Washington, DC is a great location for the event. We're looking forward to catching up with the local ArchiCAD community and showing off our new features," said Steve Benford, Managing Director, GRAPHISOFT North America. "These really are exciting times, with great challenges matched by equally great rewards. Change happens fast. To succeed, participants need to be nimble and swift. ArchiCAD is truly one of the great tools for firms to express their proprietary advantage and stay ahead of their competitors."

Top design and technical experts will be on hand to explain how GRAPHISOFT's array of software solutions helps firms adapt to the evolving world of Building Information Modeling. Monte Chapin, GRAPHISOFT Business Process Leader, North America and Yanni Alexakis, CSI, Int'l Association AIA, GRAPHISOFT Product Manager, will discuss how the OPEN BIM movement meets industry's demands for interoperability and interdisciplinary collaboration. The upgraded BIM Server™, Cloud-integrated model sharing, and support for the IFC 2x3 Coordination View Version 2.0 for facilitating Open BIM will be on display as well.

Demonstrations of the new MORPH™ tool, found in ArchiCAD 16, will show how it enables the creation of freeform elements directly in ArchiCAD. Since MORPH has no geometric limitations: every node, edge and every surface can be moved and shaped in any direction.

Visitors to the GRAPHISOFT booth will also see the latest enhancements to the revolutionary presentation and communication tool, BIMx for ArchiCAD 16. BIMx provides a dynamic way to share architectural designs on a mobile device or tablet. Now, with ArchiCAD 16, cloud-integrated model sharing service is available for BIMx users. Attendees will be provided 3D glasses to enhance their experience as they explore designs through BIMx in a 3D environment that supports real-time 3D navigation using familiar navigation techniques.

GRAPHISOFT will also demonstrate important workflow and productivity updates to its growing portfolio of solutions. From 11.00 AM-2.00 PM on May 17^th and 18^th, the new e-SPECS Specification Management product suite integration with ArchiCAD will be featured.

About GRAPHISOFT

GRAPHISOFT® ignited the BIM revolution with ArchiCAD®, the industry first BIM software for architects. GRAPHISOFT continues to lead the industry with innovative solutions such as the revolutionary GRAPHISOFT BIM Server™, the world's first real-time BIM collaboration environment, and the GRAPHISOFT EcoDesigner™, the world's first, fully integrated building energy modeling application. GRAPHISOFT's innovative solutions have fundamentally changed the way architects around the world design and collaborate. GRAPHISOFT® has been part of the Nemetschek Group, since its acquisition in 2007.

Press Information
www.graphisoft.com
press@graphisoft.com
http://twitter.com/ArchiCAD

SOURCE GRAPHISOFT

/C O R R E C T I O N -- Limitless Computing/

Mon, 14 May 2012 09:38:00 -0400

May 14, 2012 09:38 ET

/C O R R E C T I O N -- Limitless Computing/

In the news release, Limitless Computing and ArtVPS Introduce Google SketchUp Rendering to the Cloud, issued 14-May-2012 by Limitless Computing over PR Newswire, we are advised by the company that Google should be added before all mentions of SketchUp, rather than as originally issued inadvertently. The complete, corrected release follows:

Limitless Computing and ArtVPS Introduce Google SketchUp Rendering to the Cloud

Launching at the AIA National Convention and Design Expo, Booth 1908

BOULDER, Colo. and CAMBRIDGE, England, May 14, 2012 /PRNewswire/ -- Limitless Computing Inc.®,a leading provider of 3D mobile Augmented Reality, and ArtVPS Ltd, developers of Shaderlight™, the interactive rendering software for Google SketchUp, today announced the launch of Shaderlight Cloud Rendering powered by Limitless Computing. Combining the highest quality rendering from Shaderlight and proven technology from Limitless Computing, this innovative new tool delivers the fastest, most effective workflow for Google SketchUp users.

Shaderlight Cloud Rendering powered by Limitless Computing renders Google SketchUp animations up to 30x faster, and scenes up to 5x faster, delivering high resolution, photorealistic visualizations direct from Google SketchUp in hours, not days. It frees up desktop computers for other work, enabling Shaderlight users to handle multiple projects simultaneously.

Offering a low-cost alternative to rendering scenes and animations in-house, pricing starts from under $10, delivering high quality rendered images without investment in costly hardware.

Launching in booth 1908 at the AIA National Convention and Design Expo, Shaderlight Cloud Rendering powered by Limitless Computing will be available to all Google SketchUp and Shaderlight users in June.

Graham Wylie, CEO at ArtVPS said, "This launch removes any final barriers for Google SketchUp users' wanting to deliver high quality renders, quickly, without tying up their systems. This is the natural progression for Shaderlight and we are delighted to be working with Limitless Computing on this exciting innovation."

"Anyone who has limited hardware resources or a tight deadline will find this powerful solution a tremendous value," commented Dr. Errin T. Weller, president, Limitless Computing Inc. "Animation sequences that would otherwise tie up workstations for days will be done on time and within budget."

About Limitless Computing

Limitless Computing Inc. is a Boulder, CO-based company that has been providing cloud computing since 2006 and specializes in Augmented Reality. Limitless Computing brought Augmented Reality to Google SketchUp in 2011 with the release of the mobile application SightSpace 3D for Apple and added Kindle Fire and Android devices in 2012. (www.LimitlessComputing.com)

About ArtVPS

Founded in 2002, ArtVPS Limited quickly established itself as the leading developer of dedicated rendering hardware, developing the first processor designed exclusively to accelerate ray tracing of 3D data. ArtVPS is today leading the way in developing photorealistic rendering solutions that generate visually accurate representations of 3D scenes. Its revolutionary flagship rendering technology, Shaderlight, is a physically based, progressive ray-tracer that enables interactive, nonlinear changes to the materials, environments, lighting and textures at any stage within the rendering process – even on production-ready images. (www.artvps.com)

Limitless Computing and logo are registered trademarks of Limitless Computing Inc. All other brand names, product names, or trademarks belong to their respective holders.

SOURCE Limitless Computing

Limitless Computing and ArtVPS Introduce Google SketchUp Rendering to the Cloud

Mon, 14 May 2012 08:52:00 -0400

May 14, 2012 08:52 ET

Limitless Computing and ArtVPS Introduce Google SketchUp Rendering to the Cloud

Launching at the AIA National Convention and Design Expo, Booth 1908

BOULDER, Colo. and CAMBRIDGE, England, May 14, 2012 /PRNewswire/ -- Limitless Computing Inc.®,a leading provider of 3D mobile Augmented Reality, and ArtVPS Ltd, developers of Shaderlight™, the interactive rendering software for SketchUp, today announced the launch of Shaderlight Cloud Rendering powered by Limitless Computing. Combining the highest quality rendering from Shaderlight and proven technology from Limitless Computing, this innovative new tool delivers the fastest, most effective workflow for SketchUp users.

Shaderlight Cloud Rendering powered by Limitless Computing renders SketchUp animations up to 30x faster, and scenes up to 5x faster, delivering high resolution, photorealistic visualizations direct from SketchUp in hours, not days. It frees up desktop computers for other work, enabling Shaderlight users to handle multiple projects simultaneously.

Offering a low-cost alternative to rendering scenes and animations in-house, pricing starts from under $10, delivering high quality rendered images without investment in costly hardware.

Launching in booth 1908 at the AIA National Convention and Design Expo, Shaderlight Cloud Rendering powered by Limitless Computing will be available to all SketchUp and Shaderlight users in June.

Graham Wylie, CEO at ArtVPS said, "This launch removes any final barriers for SketchUp users' wanting to deliver high quality renders, quickly, without tying up their systems. This is the natural progression for Shaderlight and we are delighted to be working with Limitless Computing on this exciting innovation."

About Limitless Computing

About ArtVPS

Limitless Computing and logo are registered trademarks of Limitless Computing Inc. All other brand names, product names, or trademarks belong to their respective holders.

SOURCE Limitless Computing

Tom Oliver Joins ONE World Sports

Fri, 18 May 2012 15:52:42 -0400

Tom Oliver Joins ONE World Sports

Former HBO exec will spearhead market development and branding with cable television companies
throughout the U.S. for new international sports programming network
New York – May 18, 2012- (Virtual Press Office) – The recruitment of Tom Oliver as Senior Advisor for Market Development and Branding at ONE World Sports, an international sports programming network new to the U.S., was announced today by Dave Almstead, CEO of ONE Media Corp, Inc., parent company of the network. Created for sports fans craving access to a broad array of popular professional sports from Asia and around the World, ONE World Sports has a lineup of professional team sports, including soccer, basketball, and golf featuring today’s leading Asian, American, European and Latin American players.

A high profile veteran of the cable television business from its earliest stages, Mr. Oliver is an experienced, entrepreneurial media company builder and operating manager. He joined the first management team of Home Box Office in its initial year of operations, heading up distributor sales, consumer marketing, and branding. He oversaw evolution of the Home Box Office brand from Time Life Television to the iconic HBO.

Following HBO, Mr. Oliver was a co-founder of DMX Music, Inc., a cable TV based music forerunner to XM/Sirius Satellite; President of the Interactive Channel, the interactive TV subsidiary of Source Media Television; Co-Founder and President of Play-It-Now, Inc., an IP media company that developed and distributed casual interactive skill games for cable and satellite television; and Co-Founder and Executive Vice President of Tokyo- headquartered G-Cluster Americas, Inc, an aggregator of casual interactive games for cable and satellite television. He is presently the Founder and Principal of Los Angeles-based Convergent Media Partners, providing distribution, marketing, and management assistance to early stage, multi-platform and interactive content companies in the casual games, social media, and cable TV services sectors.

Mr. Oliver joins a team at ONE World Sports that includes other notable cable television industry veterans, including Dick Stone, a former senior domestic and international distribution executive at ESPN and HBO; Peter Frame, former Head of Affiliate Sales and Operations at HBO; Radame Rodriguez, a veteran brand marketer at Comcast and ESPN; and David Andersen, former Head of Communications at Cox, CNBC, and Charter.

About ONE World Sports
ONE World Sports is a new sports network created especially for sports fans craving access to a broad array of popular professional sports from Asia and around the World. The 24/7, English language, ad-supported network is available on all platforms, and delivers a mix of exclusive live and recorded sports programming with proprietary distribution technology. With exclusive licensing deals for championships, events, and qualification tournaments from Asia and the Pacific, ONE World Sports has broken the international sports barrier with a lineup of professional team sports, including soccer, basketball and golf featuring today’s leading Asian, American, European and Latin American players.

One World Sports is owned and operated by ONE Media Corp, a privately owned company based in Dallas. The company also owns and operates ONE Connxt, an IP transport provider; America ONE Television, a general entertainment and sports broadcast network; and ONE Sports PLUS, a leading provider of live sports via broadband pay-per-view.

To learn more about ONE World Sports, go to http://www.ONEWorldSports.com.

# # #
CONTACT
David Andersen
404.514.0424
dandersen@oneworldsports.com

Motorola Mobility Showcases the Evolution of TV and a Smart, Simple Connected Home at The Cable Show 2012

Fri, 18 May 2012 14:19:00 -0400

HORSHAM, Pa., May 18, 2012 /PRNewswire/ -- Motorola Mobility, Inc. (NYSE: MMI) empowered the history of modern TV and the smart, simple connected home—and @ The Cable Show 2012, the company will show the industry how it is driving its future.

Motorola's mix of smart software, network and in-home technologies will be on display in a Living Room setting (Booth #733), demonstrating how the company is further empowering service providers to deliver on the promise of the IP Connected Home of the Future.

Motorola's Home and Network Cloud technology is a huge differentiator for providers staking their claim in the True TV Everywhere, personalization, and connected home experiences. Motorola will also be hosting one of the first HEVC (High Efficiency Video Coding) demonstrations in North America, showcasing a revolutionary new video compression technology that enables amazingly realistic images across multiple screens.

"You can't talk about the future of TV or the connected home without talking about Motorola. We invented digital TV, launched the world's first wireless cable modem, and powered the first mass commercial launch of home automation in North America," said Dan Moloney, president, Motorola Mobility. "Today, Motorola is once again at the forefront of the next big media revolution, creating the enabling technologies for tomorrow's digital lifestyle."

EVOLVING TV THROUGH SMART SOFTWARE
Motorola unveiled its early vision for converged media experiences two years ago when it launched the Medios Multi-Screen Software Suite @ The Cable Show 2010. Since then, Motorola has continued innovating into the Medios platform and will showcase its latest advancements @ this year's show, including DreamGallery, Merchandiser, Video Flow and SecureMedia®.

Consumer demand for simple and continuous access to content will continue to explode, presenting a tremendous opportunity for service providers to extend and brand content beyond the traditional TV set. With a modular approach, Medios enables service providers to develop multi-screen offerings faster, differentiate and brand the experience, and monetize an infinite array of content—ultimately staying on top of the increasing complexity in the home.

Medios continues to attract top-tier customers, due to its flexibility, open approach and industry-leading DRM. This month, Motorola disclosed a key customer win for Medios, and plans to announce more, on a global front, in the months ahead.

Time Warner Cable Selects SecureMedia® Encryptonite ONE™ HLS+ by Motorola Medios
Finally, entertainment – everywhere. Time Warner Cable's subscribers will be able to enjoy their favorite Hollywood and network entertainment on their device of choice – thanks to SecureMedia, from Motorola Mobility. Time Warner Cable selected the SecureMedia Encryptonite ONE HLS+ solution to streamline its video distribution across a variety of devices – including smartphones, tablets, game consoles, connected TVs and Blu-Ray players – and avoid the cost and complication of operating multiple streaming platforms and security systems to reach multiple device types.

DRIVING EVEN MORE EFFICIENCIES IN THE CLOUD WITH HEVC AND nDVR
HEVC – Optimize Bandwidth Delivery in the Cloud
Motorola will showcase one of the first HEVC demonstrations in North America at The Cable Show 2012. The demonstration will highlight how HEVC dramatically improves video quality in a bandwidth-efficient, yet cost-disruptive way.

HEVC video compression technology reduces bandwidth by 50 percent in comparison to MPEG4 AVC/H.264 – while still delivering similar video quality. HEVC provides stunning video resolution in the home and makes HD video over wireless links (Wi-Fi or cellular) much more practical and attainable for service providers. Additionally, HEVC can be a significant factor in dramatically reducing storage costs for in-home and networked DVRs.

This revolutionary compression technology was jointly developed by ISO/IEC Moving Picture Experts Group (MPEG) and ITU-T Video Coding Experts Group (VCEG). Motorola's HEVC demonstration builds on its heritage of network innovations and the importance of video compression in driving the evolution of TV. Motorola has been an active contributing member of MPEG2 (1993) and MPEG4 (2008) standards.

Visit Booth #733 to see a powerful side-by-side comparison of HEVC and MPEG4 AVC/H.264.

nDVR – Say Goodbye to Storage Wars and Welcome to True TV Everywhere
Motorola will also be highlighting how new technologies such as network DVR (nDVR) leverage the efficiencies in the cloud and providers' networks to deliver the unlimited storage capacities their consumers have been clamoring for...and, ultimately, a true TV Everywhere experience.

Consumers today are already embracing the concept of accessing their video content anywhere in the world. Motorola's own research tracked a five-fold jump in mobile viewing in just one year. Enter the nDVR – the key to that true multi-screen experience. By migrating DVR functionality into the network, providers can deliver the convenience and anytime, anyplace, any screen access to content their consumers crave.

DELIVERING THE IP CONNECTED HOME OF THE FUTURE...TODAY
Motorola invites you into the Living Room of Tomorrow – where the set-top is evolving…and getting smarter and more connected.

And, with the number of connected devices predicted to increase to +24 billion by 2020, Motorola sees a very bright future.

A future in which its DCX3600 Video Gateway – nextgen set-top technology – evolves to become the entertainment hub in the Living Room...morphing into the Center of the IP Connected Home.

And while there is a lot of talk about emerging TV technologies, Motorola's Video Gateway portfolio is uniquely positioned to deliver the connectivity and access to rich content that consumers are craving, across all of their screens.

At The Cable Show, Motorola will be showcasing how its DCX3600 Video Gateway's powerful combination of hardware, software, and cloud technologies maximizes service providers' infrastructure investments to deliver the anytime, anyplace, any screen experiences their consumers crave...today. The DCX3600 will be feeding content from a variety of sources to a variety of devices – including a connected TV and tablet – to demonstrate how subscribers can view, record, or play video on any networked device (TV, tablet, smartphone, gaming console), in any room, seamlessly.

The future of the set-top is just one example of how Motorola is driving the evolution of TV and a smart, simple connected home through innovative hardware and software technologies.

Others include:

SecureMedia® Encryptonite ONE™ HLS+ from Motorola Medios
DreamGallery™ from Motorola Medios – HTML5 & Home Cloud Technology. DreamGallery is to TV what search was to the Web. Discover next-generation TV that's as personalized, dynamic and rich as the Internet. Service providers can offer an on-screen interface that can be customized to each subscriber and updated on-the-fly to include new services, features and applications. DreamGallery will also allow them to deliver the first consistent TV Everywhere experience across multiple screens.
Managed Home Solutions – End-to-End Solutions for Connected Home Services. Motorola's Managed Home Solutions – including the award-winning 4Home platform – provide a full-service suite of platform, network and cloud-based tools for enabling connected home services that help consumers save time, energy, and money via remote monitoring and control of their home.

EMPOWERING THE IP CONNECTED HOME OF THE FUTURE THROUGH SMARTER NETWORK TECHNOLOGY
Motorola also continues to add intelligence to the network to help deliver more bandwidth for more video, data and connections. At The Cable Show 2012, Motorola will be demonstrating how its intelligent network evolution empowers providers to deliver the complete home ecosystem of the future.

Motorola's latest network innovations that will be on display at the show include:

VSN200 Optical Node (NEW) – The VSN200 1 GHz 2X2 Optical Node provides the smart solution to a complex issue facing service providers today: How do you economically provide ultra-broadband services, while optimizing your existing infrastructure, to deliver the future of TV? Operators can repurpose existing housings by efficiently installing the new system using only an Electronics Package (E-Pack) and Lid swap, avoiding the costly downtime of cutting out the entire node to make the upgrade. As a result, they can quickly upgrade their network, minimize installation times, and avoid costly downtimes associated with removing the entire node
10Gig CherryPicker (NEW) – The CherryPicker® Application Platform (CAP) represents leading-edge IP-based solutions for today's high-density digital video applications for Digital Program Insertion, EBIF Ad Decision Management, rate shaping, and stream conditioning. Motorola is addressing the proliferation of 10G networking with a Fall 2012 upgrade to the CAP-1000 standard configuration that includes 10G I/O networking support—-a 10-fold increase in I/O capability. For service providers, this means reduced complexity—as the CAP-1000 can be connected directly to core networking gear—and greater flexibility in traditional DPI and multiplexing applications.
SRM10 (NEW) – Motorola will also showcase the Supervisory Routing Module (SRM) 10G, a new combined control, switch fabric and network interface card for the BSR 64000 DOCSIS platform that increases the platform's IP ingest capacity by a factor of six. Together with the TXPlus card, the SRM10G enables the BSR 64000 to expand downstream bandwidth by 300% making it the highest density CMTS available. This enables service providers to cost effectively support the growing demand for downstream bandwidth and protects their investment BSR 64000's as they migrate to CCAP.
TXPlus – Consumer demand for both OTT and managed IP video is increasing bandwidth requirements by 40-60 percent per year. Motorola continues to steadily increase channel density to keep providers ahead of this explosive growth. It recently set a new standard with the TXPlus software upgrade for Motorola's TX32 decoupled downstream module. As a result, Motorola will have the highest density integrated or modular CMTS with a fully redundant system of 384 DOCSIS 3.0 downstream and 288 upstream channels per CMTS and 768 downstream and 576 upstream channels in a standard rack
APEX3000 –Motorola will also showcase its APEX3000 high-density, CCAP compatible universal edge QAM and its Automated Backup Service, which offers secure incremental offsite data backup with automated alerts and easy management. When fully configured, the APEX3000 uses 80 percent less power or <1W of power per QAM channel versus previous versions.
ST-6000 Series Transcoder – Motorola's new ST-6000 series transcoder supports evolving network needs and headend requirements – while reducing overall costs – by delivering the highest-quality video per channel within a given bandwidth...or increasing the number of video channels in a given bandwidth with no loss of video quality. The ST-6000 offers flexible channel configurations for significant capital and operational savings and a highly simplified deployment model. With options to consolidate up to 12 channels of MPEG-2 or MPEG-4 onto a single 1RU platform, the ST-6000 provides an up to 80 percent reduction in power consumption and up to 90 percent savings in overall headend space requirements compared to single channel transcoding solutions.

IMPROVING WHOLE-HOME ENERGY EFFICIENCY
At The Cable Show 2012, Motorola also will be demonstrating its strategy for reducing energy consumption in several important ways, including:

Developing products that consume less energy
Redefining a whole-home ecosystem, driven by the DCX3600 Video Gateway, in which all connected devices work smarter together
Innovating new technologies that enable easy whole-home monitoring, control, and energy management as seen in our Connected Home Gateway, a 2012 CES Innovations Award winner and a featured innovation at this year's Imagine Park

MORE ABOUT MOTOROLA @ CABLE SHOW 2012 (BOOTH #733)

Motorola's President, Dan Moloney, will be a featured speaker in a plenary session on Monday, May 21, from 2:00–3:00 p.m. in Room 153BC East. The discussion, "Glass Act: Video, Viewers and Television's Changing Picture," will focus on how a proliferation of screens, locations and video viewing experiences is reshaping the very definition of "television" – and creating new opportunities for participants across the ecosystem.
Dan Moloney will also be honored with the Vanguard Award for Associates & Affiliates on Wednesday, May 23. The Vanguard Awards are the industry's most prestigious awards.
Motorola will have 12 additional industry expert speakers @ The Cable Show. Further details can be found at our blog at MediaExperiences2Go.

For more information visit our Cable Show 2012 press kit.

About Motorola Mobility
Motorola Mobility, Inc. (NYSE:MMI) fuses innovative technology with human insights to create experiences that simplify, connect and enrich people's lives. Our portfolio includes converged mobile devices such as smartphones and tablets; wireless accessories; end-to-end video and data delivery; and management solutions, including set-tops and data-access devices. For more information, visit motorola.com/mobility.

Media Contacts
Jeanne Russo
+1 215-323-1880
jeanne.russo@motorola.com

Kalia Farrell
+1 215-323-1059
kalia.farrell@motorola.com

MOTOROLA and the Stylized M Logo are trademarks or registered trademarks of Motorola Trademark Holdings, LLC. All other products or service names are the property of their respective owners. © 2012 Motorola Mobility Inc. All rights reserved.

SOURCE Motorola Mobility, Inc.

ARRIS Introduces New Moxi® Software and Support for Advanced Web Services and Application Development

Thu, 17 May 2012 11:00:00 -0400

May 17, 2012 11:00 ET

ARRIS Introduces New Moxi® Software and Support for Advanced Web Services and Application Development

Moxi Release 2.0 Offers WebKit-based Browser

SUWANEE, Ga., May 17, 2012 /PRNewswire/ -- ARRIS Group, Inc. (NASDAQ: ARRS) announces new software for the ARRIS Whole Home Solution. The Moxi software release 2.0 contains an advanced HTML5 WebKit-based browser as well as support for MSO customizable application storefronts and downloadable applications. The release also features an advanced Web Services application programming interface (API) and software development kit (SDK) to facilitate rapid application development on the platform. These key new offerings exemplify the ARRIS commitment to open architectures and providing broadband network operators a flexible platform to accelerate innovation and feature delivery.

Support for Rapid Web Application Development

The Moxi Web Services API provides a full featured and RESTful command and control-interface enabling authorized partners to implement functions such as:

Media Player remote control
Remote control key press interaction
Playing of linear and recorded content
Mobile device pairing for authorization

The Moxi SDK provides tools to create unique branding options within the Moxi User Interface including name, logo, and application placement within the application store. In combination, the Moxi SDK and Moxi Web Services API provide operators and third party developers a rich development environment to create value added applications driving further customization and service differentiation and ultimately stronger customer retention.

ARRIS Features iPad® App at NCTA 2012

At the upcoming NCTA Cable Show, ARRIS will also showcase a mobile application for the iPad that utilizes the new Moxi SDK and Moxi Web Services API to enable new ways for consumers to interact with the ARRIS Whole Home Solution, including the ability to remotely access and schedule recordings.

"We strive to deliver value to our customers and help them deliver an engaging and desirable consumer experience," said Ron Miller, ARRIS Vice President, Moxi Product Management. "Release 2.0 of Moxi, with its integrated browser, application store and toolsets open the platform to expand that experience and present powerful extensions for the solution."

The capabilities of current Moxi software have found wide acceptance with early users of the ARRIS Whole Home Solution including Wow!, Shaw, Bend Broadband, and Buckeye Cable. Designed to satisfy the most demanding digital cable entertainment enthusiasts, the Whole Home System is a flexible, easy-to-use platform for consumers to experience a full range of digital entertainment services and to effortlessly discover, experience, and share HD and SD media.

The ARRIS IP Video Architecture Solution includes:

The ARRIS Whole Home Solution -- a converged voice, data, and video platform consisting of media and transport gateways, players, operating systems, middleware, and user interfaces, all developed and supported by ARRIS.
The ARRIS Media Gateway and Media Player -- state-of-the-art hardware platforms supporting DOCSIS® 3.0, carrier grade PacketCable™ voice, IPv6, and residential gateway functions, including DTCP-IP and DLNA, for integration with ARRIS Moxi video software and other manufacturers' middleware and user interface systems.
The ARRIS Moxi video software solutions – middleware, user interface, and cloud services solutions for integration into ARRIS or other manufacturers' hardware.

Visit: www.arrisi.com/get/whs/index.asp for more information on the ARRIS Whole Home Solution.

About ARRIS
ARRIS is a global communications technology company specializing in the design, engineering and supply of communications and IP technologies that support broadband services for residential and business customers around the world. The company supplies broadband operators with the tools and platforms they need to deliver and monitor advanced video, data and voice subscriber services, including whole home video across multiple screens, ultra high-speed data, personalized advertising and carrier-grade telephony. Headquartered near Atlanta, in Suwanee, Georgia, USA, ARRIS has R&D centers in Beaverton, OR; Chicago, IL; Cork, Ireland; Kirkland, WA; Redwood City, CA; Shenzhen, China; State College, PA; Tel Aviv, Israel; Wallingford, CT and Waltham, MA, and operates support and sales offices throughout the world. Information about ARRIS products and services can be found at www.arrisi.com.

SOURCE ARRIS Group, Inc.

CSG International Predicts Characteristics of the Future Cable Customer

Thu, 17 May 2012 09:00:00 -0400

CSG International to Showcase Latest Innovations at National Cable Television Association's (NCTA) The Cable Show 2012

Wed, 16 May 2012 17:09:32 -0400

AVAIL-TVN'S NEW DIGITAL AD INSERTION TOOLS ALLOW CONTENT PROVIDERS TO MONETIZE VOD CONTENT

Wed, 16 May 2012 09:00:00 -0400

Media Contacts:
Liora Bram
Media Strategies
617-202-9854
lbram@msipr.com

Cheryl Delgreco
Media Strategies
617-723-4004
cdelgreco@msipr.com

AVAIL-TVN’S NEW DIGITAL AD INSERTION TOOLS ALLOW CONTENT PROVIDERS TO MONETIZE VOD CONTENT

New Service Offering Enables Mid-Roll DAI in Any Environment
Reston, Va., (May 16, 2012) - (Virtual Press Office) – Avail-TVN, the leading digital media services company, today announced its new sophisticated DAI content preparation services that allow content providers to finally realize the promise of advanced advertising and monetize their VOD assets. Building upon its Advanced Advertising Insertion and Marking service (AAIM), launched last year, Avail-TVN now provides mid-roll content marking and stream conditioning services as an enhancement to the encoding and editing workflow, allowing true DAI application at the edge and ensuring seamless playout. Avail-TVN has added Placement Opportunity Authoring and management capabilities, which allow placement opportunity business rules to be made available through a POIS interface, under SCTE-130 standards, or inserted into the content metadata in accordance with CableLabs specifications.

As part of its service development, Avail-TVN offers critical interface support to manage the metadata exchange between content providers and operators. Working closely with key industry partners, the company has successfully integrated Content Information Service (CIS) and Placement Opportunity Information Service (POIS) interfaces into multiple, commercially deployed Ad Decision Systems.

Avail-TVN’s Advanced Advertising Services will be demonstrated next week at The Cable Show, at the Boston Convention Center, Executive Suite 33 (exhibit floor), within multiple DAI ecosystems, including Harris’s SCTE 130-compliant Ad Decision Engine and SeaChange’s Infusion Ad Decision Manager and AdPulse Ad Decision Server.

“Until now, content providers have not been able to fully realize the promise of dynamic ad insertion,” said Laurie Lawrence, chief marketing officer, Avail-TVN. “With the only approach that enables mid-roll ad insertion for their content in any environment, Avail-TVN is delivering the industry’s only working solution for increased revenue opportunities from VOD content. As TV Everywhere applications and increased use of on-demand services continue to change the face of television viewing, the ability to monetize content on any screen, in any environment will be a key component of the digital video ecosystem’s growth strategy.”

With the enhanced AAIM service, Avail-TVN can now capture the live network feed, QC for the Nielsen watermark, encode the program, apply the advertising insertion mark into the stream or metadata, and author the placement opportunity rules for future advertising insertion once the C3 window expires.

According to Rentrak’s State of VOD Trend Report, there were 8.8 billion VOD transactions performed in 2011, indicating a huge opportunity for monetizing VOD assets. The AAIM solution promises simplicity and scalability, simplifying workflows and ensuring that content is delivered and works in any operator environment, with no need for additional work by the content provider. As with VOD and other services that Avail-TVN offers, it leverages its platform, experience and scale to get its customers to market quickly and economically and takes an open technology approach that enables integration into all ecosystems. Now it is applying that model to the advanced advertising sector.

About Avail-TVN
Avail-TVN is the leading provider of digital media services in North America serving both content owners and multichannel video providers. The Company's advanced services deliver a comprehensive, end-to-end solution for monetizing video content, providing high-quality viewing experiences, and improving the performance, reliability and security of its customers’ video programming distribution. For more information, please visit http://www.avail-tvn.com.

###

NBC OLYMPICS TAPS AVAIL-TVN TO SUPPORT COMPREHENSIVE MULTI-PLATFORM OLYMPICS COVERAGE

Wed, 16 May 2012 09:00:00 -0400

Media Contacts:
Liora Bram
Media Strategies
617-723-4004
lbram@msipr.com

Cheryl Delgreco
Media Strategies
617-723-4004
cdelgreco@msipr.com

NBC OLYMPICS TAPS AVAIL-TVN TO SUPPORT COMPREHENSIVE MULTI-PLATFORM OLYMPICS COVERAGE
Sherman Oaks, Calif., (May 16, 2012) – (Virtual Press Office) - Avail-TVN, the leading digital media services company, today announced that it has partnered with NBC Olympics, a division of the NBC Sports Group, to support the delivery of the largest volume of Video On Demand content ever provided to NBC Olympics Distribution Partners by NBC Olympics.

“With marquee content like the Olympics, we will rely on Avail-TVN’s digital media network expertise to publish and syndicate the largest volume of Olympic VOD content we have ever made available around the Olympic Games to our participating Multichannel Video Programming Distribution partners,” said Rick Cordella, VP and GM, NBC Sports Digital.

Avail-TVN will provide a wide array of services, including broadcast signal acquisition and file capture, C3 watermark verification, support various file formats, dynamic asset management, and distribution of the content. In participating systems, subscribers will be able to access Olympic highlights and full-event replays on demand just hours after it occurs live from London. Avail-TVN will also provide authentication services to select Operators to enable access for content available on NBCOlympics.com

“NBC is undertaking the most ambitious Olympics coverage to-date across a variety of STBs, and we’re thrilled to contribute our unique tools and services in support of that,” said Jim Riley, chief revenue officer at Avail-TVN. “We will leverage our multiplatform ADONISS and AnyView™ systems in support of NBC Olympics’ pre-Games content including Athlete Profiles and Event Trials, as well as the best of London 2012 Olympics events - for the hundreds of MPVDs across North America.”

About Avail-TVN
Avail-TVN is the largest independent provider of digital video services in North America. Working with both service providers and content owners, Avail-TVN is focused on providing its global customer base solutions that simplify content management and distribution, and enable the monetization of content. The company applies its managed service approach, powered by proprietary technology, to the areas of video-on-demand, linear content delivery, TV Everywhere, advanced advertising and data services. For more information, please visit http://www.avail-tvn.com.

###

Avail-TVN's New Digital Ad Insertion Tools Allow Content Providers To Monetize VOD Content

Wed, 16 May 2012 09:00:00 -0400

RESTON, Va., May 16, 2012 /PRNewswire/ -- Avail-TVN, the leading digital media services company, today announced its new sophisticated DAI content preparation services that allow content providers to finally realize the promise of advanced advertising and monetize their VOD assets. Building upon its Advanced Advertising Insertion and Marking service (AAIM), launched last year, Avail-TVN now provides mid-roll content marking and stream conditioning services as an enhancement to the encoding and editing workflow, allowing true DAI application at the edge and ensuring seamless playout. Avail-TVN has added Placement Opportunity Authoring and management capabilities, which allow placement opportunity business rules to be made available through a POIS interface, under SCTE-130 standards, or inserted into the content metadata in accordance with CableLabs specifications.

As part of its service development, Avail-TVN offers critical interface support to manage the metadata exchange between content providers and operators. Working closely with key industry partners, the company has successfully integrated Content Information Service (CIS) and Placement Opportunity Information Service (POIS) interfaces into multiple, commercially deployed Ad Decision Systems.

Avail-TVN's Advanced Advertising Services will be demonstrated next week at The Cable Show, at the Boston Convention Center, Executive Suite 33 (exhibit floor), within multiple DAI ecosystems, including Harris's SCTE 130-compliant Ad Decision Engine and SeaChange's Infusion Ad Decision Manager and AdPulse Ad Decision Server.

"Until now, content providers have not been able to fully realize the promise of dynamic ad insertion," said Laurie Lawrence, chief marketing officer, Avail-TVN. "With the only approach that enables mid-roll ad insertion for their content in any environment, Avail-TVN is delivering the industry's only working solution for increased revenue opportunities from VOD content. As TV Everywhere applications and increased use of on-demand services continue to change the face of television viewing, the ability to monetize content on any screen, in any environment will be a key component of the digital video ecosystem's growth strategy."

With the enhanced AAIM service, Avail-TVN can now capture the live network feed, QC for the Nielsen watermark, encode the program, apply the advertising insertion mark into the stream or metadata, and author the placement opportunity rules for future advertising insertion once the C3 window expires.

According to Rentrak's State of VOD Trend Report, there were 8.8 billion VOD transactions performed in 2011, indicating a huge opportunity for monetizing VOD assets. The AAIM solution promises simplicity and scalability, simplifying workflows and ensuring that content is delivered and works in any operator environment, with no need for additional work by the content provider. As with VOD and other services that Avail-TVN offers, it leverages its platform, experience and scale to get its customers to market quickly and economically and takes an open technology approach that enables integration into all ecosystems. Now it is applying that model to the advanced advertising sector.

About Avail-TVN
Avail-TVN is the leading provider of digital media services in North America serving both content owners and multichannel video providers. The Company's advanced services deliver a comprehensive, end-to-end solution for monetizing video content, providing high-quality viewing experiences, and improving the performance, reliability and security of its customers' video programming distribution. For more information, please visit www.avail-tvn.com.

*Media Contacts:*
Liora Bram	Cheryl Delgreco
Media Strategies	Media Strategies
617-202-9854	617-723-4004
lbram@msipr.com	cdelgreco@msipr.com

SOURCE Avail-TVN

NBC Olympics Taps Avail-TVN To Support Comprehensive Multi-platform Olympics Coverage

Wed, 16 May 2012 09:00:00 -0400

May 16, 2012 09:00 ET

NBC Olympics Taps Avail-TVN To Support Comprehensive Multi-platform Olympics Coverage

SHERMAN OAKS, Calif., May 16, 2012 /PRNewswire/ -- Avail-TVN, the leading digital media services company, today announced that it has partnered with NBC Olympics, a division of the NBC Sports Group, to support the delivery of the largest volume of Video On Demand content ever provided to NBC Olympics Distribution Partners by NBC Olympics.

"With marquee content like the Olympics, we will rely on Avail-TVN's digital media network expertise to publish and syndicate the largest volume of Olympic VOD content we have ever made available around the Olympic Games to our participating Multichannel Video Programming Distribution partners," said Rick Cordella, VP and GM, NBC Sports Digital.

Avail-TVN will provide a wide array of services, including broadcast signal acquisition and file capture, C3 watermark verification, support various file formats, dynamic asset management, and distribution of the content. In participating systems, subscribers will be able to access Olympic highlights and full-event replays on demand just hours after it occurs live from London. Avail-TVN will also provide authentication services to select Operators to enable access for content available on NBCOlympics.com.

"NBC is undertaking the most ambitious Olympics coverage to-date across a variety of STBs, and we're thrilled to contribute our unique tools and services in support of that," said Jim Riley, chief revenue officer at Avail-TVN. "We will leverage our multiplatform ADONISS and AnyView™ systems in support of NBC Olympics' pre-Games content including Athlete Profiles and Event Trials, as well as the best of London 2012 Olympics events - for the hundreds of MPVDs across North America."

About Avail-TVN

Avail-TVN is the largest independent provider of digital video services in North America. Working with both service providers and content owners, Avail-TVN is focused on providing its global customer base solutions that simplify content management and distribution, and enable the monetization of content. The company applies its managed service approach, powered by proprietary technology, to the areas of video-on-demand, linear content delivery, TV Everywhere, advanced advertising and data services. For more information, please visit http://www.avail-tvn.com.

SOURCE Avail-TVN

Tribune Media Services and Digitalsmiths Announce a Strategic Alliance to Bring API Platform to the Digital Entertainment Market

Tue, 15 May 2012 09:00:00 -0400

CHICAGO and DURHAM, N.C., May 15, 2012 /PRNewswire/ -- Tribune Media Services (TMS), a leading provider of entertainment metadata, and Digitalsmiths, the leader in video content discovery, today announced that the two companies are releasing a robust new set of data-delivery APIs enabling TMS customers to leverage TMS metadata in exciting new ways. Built on Digitalsmiths' Seamless Discovery™ platform that handles more than one billion API transactions per month, the new APIs will facilitate the development of enhanced content discovery and viewing experiences.

Through this new relationship, TMS' industry-leading metadata for TV shows, movies and celebrities will be made available through an intuitive application-programming interface (API) that significantly reduces the engineering and training requirements for developers. As a result, customers can quickly innovate and test new consumer applications that meet the changing behaviors of today's entertainment fans. The first release of these APIs will be designed to support consumer experiences such as searching for celebrities on TV or discovering new episodes of favorite shows, and will soon to be followed by additional product updates.

"Consumers increasingly expect to discover and enjoy entertainment content on their own terms," said John Kelleher, President and Chief Operating Officer of TMS. "Because our data is a critical fuel for many of the new connected devices, applications and experiences proliferating in the market, that data must also be easily connected and accessible. Digitalsmiths' proven leadership in content discovery allows us to work closely with a trusted provider, accelerate our time-to-market, and deliver a truly superior development toolset for our customers."

"We are very pleased to strengthen our long relationship with TMS," said Ben Weinberger, Chief Executive Officer of Digitalsmiths. "These new solutions provide a seamless combination of rich entertainment metadata and intelligent delivery technologies to drive the accelerated development of enhanced discovery experiences."

Under the expanded relationship, TMS will also have the ability to market Digitalsmiths' Seamless Discoveryplatform. Seamless Discovery is a robust set of content-discovery technologies that includes integrated search, recommendations and a business-rules engine powered by a data framework that includes the world's largest collection of frame-level metadata for Movies and TV.

Service providers, content providers and consumer electronics manufacturers can use Seamless Discovery to develop entertainment applications that allow consumers to instantly discover the most relevant, personalized content anytime, anywhere, on any device. TMS metadata is integrated within Seamless Discovery and available for mutual customers. Seamless Discovery will also be used to enhance personalized user experiences on TMS' consumer-facing website Zap2it.com.

Representatives from Tribune Media Services and Digitalsmiths will jointly attend The Cable Show from May 21 – 23, 2012 in Boston, MA. Conference attendees can schedule meetings in advance to ask questions and learn more about TMS/Digitalsmiths API development plans.

About Digitalsmiths

The technology leader in video search and recommendation for interactive TV, Digitalsmiths offers solutions that greatly improve the accuracy and ease with which end-users find relevant, personalized entertainment across multiple channels and devices, including second screens such as smart phones and tablets. These solutions serve customers that span all media channels and devices and reach a combined audience of millions of consumers. Customers include Warner Bros, Paramount, Technicolor, Turner, the NBA, the PGA, and NASCAR.

About Tribune Media Services

Tribune Media Services Entertainment Products is an international leader in entertainment navigation. The company provides industry-leading TV, movie and celebrity metadata as well as entertainment guides in on-screen, online, mobile and print formats. TMS also produces Zap2it and CastTV, web sites that connect engaged entertainment fans to popular TV shows, movies, celebrities and other fans. For more information about TMS Entertainment Products visit TribuneMediaServices.com.

Media Contacts

Tribune Media Services	Digitalsmiths
Shannon Oborne	Caitlin Hourigan
Executive Director of Marketing	Marketing Manager
518.955.3125	704.806.9702
soborne@tribune.com	chourigan@digitalsmiths.com

SOURCE Tribune Media Services; Digitalsmiths

RMT to Construct Seven Wind Projects in 2012

Fri, 18 May 2012 09:30:00 -0400

MADISON, Wis., May 18, 2012 /PRNewswire/ -- RMT, Inc. (RMT), a renewable energy engineering, procurement and construction (EPC) contractor specializing in the design, engineering, and construction of wind and solar energy generating facilities, is adding 555 MW to its renewable energy practice in 2012.

(Logo: http://photos.prnewswire.com/prnh/20110822/CG55479LOGO)

RMT's 2012 construction portfolio consists of the following seven wind projects:

Auwahi – Sempra U.S. Gas & Power, 24 MW, Maui, Hawaii
Colorado Highlands – Alliance Power, 67 MW, Logan County, Colorado
Kawailoa – First Wind, 69 MW, Oahu, Hawaii
KWP II – First Wind, 21 MW, Maui, Hawaii
Laurel Hill – Duke Energy, 69 MW, Lycoming County, Pennsylvania
Palouse – First Wind, 104 MW, Whitman County, Washington
Post Rock – Wind Capital Group, 201 MW, Lincoln & Ellsworth Counties, Kansas

"Wind energy projects are growing more complex—with tighter budgets and schedules—particularly in 2012 with the pending PTC expiration," said RMT President David Kutcher. "RMT remains focused on safely providing our clients with high-quality, efficient, and cost-effective design, engineering, and construction services. That is our culture and our commitment."

RMT entered the renewable energy market in 1996, designing, engineering, and constructing wind energy facilities. RMT's construction team is backed by in-house engineering and site development support professionals. As one of the only firms to self-perform both engineering and construction services in the renewable energy space, RMT provides an experienced team that works together across all project phases to deliver continuity of project vision and real-time solutions to complex project challenges.

RMT will be attending the AWEA WINDPOWER 2012 Conference & Exhibition June 3-6, 2012, in Atlanta, Georgia.

About RMT
RMT is a leading EPC contractor specializing in the design and construction of wind and solar electric energy generating facilities. RMT's experienced construction crew is backed by in-house engineering and development support professionals. RMT's EPC renewable energy portfolio includes over 5,000 MW. The company is headquartered in Madison, Wisconsin, and is a unit of Alliant Energy Corporation(NYSE: LNT), an energy holding company. We build clean energy. It's all we do. Visit www.rmtinc.com.

For more information, contact:
Stacey Pisani
Senior Communications Specialist
Phone: 608-662-5384
Email: Stacey.pisani@rmtinc.com

SOURCE RMT, Inc.

PSI Repair Services to Showcase Off-Warranty Repair Support at WINDPOWER 2012 Conference & Exhibition

Mon, 14 May 2012 08:30:00 -0400

LIVONIA, Mich., May 14, 2012 /PRNewswire/ -- PSI Repair Services, Inc., a subsidiary of Phillips Service Industries, will showcase its off-warranty repair support for wind energy operations and maintenance (O&M) professionals at the WINDPOWER 2012 Conference & Exhibition.

PSI Repair Services offers fast, affordable repairs, including upgraded/longer-life products, for out-of-warranty electronic, hydraulic and precision mechanical components that drive your turbines' pitch and yaw systems and down tower electronics. Components repaired include printed circuit boards, PLCs, control cards, VRCC components, IGBTs, thyristors, converters, pitch motors, hydraulic pumps, servo motors, transducers and much more. All repairs come with a free evaluation and one-year warranty.

PSI uses the latest diagnostic tools to detect failures down to the microchip level. Solutions range from minor component changes to full replacement printed circuit boards, with enhanced designs to improve performance and reliability. These options allow you to significantly increase mean time between failures (MTBF) and prevent costly downtime and/or repeat repairs.

In addition, PSI provides comprehensive remanufacturing services for unsalvageable, obsolete components. Plus, PSI's stocking programs provide fast turnaround to help reduce inventories.

"PSI Repair Services is a one-stop resource for wind farm O&M professionals," said Mike Fitzpatrick, General Manager of PSI Repair Services. "No other repair service provider in the wind industry can match PSI's breadth and depth of cost-saving services, or has a dynamic Engineering Services Department quite like PSI. The difference is clear to our customers."

The WINDPOWER 2012 Conference & Exhibition takes place June 3-6 at the Georgia World Congress Center in Atlanta, GA. PSI Repair Services will be exhibiting in Booth 1062. For more information about the WINDPOWER Conference & Exhibition, visit http://www.windpowerexpo.com.

For more information about PSI Repair Services, visit http://www.psi-repair.com. You can also follow PSI Repair Services on Twitter at http://www.twitter.com/psi_repair, as well as on Facebook at http://www.facebook.com/psirepair.

About PSI Repair Services, Inc. (http://www.psi-repair.com)

PSI Repair Services, a SDVOSB and subsidiary of Phillips Service Industries, is the world's largest independent component repair company for electronics, hydraulics, robotics and precision mechanical assemblies. Our repairs save customers up to 70% versus the cost of buying new components from the OEM. All repairs come with a free evaluation, performance test and one-year warranty. For optimal peace-of-mind, PSI offers the most comprehensive engineering services in the industry, featuring state-of-the-art diagnostic equipment that provides powerful failure analysis, which can be used to make more informed maintenance decisions. In many cases, PSI's engineering team can enhance the performance of a faulty OEM component with superior, more efficient technology to further extend the component's life. For unsalvageable and obsolete components, PSI offers component remanufacturing services that are second to none. In addition, PSI offers surplus parts and emergency services for customers that need to get their critical systems back up and running again as quickly as possible.

About Phillips Service Industries, Inc. (http://www.psi-online.com)

Phillips Service Industries, Inc. (PSI) oversees a diverse set of technology-based subsidiaries, which serve a wide variety of industries, from automotive, aerospace and defense, to energy, security and semiconductor. Established in 1967, our award-winning products and services help reduce costs and maximize efficiency for many Fortune 500 companies, as well as the U.S. military. PSI pushes the bounds of technology on critical programs like Homeland Security, Defense research and space exploration. Simply put, PSI is one of the most innovative companies in the world. PSI: Always innovating. Everywhere.™

CONTACT: Jay Hollingsworth
Public Relations Manager
Phillips Service Industries (PSI)
11900 Mayfield
Livonia, MI 48150-1733
(734) 853-5000
jay.hollingsworth@psi-corp.com

This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE PSI Repair Services, Inc.